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Self-assembling peptides have emerged as new nanobiomaterials and received considerable attention 
in the areas of nanoscience and biomedical engineering. In this category are ionic-complementary 
peptides, which contain a repeating charge distribution and alternating hydrophobic and hydrophilic 
residues in the amino acid sequence, leading to the unusual combination of amphiphilicity and ionic 
complementarity. Although their self-assembled nanostructures have been successfully applied as 
scaffoldings for tissue engineering, novel materials for regenerative medicine and nanocarriers for 
drug and gene/siRNA delivery, aspects of the assembly process remain unclear. Since many of these 
applications involve peptide-modified interfaces and surfaces, a better understanding and control of 
the peptide assembly on a surface are very crucial for future development of peptide-based 
applications in nano-biotechnology. 
This thesis contains two major parts: (i) fundamental study of the assembly of a model ionic-
complementary peptide EAK16-II on surfaces and (ii) potential applications of such a peptide in 
surface modification and nanofabrication. 
In the fundamental study, EAK16-II assembly on negatively charged mica was first 
investigated via in-situ Atomic Force Microscopy (AFM). It was found that EAK16-II nanofiber 
growth on mica is surface-assisted and follows a nucleation and growth mechanism involving two 
steps: (i) adsorption of nanofibers and fiber clusters (from the bulk solution) on the surface to serve as 
the seeds and (ii) fiber elongation from the active ends of the seeds. Such a process can be controlled 
by adjusting the solution pH since it modulates the adsorption of the seeds and the growth rates. 
Unlike what is observed on mica, EAK16-II formed well-ordered nanofiber patterns with preferential 
orientations at angles of 60° or 120° to each other on hydrophobic highly ordered pyrolytic graphite 
(HOPG) surfaces, resembling the crystallographic structure of the graphite. Nanofiber formation on 
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HOPG is also surface-assisted and adopts a nucleation and growth mechanism that can be affected by 
solution pH. The pH-dependent adsorption of peptides to HOPG is attributed to the resulting changes 
in peptide hydrophobicity. 
It was also found that EAK16-II assembly can be induced by the mechanical force of a tapping 
AFM tip. It occurs when the tip cuts the adsorbed EAK16-II nanofibers into segments that then serve 
as seeds for new nanofiber growth. This finding allows one to locally grow nanofibers at specific 
regions of the surface. The tip cutting has been combined with the effect that solution pH has on 
peptide assembly to develop a new AFM lithography method to fabricate local patterned peptide 
nanostructures on HOPG. 
To study the use of EAK16-II for surface modification applications, the wettability and 
stability of the peptide-modified surfaces were characterized. EAK16-II-modified mica becomes 
slightly hydrophobic as the water contact angle increases from <10° to 20.3 ± 2.9°. However, the 
hydrophobicity of the HOPG surface is significantly reduced, as reflected in a contact angle change 
from 71.2 ± 11.1° to 39.4 ± 4.3°. The EAK16-II-modified mica surface is stable in acidic solution, 
while the modified HOPG surface is stable in both acidic and alkaline solutions. The peptide-
modified HOPG shows potential as a biocompatible electrode for (bio)molecular sensing. 
The ability of EAK16-II to form nanofibers on surfaces has also promoted research on peptide-
based metallic nanowire fabrication. Our approach is to provide EAK16-II with metal ion binding 
ability by adding a GGH motif to the C-terminus. This new peptide EAK16(II)GGH has been found 
to form one-dimensional nanofibers while binding to Cu2+ ions. The dimensions of the nanofibers 
were significantly affected by the nature of the anions (SO42-, Cl- and NO3-) in the copper salt 
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A historic address entitled “There is plenty of room at the bottom”, given by physicist Richard 
Feynman in 1959, predicted the potential of atomic/molecular engineering. Two decades later, 
numerous research activities in nanotechnology had been initiated. Nowadays, nanotechnology is 
entering into all aspects of science and technology including, but not limited to, biology, 
bioengineering, materials, medicine, electronics, agriculture, aerospace, military science and 
technology. It is mainly based on “bottom-up” atomic/molecular manufacturing for building 
chemically and physically stable nanostructures or supramolecules. The key component of this 
“bottom-up” approach is molecular self-assembly. This remarkable engineering route is habitually 
adopted in nature, permitting the formation of supramolecules such as DNA, ribosomes, collagen and 
biological membranes.1 In engineering, self-assembly has emerged as a novel approach to design and 
fabricate supramolecules with novel functionalities from single and simple molecules. One major 
achievement has been the evolution of microelectronics toward molecular-scale electronic devices 
and machines through the development of nanowires, nanoarrays and molecular chips.2-5 This has 
allowed modern-day electronic devices to be scaled down considerably and achieve higher 
operational efficiency. 
Molecular self-assembly is, by definition, the spontaneous organization of molecules under 
near thermodynamic equilibrium conditions into structurally well-defined and stable arrangements 
through noncovalent interactions.1,6 Such interactions typically include hydrogen bonding, 
electrostatic attraction, hydrophobic force and van der Waals interactions.7 Frequently, molecular 
self-assembly relies on chemical complementarity and structural compatibility.1,8 These features are 
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critical to the design of molecular building blocks for the fabrication of artificial functional 
macrostructures that are commercially required to produce micro/nano-electronics. 
In both nature and engineering, the control of the self-assembly process is crucial. The failure 
to exert control over protein assembly is most exemplified by the in vivo formation of protein 
insoluble aggregates which are associated with numerous conformational diseases such as 
Alzheimer’s and prion diseases.9-12 On the other hand, proper control over DNA self-assembly allows 
the formation of assemblies with various shapes (such as X, Y and T-shapes),13,14 two-dimensional 
lattices,15 triangular and hexagonal patterns.16,17 Such molecular-level control benefits the 
development of DNA-based bionanomachines, devices and sensors. For example, DNA “tweezers”, 
“nanoactuators” and “scissors” have been constructed with rigid and flexible fragments in the 
assemblies through control of the degree of hybridization.18,19  In addition, the two- and three-
dimensional nanoarchitectures of DNA have been used to organize other functional components such 
as inorganic nanoparticles, carbon nanotubes and biomolecules (proteins and nucleic acids) into 
patterns.20 The integration of functional entities to DNA supramolecules can be applied to build 
hybrid (bio)sensing devices.  
Among the many self-assembly systems (DNA, protein/peptide, lipid and surfactant), peptides 
have drawn much attention in nanoscience and nanotechnology due to their desirable 
chemical/physical properties and biological functionalities. First, peptides can be easily engineered to 
form a variety of stable nanostructures such as fibers,21,22 rod,23 tubes,24 nanovesicles,25 globules26,27 
and so on. Second, the peptide sequence can be designed to incorporate natural binding motifs with 
affinity to inorganic materials,22,28,29 oligonucleotides (e.g. anti-senses),30,31 si-RNA and hydrophobic 
anti-cancer drugs.32 Third, they possess the natural propensities for cell penetration and targeting.33,34 
With such features, self-assembling peptides have a wide range of potential applications in nano-
biotechnology such as templates for nano-fabrication,35 scaffolds for tissue engineering,36,37 and 
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protection coatings for nano-medicines.32 Since peptides are fragments of proteins, they can serve as 
simple models to study the process of protein aggregation. A better understanding of protein 
aggregation could be crucial to understanding the onset of conformational diseases such as 
Alzheimer’s and prion diseases and discovering inhibitors and treatments for their prevention or 
alleviation. 
Most of these applications involve an interface between peptides and other entities. Therefore, 
it is necessary to understand and control peptide assembly on a surface. For example, cell membranes 
have been found to facilitate fibrillization of β-amyloid peptides upon their binding to the membrane 
surface.38,39 In addition, the fibrillization of α-synuclein, a protein associated with Parkinson’s 
disease, has been found to depend on the nature of the micelle surface in incubation solutions.40 A 
better understanding of peptide behaviour on a cell membrane surface will help develop inhibitors for 
conformational diseases. Furthermore, surface-directed assembly has been explored to construct a 
variety of nanosystems. For example, self-assembly on a hydrophobic graphite surface can lead to 
peptides being organized into patterned structures.41-43 These nanostructures can be used to construct 
nanoscopic devices such as (bio)sensors, information storage units, optical computers and solar 
cells.44-47 Dipeptide FF has been applied to modify electronic conductive materials such as gold and 
graphite to accelerate the electrochemical reaction of enzymes for amperometric biosensor 
applications.48,49 Optimization of the performance of these peptide-based devices requires a better 
understanding and manipulation of peptide assembly on surfaces. 
In this research, the ionic-complementary peptide EAK16-II is used as a model peptide to 
investigate the effect of surfaces on its assembly and potential applications. This peptide is a good 
choice for several reasons. First, it has a simple sequence and unique structure for the study of peptide 
assembly. It contains 16 amino acids in sequence, but is made of only three different amino acids: 
glutamic acid (E), lysine (K) and alanine (A). These three amino acids are arranged in a special 
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manner with hydrophobic (●, A) and hydrophilic residues (○, K or E) alternating in the sequence 
(●○●○●○●○●○●○●○●○) that renders the peptide amphiphilic. EAK16-II also contains a unique 
charge distribution with two negative and two positive charges alternating in the sequence (- - + + - - 
+ +), giving it ionic complementarity. Second, this peptide has been found to form a β-sheet-rich 
secondary structure in aqueous solutions.50 In a β-sheet arrangement, all the hydrophilic residues of 
the peptide are arranged on one side and hydrophobic resides on the other side. This unusual 
amphiphilic property allows the peptide to interact with both hydrophilic and hydrophobic surfaces. 
Third, the unique molecular structure of EAK16-II enables various interactions (hydrogen bonding, 
electrostatic and hydrophobic interactions) for peptide assembly to be possible; these interactions also 
occur in protein folding/aggregation and other biomolecular assembly systems. Therefore, the study 
of such a molecule assembly will help in the understanding of other more complicated systems. 
Fourth, fundamental aspects and applications of this peptide have been explored by our group for 
several years. Previous studies have shown that many factors such as peptide sequence26,27 and 
concentration,21,51 salt type and concentration,22,51,52 and solution pH26 affect the self-assembled 
micro-/nanostructures of the peptide and their derivatives. In addition, these peptides can be utilized 
as nanocarriers for anticancer drug and gene delivery. The combination of the simple structure, 
unique properties and our previous knowledge of EAK16-II provides a good basis to further 
investigate the surface effect on peptide assembly and to more fully control this process. 
This research project consists of two major parts: i) fundamental studies of EAK16-II assembly 
on surfaces, and ii) potential applications of such a peptide in surface engineering and 
nanofabrication. EAK16-II assembly on two different surfaces (hydrophilic mica and hydrophobic 
highly ordered pyrolytic graphite, HOPG) was systematically investigated to study the surface effect 
on biomolecular assembly and the underlying mechanisms. This further allowed us to develop 
methods to possibly control peptide assembly on surfaces. Strategies to fabricate patterned peptide 
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nanostructures at desired locations were then developed and applied. Potential applications of such a 
system include a model of protein aggregation at interfaces implicated in conformational diseases, 
formation of different patterns of peptide nanofibers on the surface and modification of surfaces to 
obtain desired properties such as wettability, biocompatibility and enzyme immobilization for 
(bio)molecular sensing. In addition, since EAK16-II can form nanofibers on surfaces, these 
nanofibers may serve as templates to fabricate one-dimensional metallic nanowires. For such a 
purpose, a metal ion binding motif was introduced into the peptide sequence. The self-assembled 
nanostructure and metal ion binding ability of this newly designed peptide has been characterized in 
detail.  
1.2 Research Objectives 
The overall objectives of this thesis are to: 
1. investigate the assembly of peptide on particular surfaces using a model ionic-
complementary peptide EAK16-II. 
2. study and propose mechanisms for peptide assembly on surfaces and, if possible, relate them 
to amyloid fibrillogenesis to help understand conformational diseases. 
3. understand and develop approaches to manipulate peptide assembly and pattern peptide 
nanostructures on surfaces. 
4. develop new applications of self-assembling peptides in surface modification and (bio) 
molecular sensing as well as in nanowire fabrication.  
1.3 Outline of the Thesis 
This thesis consists of seven chapters. The scope of each chapter is listed as follows: 
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Chapter 1 gives an introduction to the thesis, including an overview of self-assembling 
peptides, their applications and the significance of the study and control of peptide assembly on 
surfaces. The hypothesis, objectives and the scope of the thesis are also given in this chapter. 
Chapter 2 reviews the previous progress on understanding peptide self-assembly and its 
potential applications in nano-biotechnology. The roles that surfaces play in nanotechnology and 
biological systems are also reviewed. 
Chapter 3 presents the effect of a mica surface on the assembly of EAK16-II. EAK16-II 
nanofiber growth on mica surface is directly monitored by in-situ AFM. Of particular interest is the 
effect of solution pH on peptide assembly on the surface. 
Chapter 4 describes the effect of surface properties, such as hydrophobicity, on peptide 
assembly using two model surfaces (hydrophilic mica and hydrophobic HOPG) and their potential 
application in surface modification and (bio)molecular sensing. 
Chapter 5 investigates the use of a mechanical force to induce peptide assembly at liquid-solid 
interfaces. A new AFM lithography technique that combines the effects of AFM probe tapping and 
solution chemistry is developed to fabricate patterned EAK16-II nanostructures on surfaces. 
Chapter 6 describes the design, characterization and a potential application of a functional self-
assembling peptide molecule with metal ion binding capability for nanowire fabrication. The effects 
of the type of anion present in solution on the self-assembly of the peptide and the binding of the 
metal ion to the peptide self-assembly are also investigated. 
Chapter 7 presents the conclusions of this study, contributions of this research and 




Chapter 2                                                                     
Literature Review 
2.1 Self-Assembling Peptides 
The last decade has witnessed an explosion in the use and design of short peptide sequences capable 
of forming nano/microstructures for various applications in nanoscience, surface engineering and 
biotechnology.8,53-56 These self-assembling peptides are either fragments of naturally existing proteins 
or derived by de novo biomolecular design. They share a common capability of self-association in 
aqueous solutions. Short fragments of natural proteins, such as amyloid peptides and prion peptides, 
have been found to self-assemble into fibril structures in various environments.57-59 Different from 
naturally existing protein fragments, synthetic peptides can be easily engineered to self-associate by 
taking advantage of the intrinsic property of amino acids. For example, designed amphiphilic peptides 
(i.e. containing hydrophobic and hydrophilic regions in the sequence) can spontaneously associate to 
form nano/microstructures. Such synthetic peptides have been used to build functional 
supramolecules.22,60-62 Several classes of synthetic self-assembling peptides are reviewed in the 
following paragraphs. 
Peptide-amphiphiles (PAs) are an attractive class of bioactive molecules consisting of a 
hydrophilic, bioactive peptide sequence covalently linked to a hydrophobic moiety such as an alkyl 
chain.63 For example, Hartgerink et al. synthesized a PA with five different functional regions shown 
in Figure 2.1.64 Region 1 is a 16-carbon alkyl tail that imparts hydrophobic character to the molecule, 
resembling the hydrophobic tails in traditional surfactants. Region 2 is a string of four cysteines to 
stabilize the assembled structures through the formation of disulfide bonds between individual PAs. 
Region 3 is composed of three glycine residues providing a flexible linkage. Region 4 is a single 
phosphorylated serine to interact with calcium ions for the purpose of biomineralization. Finally, 
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region 5 is a cell adhesion group−RGD. The cysteine, phosphorylated serine and RGD group give the 
PA its special bioactive characteristics. The assembly of this PA can be triggered by pH. At pH 4, it 
can form nanofiber networks with the fiber dimension of ~7 nm in diameter and several microns in 
length. These nanofibers can direct the growth of hydroxyapatite crystals, mimicking the function of 
collagen fibers in bone tissue. 
 
Figure 2.1 (a) Chemical structure of the peptide amphiphile, highlighting five key structural features. 






Extensive studies have been carried out to understand the self-assembly of PAs; the ultimate 
goal is to control their assembly for a number of biomedical applications. First, modification of the 
amino acids in the peptide region and the alkyl tails has shown no significant effect on the formation 
of one-dimensional PA nanofibers. The assembly can be induced by three different methods: drying 
on surfaces, addition of divalent ions such as calcium and increase of PA concentrations.7 Recently, 
Niece et al. reported that two oppositely charged PA molecules can form nanofibers via electrostatic 
attraction,65  which indicates the importance of this type of interaction. Furthermore, the chemical and 
mechanical properties of PA nanofibers can be modulated through the addition of phospholipids into 
the assemblies.63 The self-assembled nanostructures of PAs have shown promising usage in artificial 







Figure 2.2 Chemical structure of a peptide bolaamphiphile, bis(N-α-amido-glycylglycine)-1,7-





Bolaamphiphiles are the derivatives of amphiphilic peptides that contain two hydrophilic ends 
linked by a hydrophobic alkylene chain with variable length. The two hydrophilic ends are made of 
the same number of amino acids in a symmetric fashion. Figure 2.2a shows an example of the 
chemical structure of a bolaamphiphile with two glycine amino acid residues on each end. It has been 
found that bolaamphiphiles can form microtubes and helical ribbons depending on the chain length of 
the hydrophobic portion, terminal amino acid and solution pH.68,69 An interesting property of these 
self-assembled bolaamphiphile nanotubes is that they contain free amide and carboxylic groups which 
can intercalate with other functional peptides or capture metal ions such as Pt, Pd, Cu, and Ni.67 
Matsui and his group showed that bolaamphiphile nanotubes can serve as templates for Au, Ni, Pt and 
Cu metallic nanowire fabrication.70-73 (Figure 2.2b) The ability of peptides to interact with metals or 
even semiconductors enables ‘bottom-up’ fabrication of bioelectronic and photonic devices and 
nanoscale chemical sensors.74 
Cyclic peptides consist of six or eight amino acids with alternating D- and L- enantiomers. By 
means of elegant structural design, they can stack into nanotubes.75-78 Ghadiri and colleagues have 
shown that cyclic hexa- and octa-D,L-α-peptides can stack in an anti-parallel fashion to form uniform 
nanotubes.76-79 (Figure 2.3) The stacking of the peptides is pH-dependent according to their amino 
acid sequences. The researchers were able to control the stacking by selective protonation of the 
amino acid residues on each cyclic peptide disk at different pH values.79 This peptide system has 
several important applications in nanobiotechnology. First, assembled nanotubes could be used as an 
antibacterial agent since they act preferentially on bacterial membranes to increase membrane 
permeability and collapse transmembrane ion potentials. In combination, these actions lead to cell 
death.78 Second, the physical properties of the nanotube interiors can be modified by introducing 
heterocyclic alterations allowing for the passive transportation of small molecules.80 Amorin et al. 
also reported a newly designed cyclic peptide which adopts a flat, ring-shaped conformation.81  These 
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peptides stack into nanotubes through an anti-parallel β-sheet through hydrogen bonding, creating a 
partially hydrophobic cavity and, thereby, facilitating passive diffusion of hydrophobic molecules. 
 
 
Figure 2.3 Self-assembly of eight-residue cyclic D,L-α-peptides into nanotubes. The self-assembly of 
the eight residue cyclic D,L-α-peptides with a flat and ring-shaped conformation is directed by 
backbone-backbone hydrogen bonding to give β-sheet-like tubular supramolecular structures. These 
nanotubes are open-ended and hollow.78 
 
Surfactant-like peptides are also of interest to materials scientists in nanobiotechnology. They 
are basically a molecular mimicry of membrane phospholipids and detergents. Using the varied 
nature of different amino acids, these peptides are constructed with a hydrophilic head (hydrophilic 
amino acid residue) and a hydrophobic tail (hydrophobic amino acid residue) and can self-assemble 
into well-defined nanostructures.82 With the appropriate molecular design, nanotubes and 
nanovesicles can be formed (Figure 2.4).54,56,62,83 Vauthey et al. synthesized a peptide monomer with 
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7 to 8 residues, containing a hydrophilic head of aspartic acid and a hydrophobic tail of alanine, 
valine or leucine.62  These peptide monomers self-assemble into nanotubes and nanovesicles with an 
average diameter of 30-50 nm at a pH level of 7 in aqueous solution. They later reported similar 
results with modified surfactant-like peptides. In this instance, either the hydrophobic tail was 
replaced with variable lengths of glycine residues25 or the hydrophilic head was replaced with 
positively charged lysine or histidine.84 This newly designed peptide system has the potential for use 
in drug and gene delivery, the study of prebiotic molecular evolution and tissue engineering.54 
 
Figure 2.4 The TEM images of nanotubes (a) and nanovesicles (b) from a surfactant-like peptide – 
V6D;56 molecular modeling of cut-away structures of nanotubes (c) and nanovesicles (d) formed from 
surfactant-like peptides.25 
 
Along with the development of peptide amphiphiles and surfactant-like peptides, ionic-
complementary peptides have emerged as promising materials for many biomedical applications. A 







binding protein zoutin in yeast in 1993 by Zhang et al.85,86 These peptides have a systematic 
arrangement of amino acids in sequence made of alternating hydrophobic and hydrophilic residues, 
leading to an unusual amphiphilic property. In addition, they contain a repetitive charge distribution 
in the amino acid sequence, resulting in a unique property of ionic complementarity. These peptides 
can form an unusually stable β-sheet-rich secondary structure and self-assemble into nanofibers and 
membranes.86 With relatively good biocompatibility and biodegradability, this class of peptides is a 
promising group of materials for nanobiotechnology; in particular, they have been used as scaffolds 
for tissue engineering and 3-D cell cultures, nanocarriers for therapeutic agents and novel materials 
for regenerative medicine.55,56,87 As a result, ionic-complementary peptides have attracted a great deal 
of interest in nanomaterial science. Detailed information of their physical and biochemical properties, 
self-assembly process and factors influencing the assembly will be reviewed in the following section. 
2.2 Ionic-Complementary Peptides 
2.2.1 Molecular Structure 
Ionic-complementary peptides are characterized by an alternating arrangement of negatively and 
positively charged residues. In order to have ionic complementarity, the distribution of the charges 
should follow certain patterns. The most simple and widely studied types of charge distribution are 
type I ( +− ), type II ( ++−− ) and type IV ( ++++−−−− ). Such ordered charge distribution 
results in unique electrostatic interactions which promote molecular self-assembly apart from the 
















P11-I n- QQRQQQQQEQQ -c −+  I α/β 
P11-II n- QQRFQWQFEQQ -c −+  I α/β 
P6-1 n- KTVIIE -c −+  I β/r.c. 
P6-6 n- KTVLIE -c −+  I β/r.c. 
P6-7 n- KTVIVE -c −+  I β/r.c. 
P6-8 n- KTVIYE -c −+  I r.c. 
Aβ16-22 n- KLVFFAE -c −+  I α/β/r.c. 
KADA8-I n- KADAKADA -c −+−+  I r.c. 
KFE8-IT n- KFEFKFEF -c −+−+  I β 
KFE8-I n- FKFEFKFE -c −+−+  I β 
RADA8-I n- RADARADA -c −+−+  I r.c. 
RAEA8-I n- RAEARAEA -c −+−+  I r.c. 
EFK8-I n- FEFKFEFK -c +−+−  I β 
EAKA8-I n- AEAKAEAK -c +−+−  I r.c. 
KFE12-I n- FKFEFKFEFKFE -c −+−+−+  I β 
KIE12-I n- IKIEIKIEIKIE -c −+−+−+  I β 
KVE12-I n- VKVEVKVEVKVE -c −+−+−+  I β 
KLD12-I n- KLDLKLDLKLDL -c −+−+−+  I β 
KLE12-I n- KLELKLELKLEL -c −+−+−+  I β 
EFK12-I n- FEFKFEFKFEFK -c +−+−+−  I β 
RADA16-I n- RADARADARADARADA -c −+−+−+−+  I β 
RGDA16-I n- RADARGDARADARGDA -c −+−+−+−+  I r.c. 
RAEA16-I n- RAEARAEARAEARAEA -c −+−+−+−+  I β 
KADA16-I n- KADAKADAKADAKADA -c −+−+−+−+  I β 
KFE16-I n- FKFEFKFEFKFEFKFE -c −+−+−+−+  I β 
 
 15
EAKA16-I n- AEAKAEAKAEAKAEAK -c +−+−+−+−  I β 
RAD8-II n- RARADADA -c −−++  II r.c. 
EAH8-II n- AEAEAHAH -c ++−−  II r.c. 
ELK8-II n- LELELKLK -c ++−−  II β. 
EAK8-II n- AEAEAKAK -c ++−−  II r.c. 
EAK12-a n- AKAKAEAEAKAK –c ++−−++  II r.c. 
RAD16-II n- RARADADARARADADA -c −−++−−++  II β 
EAH16-II n- AEAEAHAHAEAEAHAH -c ++−−++−−  II β 
EFK16-II n- FEFEFKFKFEFEFKFK -c ++−−++−−  II β 
ELK16-II n- LELELKLKLELELKLK -c ++−−++−−  II β 
EAK16-II n- AEAEAKAKAEAEAKAK -c ++−−++−−  II β 
KAE16-IV n- KAKAKAKAEAEAEAEA-c −−−−++++  IV β 
RAD16-IV n- RARARARADADADADA -c −−−−++++  IV β 
EAK16-IV n- AEAEAEAEAKAKAKAK -c ++++−−−−  IV β 
DAR16-IV n- ADADADADARARARAR -c ++++−−−−  IV α/β 
DAR16-IVT n- DADADADARARARARA -c ++++−−−−  IV α/β 
DAR32-IV n- (ADADADADARARARAR)2 -c ++++−−−−  IV α/β 
EAK12-b n- AKASAEAEAKAK -c ++−−+  N/A r.c. 
EAK12-c n- AKAEAEAEAKAK -c ++−−−+  N/A r.c. 
EAK12-d n- AEAEAEAEAKAK -c ++−−−−  IV/II α/β 
Note: β: β-sheet; α: α-helix; r.c.: random coil; N/A not applicable. 
 
Table 2.1 lists a number of ionic-complementary peptides that have been studied. These 
peptides are either fragments of naturally existing proteins or rationally designed to mimic natural 
proteins and help study protein folding. Aggeli et al designed a series of ionic-complementary 
peptides with 11 amino acids in sequence and a type I charge distribution −+  (P11-I and P11-II in 
Table 2.1).60 These peptides contain glutamine (Gln) residues with side chains that presumably 
interact strongly in water via hydrophobic interaction and complementary hydrogen bonding. 
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Arginine (Arg) and glutamic acid (Glu) residues have been located in positions 3 and 9 to allow 
molecular recognition between adjacent anti-parallel β-strands in fibril aggregates. These favourable 
intermolecular side-chain interactions and the intermolecular hydrogen bonding between the peptide 
backbones promote the formation of  β-sheets. As expected, these peptides were found to form anti-
parallel β-sheet rich fibrils as revealed by FTIR and electron microscopy studies.60 Another class of 
ionic-complementary peptides with a type I charge distribution has been designed with only 6 amino 
acids in their sequences (P6-1, P6-6, P6-7 and P6-8, Table 2.1).90  Among these hexapeptides, P6-1, P6-
6 and P6-7   have been found by CD spectroscopy to form predominantly β-sheet structures. However, 
only P6-1 was found to form amyloid fibrils. The substitution of the Ile residues (e.g. Ile-4 → Leu 
from P6-1 to P6-6; Ile-5 → Val from P6-1 to P6-7) completely prevents fibril growth from preformed 
β-sheets. These results highlight the importance of the specific side-chain interactions.  
The majority of the review hereafter focuses on a new class of ionic-complementary peptides 
designed by Zhang et al. (Table 2.1).8,50,55,86 The first ionic-complementary peptide of its kind is 
EAK16-II, a 16-amino-acid peptide segment originating from a Z-DNA binding protein.85,86 
Derivatives such as EAK16-I and EAK16-IV have different charge distributions. Their molecular 
structures are shown in Figure 2.5. The repetitive arrangement of hydrophilic and hydrophobic amino 
acids imparts an amphiphilic property to the peptide. Zhang et al.86 have demonstrated that this 
peptide can self-assemble into β-sheet-rich fibril structures. The supramolecular structure formation 
of such peptides may be due to the combination of electrostatic and hydrophobic interactions from the 
ionic-complementary residues and hydrophobic side, respectively. The molecular structure of 
EAK16-II forms a basis to construct other similar self-assembling ionic-complementary peptides with 
different functionalities. For example, RADA16-I was designed to enhance the biocompatibility and 
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Figure 2.5 (a) Chemical structure of the ionic-complementary peptide EAK16-II. It contains 
alternating hydrophobic (alanine, A) and hydrophilic (glutamic acid, E and lysine, K) residues,
producing amphiphilic structure that is hydrophobic on one side and hydrophilic on the other. The 
charged residues are arranged as type II, ++−−++−− , where pairs of negatively (E) and 
positively (K) charged residues alternate. (b) Three-dimensional molecular model of EAK16s. The 
top, middle and bottom schemes represent the EAK16-I, EAK16II and EAK16-IV structures with 




Ionic-complementary peptides have several important features. First, their charge distribution 
can be altered through simple molecular design, resulting in several peptide types, such as I, II and 
IV, as noted previously. For example, the sequence design based on the same components (E, A, and 
K) can generate three peptide sequences of EAK16-I, EAK16-II and EAK16-IV. The design of the 
charge distribution may determine the peptide secondary structure and influence peptide self-
assembly. 
A second feature, particular to the ionic-complementary peptides first studied by Zhang et al, is 
the specific peptide chain lengths required to exhibit ionic complementarity. The length of these 
peptides varies from eight to thirty-two amino acids in sequence due to the alternating hydrophobic 
and hydrophilic residues in the peptide sequence. (Table 2.1) The minimum number of amino acids 
required to build type I peptides is four, while the creation of type II and type IV peptides require 
eight and sixteen amino acids, respectively. The sequence of these short peptides can also be utilized 
for the design of polypeptides such as poly-EAK.92 
A third feature is that the ionic-complementary peptide family can be easily expanded with the 
same charge distribution by using different amino acids. For example, DAR can be derived from 
EAK by replacing the residues glutamic acid (E) and lysine (K) with aspartic acid (D) and arginine 
(R), respectively. Similarly, the replacement of the hydrophobic residue alanine (A) of EAK with 
phenylalanine (F) or leucine (L) will generate two other ionic-complementary peptides EFK and 
ELK, respectively. Such simple replacement maintains the intrinsic properties of ionic-
complementarity and self-assembly. This can also strengthen their propensity to form the desired 
supramolecules (e.g., the introduction of more hydrophobic residues). The increase in the 
hydrophobicity of the hydrophobic residues also reduces the shortest peptide length that can form a β-
sheet secondary structure. For example, EAK requires a minimum of sixteen amino acids to form a 
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predominant β-sheet secondary structure, whereas EFK requires a minimum of only eight amino 
acids. 
2.2.2 Physical/Biochemical Properties 
Unusually stable β-sheet formation 
An important characteristic of ionic-complementary peptides is the formation of unusually stable β-
sheets in aqueous solution.50,55,93 Once the β-sheets are formed, they remain unchanged under a broad 
range of physicochemical conditions (extreme pH, high temperature and dilution) and are even 
impervious to denaturing agents.50 The β-sheet character can be clearly seen from the maximum 
absorbance in the CD spectra of EAK16-II at 218 nm and minimum absorbance at 195 nm, 
respectively, even at the very low peptide concentration of 0.612 µM.50 In addition, the CD spectra of 
EAK16-II show that β-sheets remain stable up to 90 °C. Compared to most proteins that are 
denatured above 65 °C, β-sheets formed by EAK16-II are much more stable at higher temperature. 
Also, only a small change in the CD spectra at 218 nm was observed when the peptide solution pH 
was varied from 1.5 to 11, indicating that the β-sheets remain stable over this range. Unlike normal 
proteins that denature when the concentration of denaturation agents (e.g., guanidine-HCl and urea) is 
above 4 M, β-sheet structures of EAK16-II remained stable even in 7 M guanidine-HCl and 8 M urea. 
Such high stability was also found in 0.1% sodium dodecylsulphate (SDS) solution. 
The analysis of the molecular structures and interactions in ionic-complementary peptides may 
explain the formation of such unusually stable β-sheet structures. The β-sheet formation is mainly 
caused by the hydrogen bonding between individual peptide backbones, which is evidently found in 
protein folding and aggregation. In addition, charged residues can also interact to stabilize the β-
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sheets by means of electrostatic interactions and hydrogen bonding. Similarly, the hydrophobic 
interactions from the nonpolar residues also play a role in stabilizing the structure.  
α-β structural transition 
While some ionic-complementary peptides have very stable β-sheet structures, others can undergo 
structural transitions between α-helices and β-sheets. This conformational change is caused primarily 
by environmental factors, including solvent type, pH, salt and peptide concentration. For example, pH 
and the presence of salts can trigger or inhibit the α-β structural transitions of peptides such as 
EAK12-d and DAR16-IV.86,94,95 Peptide sequence also affects this process, as indicated by the 
observation that α-β transitions occur with DAR16-IV but not RADI6-IV and EAK16-IV.94 Other 
ionic-complementary peptides can undergo structural transition, as indicated in Table 2.1. 
Considerable effort has been made to design peptides for such a purpose. Not only could such a 
peptide be used to model the self-assembly of the peptides in conformational diseases, but it could 
also be useful in the development of nanomaterials that respond to changes in the environment. Such 
peptides could serve as a molecular switches for nanoscale devices and (bio)molecular sensors. 
Stable and biocompatible supramolecular structure 
Although small, ionic-complementary peptides can readily self-assemble into nano/microstructures, 
and interestingly some of the formed structures seem to be stable under various physiological 
conditions.50,86 Several of these self-assembled structures have been shown to resist degradation by 
acidic or alkaline environments ranging from pH 1.5-11,86 sodium dodecyl sulfate (SDS)/urea and a 
number of proteolytic enzymes including trypsin, protease K and pronase.50,86 In addition, ionic-
complementary peptides have been shown to be biocompatible when injected into rabbits, rats and 
goats.86,96 The unusual stability of the peptides in serum, combined with their high resistance to 
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proteolytic digestion, simple composition and apparent lack of cytotoxicity,36,50,86,96,97 make them 
attractive for many biomedical applications.  
2.2.3 Understanding and Controlling Supramolecular Structure Formation 
Ionic-complementary peptides are promising molecules for material fabrication because they can 
form stable nano/microstructures.8,55,56 In order to regulate its nano/microstructure formation, the 
understanding and precise control of peptide self-assembly is always a big challenge for material 
scientists. For such a purpose, studies have focused on the internal and external factors that influence 
peptide self-assembly. These factors include (a) amino acid sequence, (b) molecular size, (c) peptide 
concentration, (d) solution pH, (e) ionic strength, (f) medium components such as solvent or 
substrate, (g) presence of denaturation agents, such as SDS and urea, (h) temperature and (i) time. 
The effects of amino acid sequence, peptide concentration, salt, pH and time effects on peptide 
nanostructure formation have been studied in particular.21,51,98-100 Each factor is discussed below. 
Effect of amino acid sequence 
Peptide sequence serves as an internal factor that tunes peptide self-assembly. The type, number and 
arrangement of amino acids in the sequence play important roles in determining the secondary 
structures and self-assembled nanostructures of the peptides. For example, EFK8-I, containing eight 
amino acids in the sequence, forms β-sheet secondary structure in aqueous solution. However, when 
phenylalanine (F) is replaced with alanine (A), while maintaining the same charge distribution, the 
resulting peptide EAKA8-I forms random coils instead although it remains the same charge 
distribution. The reason for this phenomenon is still not clear. A possible explanation could be that 
the steric hindrance of the hydrophobic phenylalanine may help form β-sheets. 
In addition to the type of amino acid, the length of the peptide sequence has significant impact 
on nano/macrostructure formation.50,86,92,99 EAK16-II (16 amino acids) spontaneously associates to 
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form a macroscopic membrane when dissolved in a salt solution such as phosphate-buffered saline 
(PBS). EAK12 (12 amino acids) can also form membranes, but to a much lesser degree (<50%). In 
contrast, EAK8-II (8 amino acids) does not form membranes under the same condition. This might be 
due to the fact that peptides with a shorter chain length have fewer ionic-complementary pairs and 
less electrostatic interactions when peptides self-assemble into macroscopic structures. 
The difference in charge distribution due to the arrangement of amino acids also influences the 
nano/microstructures formed by ionic-complementary peptides. For instance, EAK16-I and EAK16-II 
form fibril-like nanostructures, while EAK16-IV forms globular aggregates at neutral pH (Figure 
2.6).26 Furthermore the globular EAK16-IV assemblies have lower surface tension, indicating a 
higher hydrophobicity than the fibrillar EAK16-II assemblies. This could be due to the bending of 
EAK16-IV via strong intramolecular electrostatic attraction to form β-turns, exposing hydrophobic 
residues to the solution and lowering the surface tension. On the other hand, EAK16-II prefers a 
stretched β-strand, resulting in linear fibrils. This speculation is supported by Monte Carlo 
simulations.27 
   





Effect of peptide concentration  
Another factor that triggers peptide self-assembly and further controls the nanostructure formation is 
the peptide concentration. Since the ionic-complementary peptides have an amphiphilic structure 
similar to surfactants, one would expect the concentration dependence of peptide self-assembly to be 
similar to that of surfactants. In analogy to the micelle formation of surfactants, having a critical 
micelle concentration (CMC), ionic-complementary peptides would have a critical aggregation 
concentration (CAC). This expectation is reasonable since the CAC has been reported for many 
proteins and amphiphilic peptides.101-105 The ionic-complementary peptide P11-I with 11 amino acids 
in sequence and a type I −+ charge distribution exhibits several critical concentrations corresponding 
to the formation of different nanostructures. It self-assembles into β-sheet tapes when the peptide 
concentration is larger than 0.01 mM.60 When the peptide concentration reaches 1 mM, loose ribbons 
are formed. Fibrils are not observed at concentrations up to 25 mM. If the concentration continues to 
increase, a gel is eventually formed. Similar behaviour was found with its derivative P11-II.  
In comparison with other self-assembling peptide systems, EAK16-II was found to have a CAC 
of ~0.1 mg/ml (60 µM) by surface tension measurements.21 AFM studies of the nanostructure of 
EAK16-II revealed that nanofiber networks are formed when the peptide concentrations exceed the 
CAC, while isolated filaments and globules are observed at concentrations below the CAC.21 In 
addition, the fibril size and network density were found to depend on the peptide concentration as 
well. Similarly, another peptide EAK16-I was reported to have a critical concentration of 0.3 mg/ml 
(180 µM).51 Unlike EAK16-II, EAK16-I assembly has been shown from AFM studies to undergo two 
nanostructure transitions.51 The first transition from globules to fibril morphology occurs when the 
peptide concentration is about 0.05 mg/ml (30 µM). The second transition involves dramatic increase 
in the fibril size as the concentration rises above 0.3 mg/ml (180 µM). 
 
 24
Effect of pH and salt 
In biological systems, the solution pH and salt content are two important environmental factors 
affecting protein and peptide structures. A pH change will influence the ionic state of the charged 
residues as well as the net charge of peptides/proteins. This will further influence the self-assembly 
behavior of the peptide and protein folding/aggregation. On the other hand, the presence of salts can 
affect the conformation and properties of many biological molecules, including their stability, 
solubility and biological activity.106,107 A well known example is that of DNA which takes on a 
random coil conformation when placed in a phosphate buffer solution, but is condensed in the 
presence of multivalent cations.108  
Interestingly, the assemblies of ionic-complementary peptides respond to the solution pH 
differently according to the peptide charge distribution. EAK16-IV with a type IV charge distribution 
has been found to undergo nanostructural transition depending on pH.98 It forms globular 
nanostructures at pH ranging from pH 6.5 to pH 7.5, while nanofiber networks appear at other pHs. In 
contrast, EAK16-II formed fibrillar nanostructures throughout the pH range from 4 to 11. These 
findings suggest that the charge distribution in sequence plays an important role in determining the 
self-assembled peptide nanostructures. With a type IV charge distribution, strong intramolecular 
electrostatic attractions occur at neutral pH, which may cause molecular bending and the formation of 
globular nanostructures. At extreme pHs such as pH 4 and 11, either glutamic acid or lysine residues 
are neutralized, resulting in weakened intramolecular electrostatic interaction and smaller tendency 
for the peptide to bind and form a β-turn structure. Thus, nanofiber formation would be predominant.  
The stability and conformation of the peptide assemblies are influenced by the presence of salts 
that can screen the charged residues and further reduce intermolecular electrostatic attractions. On the 
other hand, charge screening may also increase the hydrophobicity of the peptide which may promote 
peptide aggregation. In addition, the peptide may become less soluble in aqueous solution. It has been 
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found that the addition of salts induces the formation of EAK16-I fibrils at very low peptide 
concentration (below 0.05 mg/ml), which otherwise does not occur in the absence of salts.51 On the 
other hand, the critical peptide concentration for the secondary nanostructure transition from small 
fibrils to large fibers increases from 0.3 mg/ml (180 µM) to 0.8 mg/ml (480 µM) in the presence of 20 
mM NaCl. The reason for this phenomenon is still not clear. 
Effect of time 
Molecular self-assembly is a time-dependent, dynamic process. Hence, the self-assembled 
nanostructures of ionic-complementary peptide may evolve with time. The evolution of the peptide 
KFE8 (type I ) assembly was monitored by AFM.109 From the AFM images, left-handed helical 
ribbons were clearly visualized in the early stages, but gradually disappeared and replaced by fibril 
networks. It was believed that the disappearance of the helical ribbons was due to their subsequent 
assembly into fibril bundles. The time-dependence of the self-assembly of EAK16-II was studied 
with static light scattering and shown to be affected by the peptide concentration.21 Above the CAC 
(~0.1 mg/ml), the intensity of scattered light increased sharply with time over the first 6 hours and 
then slowly approached a plateau. This indicates that the peptide self-assembles into large aggregates 
faster at peptide concentrations above the CAC. However, below the CAC, the intensities did not 
change much with time initially and increased slightly only after 100 hours. This suggests that the 
peptide formed smaller and/or fewer aggregates that was not easily detected by this technique initially 
at very low peptide concentrations. Although kinetic effects may not be as important as those of 
concentration in the early stages of self-assembly, it becomes an essential component in later stages. 
In summary, the formation of peptide nanostructures can be controlled by peptide sequence 
design, peptide concentration, solution pH, the addition of salts and time. The controllable 
nanostructures coupled with biocompatibility and biodegradability make ionic-complementary 
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peptides promising biomaterials for use in nano-biotechnology. Some examples of such applications 
are described in the following sections. 
2.3 Applications of Self-Assembling Peptides 
2.3.1 Nanofabrication 
Certain self-assembling peptides have shown promise in nanofabrication, in particular, of nanowires 
since they are able to self-assemble into well-defined nanostructures (e.g., nanofibers and nanotubes) 
and can easily bind with a range of inorganic compounds according to their natural biomineralization 
properties. As listed in Table 2.2, the affinity of several peptide sequences to gold, copper, silver, 
platinum, nickel and some conductive polymers has been studied. These peptide motifs can be used in 
conjunction with self-assembling peptides to fabricate metallic nanowires. One well-known example 
is the application of bolaamphiphiles as nanotube templates to construct Ni, Cu, Au and Pt 
nanowires.70-73 The surface of the bolaamphiphile nanotubes can be further modified with histidine-
rich peptide motifs for specific metallic binding; such modification can also control the size and 
growth of the metallic nanocrystals on the peptide template.24,69-71,110-112  
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Table 2.2 Peptide sequences exhibiting affinity for various metal ions 
Metal ion Peptide Size (number of amino acids) Charge 
Au AHHAHHAAD72,113 9 -1 
Pt HPGAH73 5 0 
Ag NPSSLFRYLPSD111 12 0 















Another example is the use of the aromatic dipeptide FF (Phe-Phe), the shortest peptide 
possible, to form a template for Ag nanowire fabrication.29 This peptide can self-assemble into well-
ordered, discrete and stiff nanotubes in suitable organic solvents and serve as the templates. Silver 
ions can then enter the nanotubes and be reduced to metallic silver in the lumen of the tube, as shown 
in Figure 2.7. The peptide template can then be removed by enzymatic degradation, leaving an Ag 
nanowire with 20 nm in diameter. This method may have applications in molecular electronics since 
such small nanowires cannot be made by conventional top-down methods such as photolithography. 
 
Figure 2.7 Casting of silver nanowires inside peptide nanotubes.29 
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In addition, Linquist et al.35 have reported another peptide candidate, the N-terminal and 
middle region (NM) of yeast Saccharomyces cerevisiae Sup35p to function as a template for metallic 
nanowire fabrication. NM self-assembles into β-sheet-rich amyloid fibers with size and shape suitable 
for nanocircuits. The fibers have diameters of 9-11 nm and lengths from 60nm to several hundred 
micrometeres. NM can be engineered to incorporate more cysteine residues to interact with Au 
nanoparticles. The immobilized Au nanoparticles then serve as catalysts for the chemical reduction of 
Au ions in solution to fabricate nanowires. 
2.3.2 (Bio)Molecular Sensing 
Biosensors are analytical devices that combine a biologically sensitive element (bio-receptor) with a 
physical or chemical transducer to selectively detect and measure the amount of specific compounds 
in a given external environment. The biological sensitive elements are usually enzymes, 
microorganisms, cells, antibodies, tissues or DNAs. The transducer is used to convert the biological 
recognition reaction or eventually the biocatalytic process into a measurable electronic signal. For 
example, in an electrochemical enzyme biosensor, an electrical conductor such as graphite and noble 
metals can act as a transducer to convert enzyme catalysis reaction rates to electrical signals such as 
current or potential. Rapid and reliable detection of specific nucleic acid sequences, proteins, 
antibodies, antigens, cell-surface markers and pathogens is essential in the diagnosis of diseases, 
high-throughput assays, drug discovery as well as unraveling the complexities of cellular chemical 
networks. Therefore, intense research efforts have been made to fabricate novel biosensing devices 
that are highly efficient, reliable, portable, easy to use and inexpensive to operate. With fast 
developing nanotechnology, materials scientists and chemists are now focusing on using various 
nanoscale assemblies for these purposes. Some recent advances using self-assembling peptides in this 
field are reviewed below. 
 
 29
The self-assembled nanotubes of the peptide diphenylalanine (FF) have shown potential for 
biosensor applications.49 In terms of morphology and aspect ratio (length to thickness), these peptide 
nanotubes are similar to carbon nanotubes (CNTs) that have been found to be advantageous in 
sensing applications due to their small size, high aspect ratio and electrical conductance.114,115 
Additional properties such as biocompatibility and good water solubility make peptide nanotubes 
particularly attractive for electrochemical sensing. Early work involved a graphite electrode modified 
with peptide nanotubes through direct deposition on the electrode surface. The electrochemical 
characteristics of the nanotube-modified and unmodified electrodes were examined from cyclic 
voltammetry scans for the Fe(CN)64-/ Fe(CN)63- redox couple. The use of the modified electrode 
produced well-defined, reversible anodic and cathodic peaks and an improved electrochemical 
reactivity over that observed with the unmodified electrode.  Meanwhile, the difference in anodic and 
cathodic peak potentials (∆Ep) decreased from 0.14 V for the bare electrode to 0.07 V for the 
nanotube modified electrode. This result demonstrated that the presence of peptide nanotubes 
improves the reversibility of this couple and can significantly improve the electrochemical fingerprint 
of the electrode. One possible reason for this phenomenon is that the electron transfer between 
spatially aligned aromatic systems of the dipeptide (FF) assemblies can enhance the conductivity and 
electrochemical activity of the modified electrode.  
Apart from improving electrochemical parameters of graphite electrodes, peptide nanotubes 
can also modify Au electrodes for use in electroanalytical devices.48 In order to link the peptide 
nanotubes to the Au surface, researchers have incorporated thiol groups into the nanotubes using 
Traut’s reagent. The thiol-modified peptide nanotubes were then directly deposited on the Au 
electrode. This modified electrode demonstrated a direct and unmediated response to hydrogen 
peroxide and NADH. The successive additions of hydrogen peroxide and NADH at a potential of 0.4 
V (vs. a SCE reference electrode) produced rapid responses of the peptide nanotube-based Au 
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electrode so that steady-state currents were obtained within 5 s, indicating that the modified electrode 
showed high electrocatalytic activity toward hydrogen peroxide and NADH oxidation. On the other 
hand, the unmodified electrode showed virtually no response. To detect the glucose level, glucose 
oxidase, the enzyme widely used in glucose biosensors, was immobilized to the peptide nanotubes. 
This modified electrode also exhibited unmediated rapid responses to the successive addition of 
glucose. These studies illustrate successful examples of using self-assembled peptide nanostructures 
as an electrochemical sensing platform for highly sensitive detection and measurement of biological 
analytes. 
2.3.3 Model for Studying Amyloid Fibrillogenesis in Protein Conformational Diseases 
A common cause of many conformational diseases is amyloid fibril formation, in which a normally 
soluble protein undergoes a conformational transition to initiate aggressive protein aggregation into 
abnormal, insoluble, macroscopic plaques. These extracellular deposits may block cell-to-cell 
communications, damage neuronal pathways and cause neuron death. A partial list of conformational 
diseases includes Alzheimer’s diseases, bovine spongiform encephalopathy (BSE), Type II diabetes, 
Creutzfeldt-Jakob disease and various unrelated amyloidosis diseases. In spite of the significant 
clinical importance of amyloid formation, the mechanism of fibrillization is still not fully understood 
and a successful treatment not yet discovered. 
A notable common property of amyloid protein deposits is that fibrils of different origins show 
similar biophysical and ultrastructural characteristics, including three major structural criteria.116 First, 
amyloid fibrils are straight, unbranched and highly ordered fibrous assemblies with a diameter of 7-10 
nm. Second, fibrils stained with Congo red dye show green birefringence under cross-polarized light. 
Third, by X-ray fiber diffraction, they exhibit a unique cross-β  diffraction pattern in which the β-
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strand is perpendicular to the fibril axis. This diffraction pattern arises from the underlying repeating 
core structure of predominant β-sheets. 
Many self-assembling protein/peptide systems that can assemble into amyloid-like structures 
have been investigated to better understand molecular self-assembly. A notable example is the 
amyloid-β (Aβ) peptide containing 40-42 amino acid residues, which is the major constituent of the 
abnormal extracellular amyloid plaque found in the brains of Alzheimer’s patients. The Aβ (1-42) and 
Aβ(1-40) peptides are full length amyloid peptides which form β-sheet rich amyloid fibrils. Solid-
state NMR studies on the molecular structures within amyloid fibrils have shown that Aβ(1-40) fibrils 
are made of parallel β-structures; each contains a turn at residues 25-30, separating two β-strands (12-
24) and (30-40).116,117 The turn structure enables the two β strands to form intermolecular β-sheets 
that are in contact via their side chains. This arrangement results in a parallel, in-register, cross-β 
structure with a hydrophobic core and one hydrophobic face. Aβ(1-42) fibrils show similar parallel β-
sheet arrangement.  
It is widely accepted that amyloid fibrillogenesis in most cases occurs by a nucleation and 
growth mechanism.118-120 Lomakin et al.105 have proposed that the Aβ fibrillogenesis begins with the 
formation of nuclei in the Aβ solution. The nuclei are generated by either seeding or micellization, 
depending on whether the concentration of Aβ is below or above the critical micelle concentration 
(CMC). These nuclei provide a core for Aβ molecules to rearrange themselves into fibrils. Fibril 
elongation occurs by irreversible binding of the Aβ monomers to the fibril ends. 
Although the study of full length native proteins involved in conformational diseases is the best 
way to obtain structural information and elucidate the aggregation mechanism, a number of 
difficulties are encountered with this approach. First, determining the basis of molecular recognition 
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and assembly process from the full length protein is remarkably challenging.121 Second, the synthesis 
of large peptides, especially aggregative peptides is expensive and difficult. Third, but not the least, 
long and complicated protein/peptide sequences are not feasible for theoretical modeling with current 
computing capabilities. Therefore, efforts to understand amyloid formation focus on the study of short 
peptides, which are either fragments of disease-related proteins or synthetic self-assembling peptides. 
The use of peptide fragments corresponding to specific regions of Aβ has enabled the 
formation of highly ordered amyloid fibrils, more amenable to structural analysis. For example, Aβ 
(11-25) located in a central region of Aβ is thought to be essential for fibril formation. Although the 
β-sheets of Aβ (11-25) fibrils are anti-parallel rather than parallel as is the case of full length Aβ 
peptides,117 these fibrils are more rigid with a highly ordered arrangement of β-sheets than those of 
the full length Aβ peptides as revealed from their diffraction patterns.116 Such highly repeating 
structures in a single fiber can be directly visualized with electron microscopy.116 Apart from 
providing detailed structural information at a molecular-level, peptide fragments are short enough that 
they (and various analogues) can be easily synthesized by simple solid-phase chemistry. Moreover, 
the comprehensive study of a peptide fragment and its analogues should help determine the role of 
individual amino acids in amyloid fibril formation.121 Through isotropic labeling in solid-state NMR 
experiments, it has been found that the intermolecular hydrogen bonds in the hydrophobic segments 
of Aβ (11-25) vary with solution pH. F19 forms intermolecular backbone hydrogen bonds with V18 
at pH 7.4, whereas the intermolecular backbone hydrogen bonds formed between F19 and  F20 at pH 
2.3.117 
Since conformational transitions of amyloid peptides have been found to be critical to the 
formation of amyloid fibrils, the study of synthetic peptides that can undergo structural transitions to 
form amyloid fibrils would help us to understand and hopefully mitigate amyloid fibrillogenesis.122 
 
 33
Mihara et al. have formulated a class of ionic-complementary peptides that undergo α-helix-to-β-
sheet transitions.123-126  This class of peptides consists of two amphiphilic α-helix segments which are 
linked by a disulfide bond between cysteine residues at the C-termini. The N-termini are attached by 
hydrophobic amino acids or 1-adamantanecarbonyl (Ad). The peptides initially form α-helix 
structures, but gradually change to β-structures in neutral aqueous solution. This transition is found to 
depend on many factors including the peptide concentration, temperature, pH, salt type and solvent 
type. An increase in peptide concentration and temperature enhances the transition from α-helices to 
β-sheets (i.e., more β-sheets are formed). However, the presence of organic solvents and salts can 
retard and even inhibit the transition.127 The following mechanism for this transition has been 
proposed: monomeric α-helices first assemble into α-helix oligomers; when the concentration of α-
helix oligomers increases above a critical point, they begin to form large aggregates and undergo 
conformational transition to β-sheets.124 The hydrophobicity of the peptide has been found to affect 
the stability of these α-helix oligomers and thereby affect the α-β transition.124 In addition, ionic 
complementarity has also been found to be important for amyloid fibril formation from investigations 
of the effect of charge distribution (e.g., periodicity of E and K in the sequence) on such 
peptides.125,128 
Understanding the self-assembly of ionic-complementary peptides may provide insights into 
amyloid fibrillogenesis due to many similarities between ionic-complementary peptides and amyloid 
peptides.60,90,129 First, the self-assembled nanostructures of ionic-complementary peptides  and 
amyloid peptides both contain protofibrils and fibrils made of stable β-sheets.50,117 Second, both self-
assembly processes follow a nucleation and growth mechanism. This mechanism is peptide/protein 
concentration dependent. Above a critical concentration, nuclei form via monomeric assembly, which 
further induces peptide/protein aggregation into fibrils; below the critical concentration, nuclei form 
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only through seeding (i.e., from impurities or additives).21,130 Third, the intermediates such as nuclei 
or protofibrils play an important role in both self-assembly processes. Although the intermediates 
may have different structures, they all aggregate into fibrils. The similarities with amyloid peptides 
and the simplicity in the molecular structures of ionic-complementary peptides could make them good 
model systems for studying amyloid fibrillogenesis. 
2.3.4 Tissue Engineering 
Tissue engineering is an interdisciplinary field that applies the principles of engineering and the life 
sciences to the development of biological substitutes that restore, maintain or improve tissue 
function.131 It requires temporary scaffold materials for cells to control/maintain their bioactivity and 
physical properties. An ideal biologically compatible scaffold should meet several criteria: (i) 
structures resemblance to biological extracellular matrices; (ii) derived from biological sources; (iii) 
easy design and modification for specific needs; (iv) biodegradability; (v) non-cytotoxic with minimal 
immune responses and inflammation; (vi) ability to undergo good cell-substrate interactions; (vii) 
simple material production, purification and processing; (viii) readily transportable; and (ix) 
chemically compatible with aqueous solutions and physiological conditions.132 Developments in 
material chemistry offer synthetic strategies for biomimetic materials to meet the challenges of 
designing artificial extracellular matrices. The use of self-assembly to generate hierarchical 
supramolecular structures is a biomimetic strategy and is now receiving growing attention in the field 
of biomaterials.133-135  
Self-assembled peptide fibrous networks have shown potential for use in tissue engineering.55 
For example, ionic-complementary peptides EAK16-II and RAD16-II can self-assemble into well-
ordered nanofibers and porous membranes, with fiber width of 10 nm and pore size ranging from 5 to 
200 nm.86,97 Their three-dimensional nanofiber structures are similar to natural extracelluar matrices 
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such as collagen. These peptides have been used to study cell attachment, survival and 
proliferation.36,97,136 The cells were observed to spread out in a flat manner as they attached to the 
EAK16-II-coated substrate, similar to the behaviour of the cells attached to a fibronectin-coated 
substrate. In contrast, the same cells retained a round shape and did not spread on the malleable 
RAD16-II membranes. Malleable peptide membranes, unlike rigid substrates, can yield to 
cytoskeletal tensions, resulting in rounded cells. These peptide membranes provided sufficient 
attachment for endothelium cells even after the membrane was transferred to fresh culture wells. 
RAD16-I has been intensively studied for its potential in tissue engineering due to its similarity 
to the ubiquitous integrin receptor-binding site RGD.137 It has been used to culture liver-derived stem 
cells in three-dimensional systems that subsequently differentiated into functional hepatocyte-like 
cells.37 Another example is the ability of three-dimensional RAD16-I peptide nanofiber scaffolds to 
entrap migrating hippocampal neural cells.138 When hippocampal slices are cultured on such a 
nanofiber layer (~500 µm thick), a more extended interface between each tissue slice and the scaffold 
is formed. This simple method may not only allow the development of technology for neural 
progenitor cell isolation and enrichment in vitro, but also to expand the use of cell-based therapies of 
regenerative medicine. Apart from the 3D culture of liver-derived stem cells, RAD16-I matrices have 
been found to support neuronal cell attachment, differentiation and extensive neurite outgrowth.96 The 
nanofibrous RAD16-I scaffolds create an environment amenable for functional synapse formation 
between the attached neurons. Importantly, these peptides do not elicit a measurable immune 
response or tissue inflammation when introduced into rats, rabbits and goats.96,97 
Many other ionic-complementary peptides have also been found to be good candidates for 
tissue scaffolds. KFE8-I can form a matrix with an elastic modulus that compares favorably with that 
of soft tissues such as young male thigh and forearm skin and collagen sponge.139 KLD12-I can form 
3-D hydrogels that have shown potential for cartilage tissue repair.36  
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Superior scaffolds have been designed by coupling ionic-complementary peptides with specific 
functional motifs. These new scaffolds not only self-assemble into nanofiber networks that can create 
a fine-tuned microenvironment for 3D tissue cell cultures, but also enhance cell-materials 
interactions, cell proliferation, migration, differentiation and biological functions.140 For example, 
RADA16-I can be functionalized with three short motifs: osteogenic growth peptide OGP 
(ALKRQGRTLYGFGG), osteopontin cell adhesion motif (DGRGDSVAYG) and a designed 2-unit 
RGD binding sequence (PRGDSGYRGDS).141 The new peptides are synthesized by adding these 
three motifs to the C-termini of RADA16-I. These functionalized self-assembling peptide scaffolds 
significantly increase mouse preosteoblast MC3T3-E1 proliferation and differentiation towards bone 
formation in comparison to unfunctionalized RADA16-I. In addition, inclusion of bone marrow 
homing motifs (BMHP1, SKPPGTSS and BMHP2, PFSSTKT) in RADA16-I remarkably enhances 
adult mouse neural stem cell survival, proliferation and differentiation into neurons and glial cells.140 
In summary, ionic-complementary peptides have great potential as scaffolding materials in 
tissue engineering applications such as neurite outgrowth, cartilage repair, osteoblast and neural stem 
cell proliferation, differentiation and 3-D migration. Not only are they highly biocompatible and 
biodegradable, they also have suitable mechanical properties and possess diverse biological 
functionality. Ease of molecular design and the ability to self-assemble will make these small peptide 
building blocks important tools in future tissue engineering. The application of ionic-complementary 
peptides in tissue engineering involves the interfaces between the peptide scaffold and the underlying 
supporting material and between the peptide scaffold and supported cells. Thus, control of the peptide 
nanostructures at interfaces is crucial for obtaining biocompatible matrices for cells. 
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2.3.5 Drug Delivery  
The very slow progress in the efficacy of treating severe diseases such as cancer has suggested a 
growing need for novel approaches to the delivery of therapeutics to the targets regions in tissues. 
Accordingly, drug delivery systems are emerging as new strategies to control pharmacokinetics, 
pharmacodynamics, non-specific toxicity, immunogenecity, biorecognition, and drug efficacy.142 In 
order to develop novel drug delivery systems for clinical use, the design and/or discovery of effective 
delivery vehicles play important roles. 
Peptides have shown much potential for drug delivery. The most attractive aspect of peptide-
mediated drug delivery is the natural propensities of many peptides for cell penetration and 
targeting.143,144 Peptide-based delivery systems have shown the potential to deliver therapeutic 
proteins, bioactive peptides, small molecules and nucleic acids.143-145  
Ionic-complementary peptides may be a new and promising material as carriers for drug 
delivery. Their unique amphiphilic structure and ability to self-assemble allow them to encapsulate 
both hydrophobic chemotherapeutics and hydrophilic gene therapeutics. Moreover,  no detectable 
immune response is observed when these peptides were introduced into animals.86,96,97 These peptides 
can spontaneously organize themselves into nano/micro structures that may provide a protected and 
stable environment for drug/gene molecules. Another advantage of using peptide-based carriers is the 
ease of sequence modification and design for cell penetration and targeting. 
Ionic-complementary peptides have been shown to readily encapsulate hydrophobic materials 
and increase their solubility in aqueous environments. Recent work using pyrene as a model 
hydrophobic compound has demonstrated the potential of ionic-complementary peptides in the 
delivery of hydrophobic anticancer drugs.146 The use of EAK16-II was shown to stabilize pyrene 
microcrystals in an aqueous solution at concentration up to a ten-thousand fold increase beyond its 
solubility in water of 7.0×10-7 M. Since the encapsulated pyrene is in a crystalline form so that more 
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pyrene molecules are encapsulated per peptide, the loading efficiency is high. Consequently, the 
dosage of hydrophobic drugs may be dramatically reduced using self-assembling peptide vehicles. 
The encapsulated pyrene from the peptide coatings can be released into liposomes used to mimic the 
cell membrane.147 The release rate has been found to be a few hours and proportional to the peptide-
to-pyrene ratio during the encapsulation: the higher the ration, the slower the release rate. This is due 
to the difference in the density of peptide nanostructures coated on the pyrene crystals, as revealed by 
scanning electron microscopy. This example demonstrates that controllable release of drugs may be 
achieved by using ionic-complementary peptide vehicles.  
Recent work in our group has shown the ability of such peptides interacting with an anticancer 
agent and oligonucleotides. The solubility of the hydrophobic anticancer agent ellipticine was 
significantly improved upon interaction with EAK16-II.32 In addition, EAK16-II can also interact 
with oligodeoxynucleotides (ODNs) in a controlled manner at different solution pHs and peptide 
concentrations.148 In addition, the encapsulation of ODNs with ionic-complementary peptide can 
protect the ODNs from degradation as indicated by fluorescence quenching studies. These results 
show the potential of ionic-complementary peptides in gene delivery as well. 
Apart from delivery of hydrophobic compounds and hydrophilic genes, ionic-complementary 
peptides have shown success in the local delivery and release of peptide/protein drugs in a controlled 
manner. Biotinylated RADA16-II has been used to deliver insulin-like growth factor 1(IGF-1) to the 
myocardium.149 The biotinylation does not change the self-assembly property of RADA16-II. IGF-1 
is then incorporated into the biotinylated RADA16-II by using tetravalent streptavidin. This “biotin 
sandwich” approach allows specific and highly controlled delivery of IGF-1 to local myocardial 
microenvironments. After injection into the rat myocardium, the biotinylated nanofibers provide 
sustained IGF-1 delivery for 28 days and increase activation of Akt in the myocardium, indicating an 
improved cell therapy. 
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In summary, ionic-complementary peptides have shown the potential in constructing versatile 
delivery vehicles that can encapsulate both hydrophobic and hydrophilic molecules. The 
targeting/penetrating abilities can be possibly introduced by peptide design at a molecular level. The 
ability to manipulate the size of the self-assembled nano/micro-structures and complexes with various 
drugs would be essential to enhance the drug loading and release capacity and enable this type of 
peptides to be effective biocompatible carriers in cancer chemotherapy and gene therapy.   
2.4 Molecular Assembly on Surfaces 
The nanoscale assembly of molecules on surfaces play an important role in nanotechnology and many 
biological systems.150-152 Many nanoscale devices require formation of regular/patterned arrays of 
thermodynamically stable nanostructures.6 This can be achieved by surface-directed/assisted 
molecular assembly. However, it is still a challenge to precisely control the arrangement of molecular 
modules to form regular arrays at a surface or interface. Therefore, study and manipulation of 
molecular assembly at surfaces or interfaces has drawn increasing attention in recent years.153  
2.4.1 Directed/Assisted Molecular Assembly into Patterned Nanostructures 
The assembly of most molecules on surfaces has been found to be surface-directed/assisted. For 
instance, a hydrophobic graphite surface helps to organize molecules such as metal-organic 
complexes,154 long alkyl chains and fullerenes,155 peptides41-43 and polymers156 into patterned 
nanostructures. These patterned nanostructures often resemble the crystallography of the graphite. 
This occurs due to the combination of molecule-surface and molecule-molecule interactions that 
constrains the assembling molecules. Particularly, a flat surface constrains the motion of molecules to 
be two-dimensional when attached to a surface and thereby facilitates the special-organization of the 
molecules. The most important interactions for molecular assembly into well-defined architectures on 
surfaces include Van der Waals forces, hydrogen bonds, electrostatic interactions and metal 
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coordination. More often, competitive interactions occur simultaneously and the successful outcome 
of the assembly process requires not only balanced intermolecular interactions but also favorable 
molecule-surface interactions.154 
The formation of well-ordered supramolecular nanostructures from functional organic 
molecules on surfaces has attracted much interest in view of their potentials for use in electronic, 
magnetic and optic devices. Recently, one-dimensional nanostructures of a perylene-based n-type 
semiconductor molecule (PTCDI) on both glass and mica surfaces have been fabricated with the 
solvent-vapour annealing method.157 In this study, concentrated chloroform solutions of PTCDI were 
drop-casted or spin-coated onto a mica or glass surfaces to form a thin films. The thin films were then 
annealed in chloroform vapour to allow packing of PTCDI molecules on the surface. After 24 hour 
annealing, long nanobelt-like one-dimensional nanostructures were observed. The lengths of the 
nanobelt assemblies can be feasibly controlled by the nature of the surface and the concentration of 
PTCDI during casting. It has been found that the nanobelts formed on glass are longer and thinner 
than those on mica under the same condition. In addition, higher concentrations of PTCDI favour the 
formation of extended nanobelts. These one-dimensional assemblies with tuneable length have 






Figure 2.8 Assemblies of a fullerene derivative on HOPG.  (a) Structure of fullerene derivatives. (b) 
AFM image of the fullerene derivative 1 with three hexadecyl chains on HOPG spin-coated from 
CHCl3 solution. (c) High-resolution STM image of the fullerene derivative 1 on HOPG. (d) 
Schematic illustration showing the molecular organization of derivative 1 in the lamellae.155 
 
Interestingly, a highly ordered pyrolytic graphite (HOPG) surface has been shown to direct the 
assembly of fullerenes (C60) into one-dimensional architectures.155 To form these well-ordered 
nanostructures, long alkyl chains were attached to the fullerenes, as shown in Figure 2.8a, to induce 
epitaxial assembly on HOPG and to act as insulating barriers to separate the fullerene nanowires. 
These fullerene derivatives in chloroform solution were then spin-coated onto freshly cleaved HOPG 
under suitable conditions to achieve submonolayer coverage so as to reveal structural details of the 
interfacial layer. The AFM images show that fullerene derivatives formed one dimensional lamellar 
stripes on HOPG (Figure 2.8b). The observed stripes in different domains were arranged at 60º or 
120º with respect to each other, reflecting the symmetry of the underlying graphite lattice. A high-
resolution STM image revealed the zigzag-type arrangement of C60 in the lamellar structure, as shown 
in Figure 2.8c. The conformation of alkyl chains and arrangement of the fullerene derivatives were 
revealed by the periodicity of the nanostripes, which were twice the length of the fullerene derivatives 
in an all-trans conformation. Accordingly, it was proposed that the lamellae are composed of fully 
extended alkyl chains and the molecules are arranged in a head-to-head bilayer architecture (Figure 
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2.8d). This hypothesis was supported by the examination of the effect of alkyl chain length on the 
spacing of the fullerene nanostripes. It is hoped that the distance between adjacent fullerene 
nanowires may be ultimately tailored at the nanoscale level through the attached the alkyl chain 
length. 
Peptides/proteins can also form ordered structures on surfaces. It was reported that the peptide 
GAV-9 with a sequence NH2-VGGAVVAGV-CONH2 can grow epitaxially into ordered 
nanofilaments on both hydrophilic mica and hydrophobic HOPG surfaces (Figure 2.9).158 The 
formation of these nanofilaments monitored by in-situ AFM was found to follow three preferred 
orientations at 120° to each other and in a threefold symmetry pattern. Interestingly, the nanofilament 
height on these two surfaces was found to be different, indicating that the peptide molecules were 
orientated differently. The height of the nanofilament on mica is similar to the peptide length, 
whereas that on the HOPG surface is similar to is height. This observation suggests the following 
interfacial orientations on the two surfaces: peptide adopts an “upright” orientation on mica due to the 
electrostatic interaction between the positively charged N-termini and the negatively charged mica; a 
horizontal orientation on HOPG is preferred due to the hydrophobic interaction between the peptide 
and the surface. Examination of the peptide secondary structures shows that it adopts random coil 
structure in solution but anti-parallel β-sheets on mica surface, indicating that these ordered 
nanostructures are surface-directed. Surface-directed/assisted peptide assembly by emploiting surface 




Figure 2.9 AFM images and analysis of GAV-9 nanofilaments. (a) Atomic lattice of the mica 
surface; (b) GAV-9 fibrils on mica; inset is the Fourier transform image; (c) cross-section of the green 
line marked in (b); (d) cross-section along a fibril marked by the blue line in (b); (e) GAV-9 on 
HOPG; inset is the Fourier transform image; (f) layers of GAV-9 on HOPG with yellow arrow 
indicating their orientations; inset is Fourier transform of the marked region; (g) cross-section of the 
pink line marked in (e); (h) cross-section of the white line marked in (f).158 
2.4.2 Induced Biomolecular Aggregation 
In addition to directing and regulating molecular assembly, a surface can induce or catalyze 
protein/peptide aggregation. Recently, studies have shown the importance of surfaces in amyloid 
fibril formation.40,43,159,160 The size and shape of amyloid-β (Aβ) peptide aggregates, as well as the 
kinetics of their formation, exhibited a pronounced dependence on the physicochemical properties of 
the surface.41-43 On hydrophilic mica, the Aβ peptide formed linear assemblies with an average height 
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of 5-6 nm, whereas uniform, elongated sheets with height of 1 nm were found on hydrophobic 
graphite.43 Amyloid formation of Aβ peptide was found to follow a nucleation and growth 
mechanism by direct observation of its assembly on mica using in situ AFM.43,130 The formation of 
amyloid fibrils on mica occurs when protofibrils appear on the surface as seeds and are elongated by 
the addition of Aβ molecules and protofibrils to the active sites of the seeds. Such seed-dependent 
amyloid fibril growth of Aβ was also observed in real-time using total internal reflection fluorescence 
microscopy (TIRFM) on the glass surface by Ban et al.159 Interestingly, they noticed some differences 
between fibril growth on the glass surface and in solution, particularly fibril length, indicating the 
effect of surfaces on the Aβ aggregation. 
Similarly, fibrillization of α-synuclein, a protein associated with Parkinson’s disease, has been 
found to be surface dependent.40,161 Hoyer et al.40 reported that α-synuclein formed elongated β-sheets 
on a negatively charged mica surface, but not on HOPG, suggesting that negatively charged surfaces 
promote α-synuclein assembly. Such an argument was supported by the study of Necula et al. on 
fibrillization of recombinant α-synuclein in the presence of anionic lipids or surfactants.161 They 
found that the fibrillization can be greatly accelerated at low micromolar concentrations with the 
presence of micelles in the solutions. Other anionic surfaces provided by anionic phospholipid 
vesicles also induced α-synuclein assembly, with resulting filaments originating from their surface. 
These findings provide new insights into the role of anionic surfaces in α-synuclein fibrillization, 
underlying that anionic membranes may participate in amyloid fibrillization in vivo.  
Other evidence of surface-induced/catalyzed amyloid fibril formation has been reported by Zhu 
et al.160 In their investigation, a recombinant amyloidogenic light chain variable domain SMA formed 
fibrils on negatively charged mica but not on hydrophobic or positively charged surfaces. Fibril 
growth could occur from the deposited oligomeric units as well as the preformed amorphous cores on 
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the surfaces. In addition, fibril formation was accelerated significantly on surfaces compared to that 
observed in bulk solution. Also, the mechanism of SMA fibril formation on the surface was 
significantly different from that in solution. However, the surface-induced assembly may be more 
physiologically relevant since the in vivo protein deposits are associated with surfaces.  
In summary, the observed assembly of various molecules ranging from organics, fullerenes to 
peptides, on surfaces lead to the following conclusion: the surface effect on molecular 
assembly/aggregation could be a general phenomenon. Although the underlying mechanisms are still 
unclear, the substrate or surface is crucial to many of these molecular or biological assemblies. Study 
of the substrate/surface effect on supramolecular assembly using a typical model system may 
therefore shed new light on many complicated biological events and better control molecular 
architectures on surfaces. Our aim is to study the substrate/surface effect on the assembly of an ionic-
complementary peptide not only to understand the mechanisms of molecular assembly but also to 
control such processes in order to build supramolecules with desired structures and functions. 
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Chapter 3*                                                                   
Surface-Assisted Peptide Assembly: Controllable Nanofiber 
Growth  
3.1 Introduction 
Molecular assembly at a surface plays an important role in many nanotechnology and biological 
applications.150-152 Surface/substrate-directed assembly has been explored to construct a variety of 
nanosystems. For example, a hydrophobic graphite surface was reported to direct molecules, such as 
long alkyl chains, fullerene derivatives,155 peptides41-43 and polymers,156 to organize into various 
patterns. The resulting nanostructures can be used to construct nanoscopic devices, such as 
(bio)sensors, information storage units, optical computers and solar cells.44-47 Another example is the 
spontaneous organization of the negatively charged virus M13 into ordered monolayer structures on 
the surface of a positively charged, multilayered LPEI/PAA polymer film.162 These ordered, self-
assembled viral structures can be used to fabricate more powerful batteries and grow functional 
nanoparticles and nanowires.162,163  
In biomedical studies, some surfaces have been found to induce protein/peptide aggregation. 
Recent reports have shown the importance of substrates in amyloid fibril formation.40,43,159,160 The size 
and shape of amyloid-β (Aβ) peptide aggregates, as well as the kinetics of aggregation, exhibited 
pronounced dependence on the physicochemical properties of the substrate.43,130,159 The fibrillization 
of α-synuclein, a protein associated with Parkinson’s disease, has been found to depend on the nature 
of the micelle surface in incubation solution.40 It was reported that the in vitro fibril formation of 
some proteins, such as SMA, a recombinant amyloidogenic light chain variable domain, is sensitive 
to the contact surface of test tube materials and a stir bar.160 All these observations point to a notion 
*This chapter is based on a paper “H. Yang, S.Y. Fung, M. Pritzker, P. Chen, Surface-Assisted Assembly of an Ionic-
Complementary Peptide: Controllable Growth of Nanofibers, J. Am. Chem. Soc. 2007” (in press). 
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that the substrate effect on protein/peptide assembly and aggregation is important and critical to many 
nanoscale biomedical processes.  
Our understanding of the substrate-assisted assembly and aggregation of biomolecules however 
remains incomplete. This is partially due to the complexity of biomolecules and the experimental 
difficulties in nanoscale in-situ examination of the assemblies. A relatively simple, self-assembling 
peptide with residues that possess a variety of molecular interactions occurring in proteins could be a 
good model molecule to investigate such complicated processes. The purpose of this work is thus to 
study the substrate/surface effects on the nano-assembly of a model peptide, to better understand the 
assembly kinetics and further to control the peptide aggregation at a surface.  
The model peptide used is an ionic-complementary, self-assembling peptide, EAK16-II (Figure 
3.1). 21,26,86 This peptide is capable of hydrogen bonding, electrostatic and hydrophobic interactions. 
The amino acid sequence of this peptide bears a repetitive, alternating charge distribution (type 
II: ++−−++−− ) leading to ionic complementarity.50,86 In addition, alternation of the hydrophobic 
(A) and hydrophilic (E and K) residues results in an amphiphilic feature. Such an amino acid 
sequence allows the peptide to self-assemble into β-sheet rich nanofibers in solution.21,26,50,86 Our 
previous studies have shown that many factors, such as peptide sequence26,27 and concentration,21,51 
salt type and concentration,22,51,52 and solution pH,26 affect the self-assembled micro-/nanostructures 
of the peptide and its derivatives. The simple, regular structure and our previous knowledge of 
EAK16-II provide a good basis to study the substrate/surface effect on the peptide aggregation and to 



























































Figure 3.1 Molecular structure of EAK16-II 
 
The main tool used was in-situ Atomic Force Microscopy (AFM). This technique is especially 
suitable for real-time monitoring the assembly of biomolecules in solution. First, this method enables 
the repetitive imaging of mechanically delicate biomaterials with minimum lateral forces between the 
probe and sample. Second, it is possible to directly study the dynamics and kinetics of the assembly 
of proteins/peptides under the solution conditions appropriate for biological events.164 Third, the 
kinetics of each individual assembly can be quantified. The surface used in this study was mica, 
which is negatively charged even at a low pH value of 3,165 and provides an atomically flat surface 
that enables high resolution AFM imaging. To complement the AFM surface observations, Dynamic 
Light Scattering (DLS) and zeta potential measurements were employed to monitor the assembly 
process and the charge of the peptide in bulk solution, respectively. It is known that the surface 
charge of a particle plays an important role in aggregation of colloidal dispersions, polyelectrolytes 
and proteins.166,167 These solution properties of EAK16-II should provide essential information and 
evidence in relation to surface-assisted assembly.  
We in particular investigated the surface-assisted EAK16-II assembly at different solution pHs. 
It is expected that a change of the solution pH would alter the charge status of the peptide and its 
electrostatic interaction, which in turn should affect the peptide-peptide and peptide-surface 
interactions. As a result, the assembly behavior of EAK16-II on the substrate may be modified. This 
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will provide a way to control the surface-assisted assembly, leading to construction of functional 
nanostructures. These findings are also related to amyloid fibrillogenesis, providing a simple model to 
understand peptide/protein aggregation. 
3.2 Materials and Methods 
3.2.1 Materials 
The peptide EAK16-II (C70H121N21O25, molecular weight 1657 g/mol) has a sequence of 
AEAEAKAKAEAEAKAK (Figure 3.1), where A corresponds to alanine, E to glutamic acid and K to 
lysine. At neutral pH, A is neutral, hydrophobic residue, while E and K are negatively and positively 
charged, respectively. This peptide was purchased from CanPeptide Inc. (Québec, Canada) with a 
purity of >95% (purified by reverse-phase High-Performance Liquid Chromatography). The N-
terminus and C-terminus of the peptide were protected by acetyl and amino groups, respectively, to 
minimize end-to-end electrostatic interaction between peptides.27 
The EAK16-II stock solutions were prepared in pure water (18.2 MΩ; Millipore Milli-Q 
system) at concentrations of 12 µM and 120 µM, and stored at 4°C before use. Unless otherwise 
noted, the 12 µM peptide stock solution was used for all AFM studies while the 120 µM peptide stock 
solution was for TEM imaging. Reagent grade sodium hydroxide with purity of 99+% and 
hydrochloric acid (36-38% by weight) were obtained from BDH Chemicals Ltd. (Toronto, Canada) 
and Fisher Scientific, Inc. (Nepean, Canada), respectively.  
Grade V-4 muscovite mica (KAl2(AlSi3)O10(OH)2, SPI Supplies, West Chester, USA) was used 
as the supporting surface. A mica slide was fixed on an AFM sample plate using a double sided tape. 




3.2.2 In-situ AFM Imaging 
To monitor how a single EAK16-II nanofiber assembles on a mica surface under desired 
experimental conditions and avoid any drying effects, in-situ AFM imaging was performed on a 
PicoScanTM AFM (Molecular Imaging, Phoenix, AZ) in a liquid cell (custom-made). The cell was 
mounted on a freshly cleaved mica surface and injected with 500 µl of pure water, 1 mM HCl, 10 
mM HCl, 1 mM NaOH or 10 mM NaOH solution. 100 µl of the 12 µM EAK16-II stock solution was 
then injected into the liquid cell with a microsyringe to obtain a final peptide concentration of 2 µM. 
This slightly diluted the concentrations of HCl and NaOH solutions (0.83 mM and 8.33 mM); 
however, the same initial concentrations (1 and 10 mM of HCl or NaOH solutions) before the 
injection of the peptide solution were used throughout this study. The pH values of the final solutions 
in the liquid cell are indicated in Table 3.1.  
Atomic force microscopy images were obtained using a scanner with a maximum scan area of 
6 × 6 µm2. All AFM experiments were conducted in an environmentally controlled chamber at room 
temperature to avoid evaporation of the working solution. Silicon nitride cantilevers with a nominal 
spring constant of 0.58 N/m (DNP-S, Veeco Probes, Santa Barbara, USA) and a typical tip radius of 
10 nm were used in AFM tapping mode. To obtain the best imaging quality, the typical tapping 
frequency was set between 16 kHz and 18 kHz and the scan rates were controlled between 0.8 and 1 
Hz (~5 min to take each AFM image). All AFM images were collected at a resolution of 256 × 256 
pixels. In general, the elapsed time associated with each image refers to the point when EAK16-II 
stock solution was injected into the liquid cell containing a desired working solution. An initial image 
of a newly cleaved mica surface immersed in the working solution was taken to confirm the absence 
of contaminating dust particles.  
The lengths of EAK16-II fibers on the mica surface at different times were measured with the 
Image J software (http://rsb.info.nih.gov/ij/). The width and height of EAK16-II nanofibers were 
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determined by the cross-section analysis tool of the PicoScanTM software (Molecular Imaging, 
Phoenix, AZ). The peptide fiber widths reported were obtained using the deconvolution method 
reported by Fung et al.21 In each solution condition, at least 50 nanofibers were collected and 
analyzed from the AFM images of at least three independent experiments. 
3.2.3 TEM Imaging 
Transmission Electron Microscopy (TEM) was performed with a Philips CM20 electron microscope 
(Philips Electronics Ltd. Guildford, UK) at an accelerating voltage of 200 kV. Images were 
digitalized using a Gatan 679 slow-scan CCD camera and analyzed using DIGITALMICROGRAPH 
(version 2.1, Gatan Inc. Pleasanton, CA). A 120 µM EAK16-II stock solution was diluted with pure 
water 5 times first, and then 10 µl of the diluted solution was incubated on a 400-mesh carbon-coated 
formvar copper grid (Marivac Ltd., St. Laurent, QC) for 10 min. Excess solution was drawn off the 
edge of the grid with tissue paper. After air drying for 20 min, the grid was negatively stained with 
2% (wt/vol) uranyl acetate for 5 s. Excess stain was drawn off with tissue paper and the grid air-dried 
before TEM imaging. 
3.2.4 Dynamic Light Scattering 
Dynamic Light Scattering experiments were performed using a Zetasizer Nano ZS (Malvern 
Instruments, Worcestershire, UK) with the appropriate viscosity and refractive index settings and the 
temperature maintained at 25°C during the measurement. A small-volume (45 µl) black quartz 
cuvette with a 3 mm light path was used. A 0.3 mM EAK16-II solution was prepared in pure water, 1 
mM HCl, 10 mM HCl or 10 mM NaOH, and sonicated for 10 min and then filtered (0.22 µm) before 
the measurement was taken. The scattered light intensities of samples at the angle of 173° were 
collected at various times. The pH of 0.3 mM EAK16-II dissolved in pure water, 1 mM HCl, 10 mM 
HCl and 10 mM NaOH was measured to be 3.9, 3.1, 2.0, and 11.9, respectively. The viscosity and 
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refractive index of pure water, 1 mM HCl, 10 mM HCl and 10 mM NaOH at 25 °C were also 
measured by a Cannon Ubbelohde Semi-Micro viscometer (size 75, Cannon Instrument Company, 
State College, PA) and refractometer (Bausch & Lomb, Inc., Rochester, New York, USA)), 
respectively, and found to be very close to those of pure water at 25 °C.  
Under each condition, two samples were used and triplicate measurements were made for each 
sample. The sample was monitored frequently within the first day, twice a day for the following 4 
days and once every 2 or 3 days for the following 3 weeks. The intensity-based size distribution of 
peptide assemblies in solution was obtained with the multimodal algorithm CONTIN,168 provided in 
the software package Dispersion Technology Software 5.0 (Malvern Instruments, Worcestershire, 
UK). 
To study the kinetics of peptide assembly in solution, the total light intensity of the peptide 
solution was monitored over time. The light intensities reported as a function of time were the 
average values obtained from three measurements of each sample. The light intensity of the peptide 
dissolved in pure water was plotted versus time and fitted to a single exponential function:  
)exp()( tkAItI appeq −+=        (3.1) 
where I(t) is the light intensity at time t, Ieq is the maximum light intensity at the end of the observed 
exponential phase, A is the pre-exponential coefficient and kapp is the apparent rate constant. 
3.2.5 Zeta Potential Measurements 
The surface charge of EAK16-II assemblies in solution was determined by zeta potential 
measurements on a Zetasizer Nano ZS (Malvern Instruments, Worcestershire, UK) at 25°C. A freshly 
prepared 0.18 mM EAK16-II solution was used for each measurement. The pH of the peptide solution 
was adjusted to the desired value using small amounts of 2 M NaOH or 2 M HCl. A correction of the 
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peptide concentration for the volume change was not made for this measurement because the change 
in peptide concentration (<1%) due to the addition of NaOH or HCl was negligible. Samples were 
injected into a disposable cell (folded capillary DTS-1060 from Malvern, Worcestershire, UK) with a 
volume of ~1 ml and analyzed at constant voltage. The zeta potential distribution (in mV) was 
automatically calculated from the electrophoretic mobility distribution based on the Smoluchowski 
formula.169,170 For each solution condition, the zeta potentials were repeated with two independent 
samples; at least three measurements were carried out for each sample. The zeta potentials reported 
herein correspond to the average of the peak values of the zeta potential distributions from the 
repeated measurements. 
3.3 Results 
3.3.1 Real-Time Observation of EAK16-II Nanofiber Growth on Mica 
Figure 3.1 (panels a-d) shows a sequence of the in-situ AFM images of EAK16-II nanofibers taken on 
the same location of a mica substrate immersed in an aqueous solution containing 2 µM EAK16-II. It 
can be seen that the length of nanofibers increases with time. A couple of short nanofibers (~200 nm 
in length) initially appearing after ~21 min incubation (Figure 3.2a) are observed to continually grow 
on mica (Figure 3.2b-d). After ~81 min, the nanofiber length increases to ~2.3 µm. The green arrows 
indicate the two ends of a fiber, while the red arrow points to a reference spot to show that the 
nanofiber can grow at both ends (bidirectional growth). The elongation from the two ends of a fiber 
may result from the addition of peptide monomers or oligomers at the two active ends. At this stage, 

























Figure 3.2 Time evolution of EAK16-II nanofiber growth on mica in pure water at (a) 1285 s, (b) 
2107 s, (c) 3251 s, and (d) 4874 s. Time zero is when peptide solution is added into the AFM liquid 
cell. The scale bar represents 500 nm. The green arrows point at two ends of a fiber and the red 
arrow points at a small globule serving as a reference location on mica. (e) TEM image of EAK16-
II self-assembled nanofibers. The scale bar represents 50 nm. (f) Variation of EAK16-II nanofiber 






From the AFM images, the width and height of newly grown part of fibers on the surface are 
similar to those of the nanofiber “seeds”, which are presumably formed in solution. This suggests that 
nanofibers formed in bulk solution and on the surface are similar. The width and height of these 
nanofibers are ~7 nm (after tip deconvolution) and ~1.5 nm, respectively. Since the fiber width 
measured by AFM is usually affected by the AFM tip,21 the fiber width was also examined by TEM 
for comparison (Figure 3.2e). The TEM image shows that a single EAK16-II nanofiber has a width of 
~5 nm, which compares well with the AFM results. The uniform fiber width and height may indicate 
a special arrangement of peptide molecules in the nanofiber and a possible fiber growth mechanism, 
as will be discussed later. 
The uniform width of nanofibers enables precise analysis of the growth rate of an individual 
fiber length. Figure 3.1f shows a plot of the variation of the peptide fiber length (measured between 
two green arrows) with time. The length of the fiber monitored in Figures 3.1a-d increases linearly 
with the incubation time at a rate of 0.57 nm/s over the experiment. The lengths of other fibers also 
show a predominant linear growth although the growth rates vary from one nanofiber to another. This 
may be due to the (minute) differences in the fiber characteristics and/or the change of the local 
environments. It is also worth noting that the growth rate in our study may represent the initial growth 
state since the time period of in-situ AFM imaging is usually less than 2 h. In some cases, the active 
ends of a growing fiber can be terminated when they encounter other fibers or other small surface 
features (dots or globules in the AFM image). This will lead to the fiber network formation on the 
mica surface. These small surface features may be peptide globular aggregates or some other 
components in solution (e.g., impurities). The presence of some globules/small dots through out all 
AFM images is reasonable since EAK16-II has been shown to form both globules and fibers 
especially when the peptide concentration is very low.27 However, unlike the nanofibers, these 
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globules and small dots do not grow on the surface. If one active end is blocked, the nanofiber can 
grow from the other end; such a growth pattern can be termed unidirectional fiber growth.  
From the analysis of at least 50 independent, growing nanofibers with two active ends on mica, 
an average growth rate of 0.74 ± 0.40 nm/s is obtained. The observed linear growth of nanofibers 
might indicate that the fiber elongation occurs by the addition of peptide monomers to the active ends. 
To relate this growth rate to the number of monomers added, the width of the β-strand EAK16-II 
molecule was estimated using ChemSketch software (Toronto, Canada). This software determined the 
width to be 0.3-0.5 nm from the distance between the top-most and bottom-most atoms in the van der 
Waal-based structure (i.e., direction in and out of the plane of the structure shown in Figure 3.1). 
Thus the observed growth rate corresponds to the attachment of one or two monomers to the active 
ends of a nanofiber “seed” every second by presuming that the arrangement of peptides in the 
nanofiber follows a cross-β fashion (see Section 3.4.2). 
The increase in the fiber length as a function of time can be described by the following linear 















       (3.2) 
where l is the fiber length at time t; l0 is the length of a nanofiber “seed”; τ0 is the time when a 
nanofiber “seed” deposits on mica; v is the fiber growth rate on mica. Although each nanofiber has a 
different growth rate, one can use an average growth rate at the same solution condition to estimate 
the length of the nanofiber on the surface at a given time with these equations. One can also estimate 
the deposition time τ0 of a “seed” by monitoring its growth rate. For instance, if the length of a 
nanofiber “seed” is known (e.g., l0 ~54.6 nm in 12 µM peptide stock solution, obtained from the 
statistical analysis of nanofiber length in 10 mM HCl, see Section 3.3.2), τ0 for “seed” deposition 
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(Figure 3.2) is estimated to be ~ 918 s for a fiber that has a growth rate of 0.57 nm/s (l = 2855.9 nm at 
t = 5833 s). 
The assemblies in self-assembly systems are typically polydispersed with various sizes.171-173 
As will be shown in Section 3.3.3, we also observed this behavior for EAK16-II dissolved in solution. 
A manifestation of this polydispersity is the formation of large peptide aggregates as fiber clusters on 
the mica surface, as shown in Figure 3.3. Over time, many nanofibers begin to grow from these fiber 
clusters (Figure 3.3a-d). This suggests that the large aggregates consist of nanofiber 
bundles/entanglements; and the active ends of these fibers on the outer edges of the fiber clusters can 
continue to grow radially outward.  
In order to investigate the rate at which these nanofibers grow from the clusters, the area 
covered by the fiber clusters on the mica substrate has been analyzed and plotted as a function of time 
in Figure 3.3e. It can be seen that the area covered by the fiber clusters also increases linearly with 
time. Since the nanofiber width remains uniform, the area increases linearly due to a linear increase of 
the nanofiber length. This suggests that the nanofiber growth from the fiber clusters is similar to that 
from the single nanofiber “seeds” except that each nanofiber in the former case grows at one end 
while it can grow at both ends in the latter. The equivalent growth rate of nanofiber from the fiber 
clusters can be obtained to be 3.21 nm/s through dividing the area of peptide aggregates by the width 
of nanofibers (15.6 nm prior to deconvolution). This value is almost 4 times higher than that of the 
average bidirectional growth rate of nanofibers (0.74 ± 0.40 nm/s). The much faster growth rate of 
nanofibers from the fiber clusters may be due to the peptide concentration being locally higher around 
the fiber clusters. 
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Figure 3.3 Time evolution of EAK16-II nanofiber growth from fiber clusters in pure water at (a) 120 
s, (b) 1320 s, (c) 2520 s, and (d) 3120 s. The area covered by the clusters as a function of time is 
plotted in (e). Each in-situ AFM image corresponds to a scan area of 2000 nm × 2000 nm. 
3.3.2 Effect of Solution pH on EAK16-II Nanofiber Growth on Mica 
EAK16-II is ionic-complementary and contains four positively charged residues (K, pKa of 10.54) 
and four negatively charged residues (E, pKa of 4.05) at neutral pH (Figure 3.1).174 Thus, it is 
expected that the charge status of this peptide can be tuned by adjusting the solution pH. In an acidic 
environment, the peptide becomes positively charged; whereas, it becomes negatively charged under 
basic conditions. A change in the peptide charge can affect its affinity to the negatively charged mica 





nanostructure formed after injecting a 100 µL EAK16-II stock solution into 500 µL of 1 mM HCl, to 
yield a final peptide concentration of 2 µM and a solution pH value of 3.4. Only 2 min after the 
injection, many short nanofibers ranging in length from ~30 to 100 nm are observed on the mica 
substrate (Figure3.4a). A slight increase in the nanofiber length is observed over time. After 17 min, 
the lengths range from ~110 to 490 nm (Figure 3.4d). A representative analysis of the variation of 
nanofiber length with time is plotted in Figure 3.4e. The nanofiber length increases linearly with time 
at a rate of 0.078 nm/s, which is ~7 times slower than that observed in pure water (Figure 3.2f). The 
pH (3.4) of this solution is lower than the pKa of the glutamic acid and results in the partial 
neutralization of the glutamic acid residues and leads to a net positive charge of the peptide molecule. 
Repulsive forces between positively charged molecules may explain the observed decrease in the 
fiber growth rate. On the other hand, the more positively charged peptide nanofibers and molecules 
should more easily adhere to the negatively charged mica substrate, resulting in a significant increase 
in the amount of adsorbed EAK16-II nanofibers on mica at the start of the incubation time (compare 
































Figure 3.4 EAK16-II nanofiber growth on mica substrate in 1 mM HCl solution at (a) 120 s, (b) 420 
s, (c) 720 s, and (d) 1020 s. The EAK16-II nanofiber length on mica in 1 mM HCl solution is plotted 
as a function of time in panel (e). Each in-situ AFM image corresponds to a scan area of 2000 nm × 
2000 nm. 
 
The assembly of EAK16-II in 10 mM HCl on mica was also investigated. Figure 3.5 (panels a 
and b) shows the in-situ AFM images of EAK16-II nanofibers on the mica surface in this solution 
having a measured pH of 2.2. Within about 2 min after the addition of the peptide solution to the HCl 
solution, short nanofibers are observed to densely cover the surface (Figure 3.5a). After ~19 min, no 
significant change in fiber length is observed (Figure 3.5b), indicating that very little growth of these 
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fibers occurs in such a solution. The very acidic environment could make the EAK16-II molecules 
positively charged enough to inhibit peptide-peptide and peptide-nanofiber assembly. On the other 
hand, this would tend to strengthen the affinity of the nanofibers to the negative mica surface relative 
to that observed in pure water and 1 mM HCl solution, and lead to a significant increase in the 
amount of EAK16-II adsorbed as nanofiber “seeds” on the surface (compare Figure 3.4a and Figure 
3.5a). 
The fact that very little growth of the nanofibers occurs after adsorption under highly acidic 
conditions may provide a method to characterize the dimensions of the nanofibers formed in the bulk 
solution. The nanofibers are stable upon injection into 10 mM HCl solution (see Section 3.3.3). 
Therefore, the size of nanofibers in Figure 3.5 (panels a and b) should reflect that of the nanofibers 
dissolved in the peptide stock solution. Figure 3.5c shows the length distribution of nanofibers shown 
in Figure 3.5a. The nanofibers in the peptide stock solution (12 µM) predominantly have lengths 




























Figure 3.5 EAK16-II nanofiber growth on mica in 10 mM HCl solution at (a) 120 s and (b) 1140 s. 
The fiber length distribution of EAK16-II in 10 mM HCl is plotted in panel (c). Each in-situ AFM 
image corresponds to a scan area of 1000 nm × 1000 nm. 
 
EAK16-II molecules can become negatively charged when the solution pH is greater than the 
pKa (10.54) of the lysine residues. Figures 3.6 (panels a-c) shows the in-situ AFM images of EAK16-
II nanofibers growing on the mica substrate in 1 mM NaOH (final pH 9.9). Several short nanofibers 
with lengths ranging from ~20 to 55 nm are dispersed on the mica surface after 197 min incubation. 
The length of these fibers increases slightly with time (Figure 3.6b and c). A representative plot of the 
fiber length as a function of time is shown in Figure 5d. The fiber length again increases linearly with 
time, similar to that observed in the other solutions. However, the growth rate is only 0.014 nm/s, 
much smaller than that in pure water and 1 mM HCl. When the NaOH concentration is further 
increased to 10 mM (pH 11.5 after the injection of peptide stock solution), no nanofibers are observed 
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on the mica substrate in the first hour of incubation; after 1.5 hr incubation, only a few fibers are 

























Figure 3.6 EAK16-II nanofiber growth on mica in 1 mM NaOH solution at (a) 11820 s, (b) 12420 s, and (c) 
13020 s. The EAK16-II fiber length on mica in 1 mM NaOH solution is plotted as a function of time in panel 








Figure 3.7 EAK16-II nanofiber growth on mica in 10 mM NaOH solution at (a) 5400 s and (b) 6660 
s. Each in-situ AFM image corresponds to a scan area of 2000 nm × 2000 nm. 
 
A statistical analysis was conducted to obtain the distribution of EAK16-II nanofiber growth 
rates under the different solution conditions. The frequencies of the fiber growth rates within the 
following ranges are assigned to generate the histogram shown in Figure 3.8: very slow (<0.01 nm/s), 
slow (0.01-0.2 nm/s), intermediate (0.2-0.5 nm/s) and fast growth (>0.5 nm/s). In pure water solution, 
most nanofibers grow at a fast growth rate above 0.5 nm/s, while the peptide nanofibers grow 
predominantly at a slow speed of 0.01-0.2 nm/s in 1 mM HCl and even more slowly (<0.01 nm/s) in 1 
mM NaOH solution. The average growth rates of the peptide nanofibers in the different environments 
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Table 3.1 Effect of pH of 100 µl 12 µM EAK16-II obtained by preparation in pure water and then 
addition to various solutions on fibril growth on mica  
Solution conditions Final pH Fibril deposited 
on mica 




EAK16-II in 10 mM HCl 2.2 Yes No 0 
EAK16-II in 1 mM HCl 3.4 Yes Yes 0.17 ± 0.10 
EAK16-II in pure water 5.0 Yes Yes 0.74 ± 0.40 
EAK16-II in 1 mM NaOH 9.9 Yes Yes 0.008 ± 0.003 
EAK16-II in 10 mM NaOH 11.5 Yes No 0 
 
3.3.3 Self-Assembly of EAK16-II in Bulk Solution 
Dynamic Light Scattering (DLS) of EAK16-II in solution  
To better analyze and understand the assembly behavior of EAK16-II on mica, the self-assembly 
process of EAK16-II in the bulk solutions was monitored using DLS. Figure 3.9a shows the time 
evolution of the scattered light intensity of 0.3 mM EAK16-II in pure water, 1 mM HCl, 10 mM HCl 
and 10 mM NaOH solutions. For the peptide dissolved in pure water, the scattered light intensity 
rapidly increases with time at the outset before leveling off and slowly approaching a plateau after 
~300 h (12.5 days), indicating that the self-assembly of the peptide has reached steady-state. 
However, such an equilibrium state in peptide assembly will be changed when the peptide is in 
contact with the mica surface. Upon the adsorption on the surface, the active ends of the nanofiber 
“seeds” and fiber clusters can continue to grow. The dramatic change of EAK16-II assembly due to 
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Figure 3.9 (a) Variation of scattering intensity of 0.3 mM EAK16-II in various aqueous solutions 
with time. The solid line represents a fitting curve to the equation (1). (b) Representative size 
distribution (based on the scattered intensity) of EAK16-II obtained in pure water after 55 h. (c) AFM 
image of 0.3 mM EAK16-II (prepared in pure water) after 550 h, obtained in 10 mM HCl solution. 
(d) Light intensity of EAK16-II aggregates in 10 mM HCl as a function of time. (e) The fiber length 
distribution obtained from AFM image in (c). Scale bar represents 200 nm. 
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On the other hand, the scattered light intensity shows no significant change with time in the 
case of the peptide dissolved in 1 mM HCl, 10 mM HCl and 10 mM NaOH solutions. This suggests 
that the peptide does not tend to self-assemble in these acidic and basic solutions. It has been reported 
that very acidic conditions can significantly slow the kinetics of the assembly of an amyloid 
peptide.105 This may be due to the charge repulsion among peptide molecules under these solution 
conditions. 
Figure 3.9b shows a representative hydrodynamic diameter distribution based on the light 
intensity of the peptide in pure water after 55 h incubation. This shows two distinct size populations, 
one centered at ~33 nm and the other at 320 nm. The first population may correspond to the peptide 
nanofibers, while the second one may be associated with the fiber clusters. The presence of these two 
size populations in solution is consistent with the in-situ AFM observation (Figures 3.2 and 3.3) of 
the co-existence of nanofibers and large fiber aggregates. 
To compare the dimensions of the nanofibers observed by AFM with those obtained by DLS, 
AFM images of the aged peptide (0.3 mM EAK16-II in pure water after 550 h, having reached 
equilibrium state) were taken in 10 mM HCl (Figure 3.9c). The nanofibers observed on mica are 
taken to be those that originally formed in pure water for the following reasons. As shown above, 
EAK16-II nanofibers do not further grow on the mica substrate under very acidic solution conditions 
(e.g., Figure 3.5). Also, nanofibers formed in pure water have been found to remain stable for at least 
1 hr after their addition to a 10 mM HCl solution, as indicated in Figure 3.9d which shows very little 
change in the scattered light intensity of this solution over this period. This assures a new method 
using AFM to characterize the peptide assemblies in bulk solution, in addition to the well-known 
Cryo-TEM technique, i.e., AFM imaging of peptide assemblies in an acidic solution.25,109,175 
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Images of 50 individual nanofibers obtained by AFM were analyzed to generate a distribution 
of their lengths (Figure 3.9e). This analysis shows that all nanofibers have lengths greater than 30 nm 
and the highest frequency is observed for lengths between 60 and 90 nm. The average nanofiber 
length is calculated to be 93.4 ± 37.8 nm. Based on the assumption that the nanofibers have a 













dx −×+= , L is the fiber length and d is the fiber width. The use of this 
equation yields a hydrodynamic diameter of 31 ± 8 nm (n=50), which is very close to that obtained 
from the DLS experiment in water (~33 nm, Figure 3.9b). It should be noted that this estimation is 
approximate since the assumption that the nanofiber has a cylindrical shape may not be entirely 
correct. In fact, the EAK16-II nanofibers are ribbon-like, with their heights (~1-2 nm) being much 
smaller than their widths (~7 nm). In addition, these ribbon-like nanofibers may not be as rigid as a 
cylinder. However, no simple equation is available to correlate the hydrodynamic diameter with such 
a structure. Usually, a more complicated approach or analysis is required for fiber-like 
structures.176,177 Regardless, this rough estimation shows a reasonable correlation between the AFM 
observation and the DLS measurement. 
Zeta potential of EAK16-II  
Zeta potential measurements were made to determine the surface charge of EAK16-II assemblies in 
solution. The net surface charge of particles is an important parameter to predict their tendency to 
aggregate and adsorb onto surfaces. Theoretically, the larger the zeta potential, either positive or 
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negative, of a particle, the more stable the resulting suspension will tend to be (i.e., no aggregation). 
Figure 3.10a shows zeta potentials of 0.18 mM EAK16-II solution as a function of solution pH. From 
this analysis, an isoelectric point (pI) for the EAK16-II system is found to be 6.3, which is 
comparable to the calculated pI value of 6.7 for EAK16-II molecule.50 Note that the pI being 
measured in these experiments is not for EAK16-II monomers alone, but rather for a mixture of 
monomers and aggregates that exist in these EAK16-II solutions. Figure 3.10 (panels b-d) shows the 
AFM images of 2 µM EAK16-II obtained in 1 mM HCl (final pH 3.4), pure water (final pH 5.0) and 
1 mM NaOH (final pH 9.9) after 30 min incubation. Densely dispersed and shorter nanofibers are 
observed at lower pH (1 mM HCl), while sparsely dispersed and longer nanofibers are observed at pH 
5.0 close to the pI of the EAK16-II system. At pH 9.9, which is above the pI, no fibers are observed 
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Figure 3.10 (a) Zeta potential of EAK16-II as a function of pH. The standard deviation of zeta 
potentials are less than 4 mV. (b)-(d) AFM images of EAK16-II on mica in various solutions after 30 


























Comparing the zeta potential results with the AFM observations, it can be clearly seen that the 
charge status of the EAK16-II system is crucial to the assembly of EAK16-II on mica. At low pH, the 
peptides/nanofibers are positively charged (very positive zeta potential) and so have a strong affinity 
for the negatively charged mica surface, leading to a dense dispersion on the surface (Figure 3.10b). 
However, the electrostatic repulsion between peptides tends to retard fiber growth (Figures 3.4 and 
3.5, Table 3.1) and yield shorter lengths. In pure water, on the other hand, the attraction between the 
peptide and the mica surface is moderate, but less repulsion between peptide molecules/fibers results 
due to a close to zero zeta potential. Thus, on the same time scale, fewer but longer peptide nanofibers 
than in 1 mM HCl are observed on mica (Figure 3.10c). The absence of nanofibers in 1 mM NaOH 
(Figure 3.10d) is likely due to the large electrostatic repulsion between the negatively charged peptide 
and the mica surface. Under this condition, nanofibers appear only after a long incubation time (197 
min) and the fiber growth rate is very low (Figure 3.6 and Table 3.1) 
3.4 Discussions 
3.4.1 Control of Nanofiber Growth on Mica by Adjusting Solution pH 
Surface-assisted assembly of EAK16-II on mica appears to be governed by two principal interactions: 
1) peptide-surface interaction that enables nanofiber “seeds” and fiber clusters to adsorb onto mica 
and serve as “nuclei”; 2) peptide-peptide interaction that enables elongation of the nanofiber “nuclei”. 
A simple way to control this process is to modulate the two interactions by adjusting the solution pH.  
Peptide-surface interaction  
At different pHs, the amount of nanofibers deposited on the mica surface at the same time scale can 
be significantly altered and follows the order: 10 mM HCl > 1 mM HCl > pure water > 1 mM NaOH 
> 10 mM NaOH. This is because the charge status of the peptide monomers and aggregates can be 
changed according to different solution pHs. By adjusting the solution pH, one could control the 
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adsorption of the nanofiber “seeds” to mica, which will determine the density of growing nanofibers 
on the surface.  
The adsorption of the nanofiber “seeds” on a surface is a prerequisite for surface-assisted 
nanofiber growth. The deposited nanofiber “seeds” serve as the nuclei for subsequent fiber growth. A 
high affinity for a surface will concentrate peptides at the surface and facilitate peptide-peptide 
association. This also explains why nanofiber growth of EAK16-II on mica is possible at a peptide 
concentration of 2 µM, much lower than its critical aggregation concentration (CAC) of ~60 µM.21 
The importance of the surface charge on the adsorption of peptides and proteins onto surfaces of mica 
and micelles has been demonstrated by M. Zhu et al.160 and M. Necula et al.161 It is also worth noting 
that the surface restricts the mobility of the adsorbed nanofibers and may influence their growth 
mode. 
Peptide-peptide interaction  
While the peptide-surface interaction initiates surface-assisted assembly, the growth of deposited 
nanofiber “seeds” is mainly controlled by peptide-peptide interaction. The growth rate of EAK16-II 
nanofibers on mica in various solutions follows the order: pure water > 1 mM HCl > 1 mM NaOH > 
10 mM HCl ≈ 10 mM NaOH ≈ 0 (Table 3.1 and Figure 3.8). This is because the peptide-peptide 
association can be significantly affected by the electrostatic repulsion. The fastest nanofiber growth 
occurs in pure water, where the electrostatic repulsion is minimum. The electrostatic repulsion 
increases in acidic or basic solutions, which resists the peptide-peptide association, leading to slower 
or no fiber growth. By adjusting the solution pH, one could control the growth of the nanofiber 
“seeds”, which further determines the length of the growing nanofibers at a given time period.  
Overall, the surface-assisted nanofiber growth of EAK16-II can be controlled by adjusting the 
solution pH to have the desired amount and dimension (long or short) of the nanofibers. The amount 
 
 75
of nanofibers deposited on the surface can be regulated at the step of “nucleation” (i.e., the adsorption 
of the nanofiber “seeds” to mica); the strength of the electrostatic repulsion between peptide 
molecules will determine the growth rate of the nanofibers and further control the length of 
nanofibers at a specific time. The controllable nanofiber growth on a surface may be beneficial to 
fabricate many peptide-based functional nanostructures. 
3.4.2 Proposed Model of EAK16-II Nanofiber Growth on Mica 
All AFM images have shown that the nanofibers formed on mica have a uniform width of ~7 nm and 
a height ranging from ~1 to 2 nm. Our previous results have shown that EAK16-II predominantly 
adopts a β-sheet secondary structure in aqueous solution.26 The height of a single β-sheet of EAK16-
II can be estimated to be ~1 nm. Comparison of this value with the observed nanofiber height of 
EAK16-II (~1-2 nm) suggests that the EAK16-II nanofibers observed on mica are probably made of 
one or two β-sheet layers. The width of nanofibers of ~7 nm from the AFM results is very close to the 
length of an EAK16-II molecule in β-strand conformation (~5.9 nm). Thus, we may propose that 
EAK16-II adopts a cross-β sheet arrangement when forming nanofibers (i.e., the peptide β-strands are 
arranged perpendicularly to the direction of fiber elongation).  
Accordingly, a simple model of EAK16-II nanofiber growth on the mica surface may be 
proposed in Figure 3.11. EAK16-II nanofiber “seeds” first adsorb on mica. These nanofibers are 
probably made of single or double layers of β-sheets. The two active ends of the nanofiber can further 
associate with peptide monomers or oligomers, and continue to grow. Peptide-peptide interactions 
may involve hydrogen bonding between backbones, electrostatic attraction between charged residues 
and hydrophobic interaction between alanine (A) residues. When a peptide monomer interacts with a 
β-strand at one active end, the electrostatic interaction, due to the ionic complementarity, may allow it 
to shift in the direction perpendicular to the fiber length, as shown in Figure 3.11. This may explain 
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why nanofibers are sometimes observed to have a wavy shape along its length. This model may also 
explain why the nanofibers have a consistent width. However, whether these β-sheets preferentially 
adopt an anti-parallel or parallel fashion is still unclear since both arrangements can occur in an ionic-
complementary peptide. Further experiments, such as solid state NMR and X-ray fiber diffraction, are 
required to distinguish these two arrangements.  
 
Figure 3.11 Proposed model of EAK16-II nanofiber growth on mica. 
3.4.3 Comparison of EAK16-II Assembly with Amyloid Fibrillization 
The surface-assisted assembly of EAK16-II has many similarities to amyloid fibrillization, which is a 
main characteristic of many conformational diseases.9,10 Surface-assisted EAK16-II nanofiber growth 
seems to follow a nucleation and growth mechanism. The deposited nanofiber seeds or fiber clusters 
can serve as nuclei on the hydrophilic, negatively charged mica surface for surface-assisted nanofiber 
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The growth of the deposited nanofiber “seeds” is bidirectional (i.e., from two active ends); such a 
growth pattern has been found in the fibrillization of synthetic human amylin,186 β-amyloid130 and 
prion protein either in solution or on a surface.12,187 The nanofiber growth from the fiber clusters is 
radial and unidirectional, which is also similar to amyloid fibrillization on mica and glass 
substrates.130,159,160 The kinetics of EAK16-II assembly is significantly increased upon adsorption on a 
negatively charged mica surface at a very low peptide concentration (2 µM). This is much the same as 
the finding that anionic micelles can greatly accelerate fibrillization of recombinant α-synuclein at 
low micromolar concentrations.161 These similar characteristics between EAK16-II and other disease-
related peptides/proteins suggest that a simple model peptide can be used to study the surface effect 
of the more complicated amyloid fibrillization. 
This study has demonstrated that the assembly of EAK16-II on the negatively charged mica 
surface can be controlled by modulating the peptide surface charges. The repulsion between 
negatively charge peptides and mica inhibits their adsorption and their growth. This may provide 
means to control amyloid fibrillization on negatively charged cell membranes. It has been found that 
the binding of amyloid-β peptides to cell membranes facilitates amyloid fibrillization, which in turn 
disturbs the structure and function of the membranes (e.g., membrane fluidity and ion channels).38,39 If 
the amyloid peptides/proteins becomes very negatively charged, their ability to bind to the cell 
membrane and surface-induced fibrillization may be significantly reduced. This could be achieved by 
introducing negatively charged molecules (e.g., polyglutamates) grafted with a binding motif to these 
amyloid peptides/proteins. 
3.5 Conclusions 
The growth of EAK16-II nanofibers on a mica surface has been observed via in-situ AFM. The 
growth kinetics of single nanofibers can be directly quantified. In pure water, the average nanofiber 
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growth rate is 0.74 ± 0.40 nm/s. The nanofiber growth appears to follow a nucleation and growth 
mechanism that involves the adsorption of nanofiber “seeds” or fiber clusters formed in stock 
solution, to serve as nuclei, and fiber elongation at the active ends of these nuclei. Dynamic light 
scattering experiments indicate that the nanofiber growth is a surface-assisted phenomenon; 
nanofibers that no longer grow in solution can start to grow once they adsorb onto the surface. Such 
surface-assisted nanofiber growth can be controlled by adjusting the solution pH to regulate both 
nucleation and growth steps. The amount of nanofiber “seeds” that adsorb on mica decreases as the 
solution pH increases. The growth rate of EAK16-II nanofibers in different solutions follows the 
order: pure water > 1 mM HCl > 1mM NaOH > 10 mM HCl ≈10 mM NaOH ≈ 0. This controllable 
nanofiber growth may be beneficial to the construction of functional, supramolecular structures. We 
have demonstrated that, at very acidic condition (10 mM HCl), in situ AFM is capable of directly 
“seeing” the assemblies formed in the bulk solution. The surface-assisted EAK16-II assembly has 
many similar characteristics to amyloid fibrillization on surfaces. This study provides a model to help 









Chapter 4*                                                                   
Modification of Hydrophilic and Hydrophobic Surfaces Using an 
Ionic-Complementary Peptide 
4.1 Introduction 
Surface modification plays an important role in materials science and interfacial engineering and has 
been widely used to improve the compatibility of given materials with other materials or 
environments. For example, biocompatibility is an important issue for materials used for 
transplantation and bioanalytic applications.188,189 For such a purpose, the material surface usually has 
to be physically/chemically modified to improve the compatibility with the human body.190,191 Surface 
modification can also impart additional functionalities to the materials; in particular, smart drug 
delivery vehicles have benefited from surface modification for cellular targeting and membrane 
penetration.192-194 
Recent advances in surface modification have had a significant impact on the development of 
microfluidic bioanalysis,195 immobilization of enzymes and DNA for the purpose of developing 
biocompatible biosensors196 and the control of cell adhesion in tissue engineering and biomedical 
applications.197,198 One achievement is the conjugation of both polyethylene glycol (PEG) and tri-
peptide Arg-Gly-Asp (RGD) on polymethyl methacrylate (PMMA) to control cell adhesion and 
growth for keratoprosthesis applications.199 Another is the surface modification of a conductive gold 
surface with a protein fragment containing a cell adhesion domain in order to grow and pattern 
neurons for potential use in multi-electrode array recording technology.200 Furthermore, the use of a 
dipeptide Phe-Phe (FF) to modify graphite and gold electrodes has improved the electrochemical 
reactivity of these surfaces to detect hydrogen peroxide and NADH.48,49  
*This chapter is based on a paper “H. Yang, S.Y. Fung, M. Pritzker and P. Chen, Modification of Hydrophilic and 
Hydrophobic Surfaces Using Ionic-Complementary Peptide, PLoS ONE 2007” (submitted)
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Among the many emerging materials, self-assembling peptides show promise for use in surface 
modification. In this category is a special class of ionic-complementary peptides, whose sequences 
were derived from a fragment of a Z-DNA binding protein in yeast.86 They have unique sequences 
with alternating hydrophobic and hydrophilic residues, imparting them with amphiphilic 
characteristics. They can self-assemble into β-sheet-rich nanofibrils and macroscopic membranes. 
These β-sheets were found to be very stable over a wide range of pHs (1.5-11), at high temperature 
(up to 90°C) and in the presence of denaturation agents (e.g., 0.1% SDS and 8 M urea) and some 
proteases.50,86 These peptides have been studied for a wide number of applications, ranging from 
tissue scaffolding, biological surface patterning to drug delivery.32,36,55,86,96,136,147,201,202 A special 
design of these peptides can form a self-assembled monolayer (SAM) on gold surfaces and facilitate 
cell patterning for purposes of investigating cell communications and signal transduction.203 
The ionic-complementary peptides have several features that are advantageous for modifying 
surfaces. First, their amphiphilic nature allows them to interact with both hydrophobic and 
hydrophilic surfaces. Second, the charge state of the peptide residues can be adjusted by the solution 
pH, which can affect the interaction of the peptide with the surface and the peptide assembly on the 
surface. Third, the peptide sequence can be designed and synthesized to incorporate certain amino 
acids with desired functions, such as RGD for cell attachment199 and residues containing COOH204 
and NH2205 groups for protein immobilization. Fourth, the self-assembled peptide nanostructures 
exhibit excellent chemical stability50 with good in vitro and in vivo biocompatibility.86,97,136,202 With 
these promising features, self-assembling peptide modified surfaces have great potential for use in 
(bio)molecular sensing and tissue engineering. 
In this study, we demonstrate how a model ionic-complementary peptide EAK16-II assembles 
on a hydrophilic (mica) and a hydrophobic (HOPG) surface. This peptide has been extensively 
studied in our group.21,26,27 We take this research one step further by examining how the assembly of 
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EAK16-II modifies mica and HOPG surfaces. The operation of AFM in liquid is the primary method 
used to observe the peptide assembly on the model surfaces. The hydrophobicity of the peptide-
modified surfaces is characterized by water contact angle measurements. The stability of the modified 
surfaces in acidic and alkaline solutions is evaluated in terms of the surface coverage changes 
determined from AFM image analysis. The information obtained in this study is to provide a more 
complete picture of the peptide assembly on both hydrophilic and hydrophobic surfaces and help the 
fabrication of peptide-modified electrodes for (bio)molecular sensing and biocompatible templates for 
tissue engineering.  
4.2 Materials and Methods 
4.2.1 Materials 
The ionic-complementary peptide EAK16-II (C70H121N21O25, molecular weight 1657 g/mol) has the 
sequence AEAEAKAKAEAEAKAK (Figure 4.1) where A corresponds to alanine, E to glutamic acid 
and K to lysine. At neutral pH, A is neutral, while E and K are negatively and positively charged, 
respectively. This peptide was purchased from CanPeptide Inc. (Quebec, Canada) with a purity >95% 
(purified by reverse-phase high-performance liquid chromatography). The N-terminus and C-





























































Figure 4.1 Schematic diagram of EAK16-II structure. The red portion shows the hydrophilic side of 
the peptide and the green portion shows the hydrophobic side of the peptide. 
 
EAK16-II peptide stock solutions were prepared in pure water (18 MΩ; Millipore Milli-Q 
system) at concentrations of 12 µM and 29 µM. All peptide stock solutions were stored at 4 °C before 
use. Reagent grade sodium hydroxide with purity of >99% and hydrochloric acid (36.5-38%) were 
obtained from BDH Chemicals Ltd. (Toronto, Canada) and Fisher Scientific (Nepean, Canada), 
respectively. 
Grade V-4 muscovite mica (KAl2(AlSi3)O10(OH)2) and highly ordered pyrolytic graphite 
(HOPG, ZYB grade) were obtained from SPI Supplies (West Chester, PA, USA). Mica is negatively 
charged even at pH 3165 and serves as a model hydrophilic surface, whereas HOPG serves as a model 
hydrophobic surface. Mica and HOPG were first fixed on glass slides using double-sided tape. An 
adhesive tape was then used to remove the outer layer of mica and HOPG surfaces prior to contact 
with the EAK16-II solutions.  
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4.2.2 Preparation of EAK16-II Modified Surfaces 
Appropriate amounts of the 12 µM or 29 µM EAK16-II stock solution were diluted to the desired 
concentrations (2 – 12 µM) for the experiments to measure the peptide surface coverage on mica and 
HOPG surfaces. The diluted EAK16-II solutions were added to a liquid cell with a freshly cleaved 
mica or HOPG surface at the bottom and immobilized for a time period varying from 1 min to 160 
min to allow the peptide to adhere and assemble on the surface. The EAK16-II-treated surface was 
then thoroughly rinsed with pure water three times. To avoid any drying effects on the adherence and 
assembly of the peptide on the surface, AFM imaging was carried out in pure water. 
   For contact angle measurements, 30 µl and 300 µl of the 29 µM EAK16-II stock solution 
were placed on a freshly cleaved mica or HOPG surface and allowed to contact each surface for 2 
hours under a Petri-dish cover to reduce contamination. Each modified surface was then thoroughly 
rinsed with pure water three times to remove unattached peptides and air-dried prior to measuring the 
contact angle of a water drop on the surface.   
To study the stability of EAK16-II-modified surfaces under different environments, the 
following procedure was adopted. First, a freshly cleaved mica or HOPG substrate was placed on an 
AFM sample plate on which an AFM liquid cell was mounted. Then, 500 µl of 4 µM EAK16-II 
solution was poured into the liquid cell when a mica substrate was used, while 500 µl of a 6 µM 
EAK16-II solution was contacted with HOPG substrates. These samples were then incubated for ~10 
hours to ensure a high degree of EAK16-II surface coverage. During this incubation period, all 
samples were sealed in an environmental chamber saturated with pure water to avoid evaporation of 
peptide solution. These EAK16-II treated surfaces were then rinsed with pure water three times to 
remove unattached peptides. The stability of these EAK16-II-modified surfaces was assessed through 
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AFM images to analyze the changes in peptide surface coverage after exposure to different 
environments: water, 10 mM HCl and 10 mM NaOH. 
4.2.3 AFM Imaging in Liquid 
The AFM imaging in liquid was performed on a PicoScanTM AFM (Molecular Imaging, Phoenix, AZ) 
in 500 µl of pure water, a 10 mM HCl or 10 mM NaOH solution (last two solutions were used to 
assess the stability of EAK16-II-modified surfaces). A scanner with a maximum scan area of 6 × 6 
µm2 was used. Silicon nitride cantilevers with a nominal spring constant of 0.58 N/m (DNP-S, Digital 
Instruments, Santa Barbara, CA) and a typical tip radius of 10 nm were used for tapping mode 
operation. For the best imaging quality, the tapping frequency was typically set between 16 kHz and 
18 kHz and the scan rates controlled between 0.8 and 1 Hz. To minimize interference of the AFM tip 
on peptide nanofibers, the amplitude of the tip displacement between each tap was controlled so that 
the tapping would not break any nanofibers. All images were obtained in an environmentally-
controlled chamber at room temperature to avoid evaporation of the solution. All AFM images were 
obtained at a resolution of 256 × 256 pixels. 
4.2.4 Quantitative Analysis of AFM Images 
The width and height of EAK16-II nanofibers on mica and HOPG surfaces were determined using the 
cross-sectional analysis tool of the PicoScan software. The peptide fiber widths reported herein were 
obtained using the deconvolution method reported by Fung et al.21 The surface coverage of EAK16-II 
on mica and HOPG was analyzed with Image J software (http://rsb.info.nih.gov/ij/). For each sample, 
at least five images (6 µm × 6 µm) at different locations were analyzed to obtain the average surface 
coverage of the peptide assemblies. The AFM tip size effect was not taken into account in estimating 
the surface coverage of the EAK16-II nanofibers on the mica and HOPG substrates. Therefore, the 
surface coverage values reported in this study are apparent values and higher than the true values. 
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This should be sufficient since our objective is to show the trends on the effect of incubation time and 
peptide concentration on the coverage of EAK16-II nanofibers on mica and HOPG surfaces. Another 
purpose of the surface coverage measurements is to compare the stability of EAK16-II-modified 
surfaces in various environments. 
4.2.5 Contact Angle Measurement 
Contact angle measurements were made to determine changes in the hydrophobicity of the surfaces 
upon their modification by EAK16-II. A sessile drop of water (30 µl) was manually deposited on the 
unmodified and EAK16-II-modified surfaces placed inside a sealed, water-saturated chamber (to 
prevent evaporation). A sequence of images of the water drop was then recorded over a period of 5 
minutes in 5-second intervals. The recorded images were analyzed by the Axisymmetric Drop Shape 
Analysis-Profile (ADSA-P) program206 to yield a water contact angle. All the experiments were 
controlled by a refrigerated bath/circulator digital controller (NESLAB Instrument, Inc., Georgetown, 
Ontario) to ensure that the temperature remained at 20 ± 0.1 °C during the measurements. The water 
contact angle for each surface reported herein represents the static one and the average value was 
obtained from three different drops.  
4.3 Results and Discussion 
4.3.1 EAK16-II Assembly on Hydrophilic Mica Surface 
The AFM images (Figure 4.2a-i) show that EAK16-II can adhere to a mica surface and assemble into 
nanofibers after a certain time in pure water. In the presence of 4 µM EAK16-II, a few single and 
unbranched short fibers are observed after 1 minute of incubation (Figure 4.2a). With time, longer 
and more fibers appear on the mica surface (Figures 4.2b and c). After 10 minutes, fiber networks are 
observed (Figures 4.2d-i). The evolution of the surface coverage of EAK16-II nanofibers with the 
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incubation time is plotted in Figure 4.2j. The surface coverage of EAK16-II nanofibers increases 
rapidly with time over the first 30 or 40 minutes before leveling off to a plateau of about 27% after ~1 
hour, indicating that saturation has been reached.  
 
(a) 1 min 
 
(b) 2 min 
 
(c) 5 min 
 
(d) 10 min 
 
(e) 23 min 
 
(f) 40 min 
 
(g) 80 min 
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Figure 4.2 Time evolution of 4 µM EAK16-II assembly on the mica surface. AFM images collected 
at various incubation times: (a) 1 min; (b) 2 min; (c) 5 min; (d) 10 min; (e) 20 min; (f) 40 min; (g) 80 
min; (h) 120 min; (i) 160 min. Surface coverage of EAK16-II on mica as a function of incubation 
time is plotted in panel (j). Each image corresponds to a scan area of 2000 nm × 2000 nm. 
 
As expected, the surface coverage of EAK16-II nanofibers on mica is affected by the peptide 
concentration. Figure 4.3 shows images obtained at different peptide concentrations after an 
incubation time of 10 min. Only a few short fibers are observed on mica at a low EAK16-II 
concentration of 1 µM (Figure 4.3a). When the EAK16-II concentration is raised to 2 µM, the number 
and length of the nanofibers increase (Figure 4.3b). A further rise in the concentration to above 4 µM 
leads to the formation of fiber networks, which become denser as the peptide concentration continues 
to increase (Figure 4.3c-e). Quantitative analysis of the images yields the variation in surface 
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coverage of EAK16-II nanofibers with peptide concentration shown in Figure 4.3f. This indicates that 
the peptide concentration may serve as an operating variable to control the surface coverage on the 
mica surface.  
 
 






























Figure 4.3 Effect of EAK16-II concentrations on the surface coverage of peptide assemblies on mica. 
AFM images of EAK16-II-modified mica surfaces at 10 min incubation with various peptide 
concentrations: (a) 1 µM; (b) 2 µM; (c) 4 µM; (d) 8 µM; (e) 12 µM. Surface coverage of EAK16-II 
assemblies on mica as a function of peptide concentrations is plotted in panel (f).  Proposed molecular 
arrangement of EAK16-II assembly on mica is plotted in panel (g). Each image corresponds to a scan 
area of 2000 nm × 2000 nm. 
 +     +                       +     +                               
-      -                        -       -        
  mica
          +     +                      +      + 
-        -                       -      -                                  
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The width and height of the nanofibers are observed to be independent of peptide concentration 
and incubation time, and estimated to be ~7.0 ± 2.6 nm and ~1.8 ± 0.2 nm, respectively, after AFM 
tip deconvolution.21 These dimensions may provide information on the molecular arrangement of 
EAK16-II in the nanofibers and form the basis for the proposed structure shown in Figure 4.3g. It has 
been reported that EAK16-II forms β-sheets in pure water and salt solutions.27,50,86 In a β-sheet 
structure, successive side chains of a polypeptide extend to opposite sides of the pleated sheet, 
resulting in a distance of ~0.7 nm between two adjacent residues on one side of the sheet.207 A 16-
residue β-strand would therefore have a length of 5.6 nm. Considering the N and C-terminal 
protection groups contribute an additional length of about 0.4 nm (estimated from Chemsketch 
software, Toronto, Canada), the total length of an EAK16-II β-strand would be approximately 6 nm. 
This length is close to the fiber width (7.0 ± 2.6 nm) observed on the mica surface. The height of a 
single EAK16-II molecule in a β-strand conformation is ~0.9 nm (estimated from Chemsketch 
software). By comparing the height of a single EAK16-II molecule with that of the EAK16-II 
nanofibers, we may infer that the nanofibers on the mica surface are made of two β-sheet layers 
stacked on top of one another. With such a structure, charged residues of the bottom layer peptide are 
oriented toward the hydrophilic mica surface and those of the top layer peptide toward the aqueous 
solution. The two β-sheet layers are held together by hydrophobic interactions between the 
hydrophobic residues of the two EAK16-II molecules. This arrangement minimizes the contact of the 
hydrophobic residues with either mica or the solution. 
In the proposed model (Figure 4.3g), the modification of the mica surface by the peptide 
nanofibers is due to the electrostatic attraction between the peptide and the surface. The negatively 
charged mica surface can attract positively charged lysine residues at neutral pH. This electrostatic 
attraction is expected to be the major driving force for the adsorption and adhesion of the peptide on 
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mica (see Section 4.3.4). Since a chemical bond between the peptide and mica surface is unlikely to 
form, the adhesion of the peptide to the mica surface may be classified as physical adsorption. The 
growth of short peptide nanofibers into long fibers and fiber networks is thought to occur by the 
attachment of monomers and small protofibers onto the fiber ends at the mica surface, which has been 
characterized as surface-assisted nanofiber growth (see Chapter 3).  
4.3.2 EAK16-II Assembly on Hydrophobic HOPG Surface 
The AFM images of EAK16-II nanofibers formed on HOPG are shown in Figure 4.4. At a low 
EAK16-II concentration (2 µM), a few long peptide nanofibers are observed after 25 min incubation 
time (Figure 4.4a); a longer incubation time of 2 hours results in more nanofibers on the surface, 
which are either parallel or aligned 60° or 120° to each other (Figure 4.4b). Such an orientation of the 
fibers presumably arises due to the hexagonal crystal structure of the HOPG (0001) surface and 
reflects the importance of the substrate to the peptide nanofiber orientation. When the EAK16-II 
concentration increases to 6.2 µM, nanofibers arranged at 60° or 120° to each other are observed 
within 10 minutes of incubation (Figure 4.4c). As the incubation time increases to 2 hours, more 
nanofibers appear (Figure 4.4d). These results show that EAK16-II can assemble into patterned 





(a) 2 µM, 25 min (b) 2 µM, 120 min 
  
(c) 6 µM, 10 min (d) 6 µM, 120 min 
Figure 4.4 AFM images of EAK 16-II modified HOPG surfaces at different concentrations and time 
periods. (a) 2 µM 25 min, (b) 2 µM 120 min, (c) 6 µM 10 min and (d) 6 µM 120 min. Each image 
corresponds to a scan area of 1000 nm × 1000 nm 
 
Unlike the case with mica, the affinity of EAK16-II to HOPG is likely due to hydrophobic 
interactions. As mentioned, the peptide has an amphiphilic structure in which the alanine residues lie 
on one side of the backbone, while the lysine and glutamic acid residues lie on the other side (Figure 





hydrophobic interaction in which the alanine side is oriented toward HOPG and the lysine and 
glutamic acid groups face the solution, resulting in side-on adsorption (i.e., peptide molecules lie 
down with their long axes parallel to the substrate surface).208 Thus, each fiber would be made up of 
only a single layer of peptides on the surface, different from the situation with mica where two layers 
may be stacked on top of one another. This reasoning is supported by the observation that the fibers in 
Figure 4.4 at both peptide concentrations have a uniform width and height of 6.2 ± 2.0 nm and 0.9 ± 
0.2 nm, respectively. The height of these nanofibers is close to that of a single peptide molecule in an 
extended β-strand. 
Another question to address is whether the self-assembled nanofibers preferably form on the 
HOPG surface along the edges between adjacent terraces or on the terraces. It is known that the 
electrodeposition of metal ions occurs preferably along step edges of a surface.209,210 In addition, 
Gettens et al. reported that the protein fibrinogen tends to adsorb on the step edges of HOPG rather 
than on the terraces.208 However, our observation from the AFM image (Figure 4.5a) indicates that 
the EAK16-II nanofibers are primarily on the terraces and not at the step edges of HOPG. Figure 4.5b 
shows cross-sectional profiles of the HOPG surface along the two line segments indicated in Figure 
4.5a. One line segment (green) crosses two closely-spaced fibers lying on the same terrace of HOPG, 
as indicated by the corresponding cross section showing that the height of the surface is the same on 
either side of the two bumps corresponding to the fibers (bottom plot in Figure 4.5b). On the other 
hand, very few of the nanofibers are oriented along the step edges. As an example, the red line 
segment crosses an edge without intersecting any fibers (Figure 4.5a and top plot in 4.5b). A possible 
explanation for this phenomenon is as follows. When adopting a β-sheet secondary structure, EAK16-
II has a unique structure with charged residues on one side and hydrophobic residues on the other 
side. The strongest interaction of the peptide with a hydrophobic surface would involve contact of the 
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hydrophobic side of the peptide with the terrace of the substrate. Therefore, it is not necessary for the 




Figure 4.5 The preferred location of EAK16-II self-assembled nanofibers on the HOPG surface. (a) 
A representative AFM image of EAK16-II on HOPG surface over a scan area of 800 nm × 800 nm; 
(b) cross sectional analysis of EAK16-II nanofibers on one terrace (green line) and a step edge of 
HOPG (red line); (c) schematic diagram of EAK16-II nanofibers on HOPG surface. 
 
Another interesting feature of the patterns formed on HOPG is that long EAK16-II nanofibers 
can actually drape over step edges from one terrace to the next. One advantage of such behavior is 
that surface defects such as edges and kinks may not significantly inhibit the formation of the 
EAK16-II nanofiber structure. Thus, the EAK16-II nanofibers can be evenly distributed, allowing 
control of their density over the entire surface. 
Previous research has shown that HOPG surface can direct peptides and proteins to form 
patterned nanostructures. Examples are elastin-like peptides42, de novo proteins41 and amyloid 




another. However, the detailed mechanism of how proteins or peptides assemble at liquid/inorganic 
substrate interfaces still remains unclear. 
Based on the analysis of the EAK16-II and HOPG structures, we herein propose a model of 
EAK16-II assembly into nanofibers on HOPG. The length of an EAK16-II molecule in β-strand is ~6 
nm, which is comparable to the fiber width observed on the HOPG surface (~6 nm after 
deconvolution for the AFM tip size effect). In addition, the HOPG surface is made of hexagonal 
lattices, as shown in Figure 4.6a. In order to attain the largest hydrophobic contact between EAK16-II 
and the HOPG surface, it is expected that a peptide molecule would arrange itself to cover as many 
carbon atoms as possible. From the length of each C-C bond (0.246 nm) in the graphite lattice and the 
dimension of an EAK16-II β-strand, one extended strand would cover 29 carbon atoms in a row 
(Figure 4.6a). The peptide can assume the three possible orientations on the HOPG shown as green 
stripes in order to meet this requirement. The peptide strands can then line up parallel to one another 
to form nanofibers in the directions indicated by the three purple arrows at an angle of 60° or 120° to 
one another. Such a pattern is very similar to the fiber orientation shown in the AFM image in Figure 
4.6b. The special orientation of peptide fibers is also indicated by the characteristic 6-fold symmetry 
of the 2-dimensional Fourier transform of the image (Figure 4.6b inset)  
A comparison of the height of the patterned nanofibers (0.9 ± 0.2 nm) with that of a single 
peptide strand (~0.9 nm) suggests that these fibers consist of single layer β-sheets. These single layer 
sheets likely adsorb through the hydrophobic interaction between the alanine residues of the peptide 
and HOPG surface, leaving the hydrophilic lysine and glutamic acid residues facing the aqueous 
solution (Figure 4.6c). If such a structure forms, the EAK16-II-modified HOPG surface should be 






Figure 4.6 Proposed model of EAK16-II assembly on HOPG surface. (a) Schematic representation of 
EAK16-II strands assembled on HOPG; (b) AFM image of EAK16-II on HOPG surface over a scan 
area of 1000 nm × 1000 nm; the inset is the two-dimensional Fourier transform of the AFM image, 
showing a characteristic 6-fold symmetry; (c) schematic diagram of EAK16-II in a β-strand 
conformation on HOPG.  
4.3.3 Water Contact Angles of EAK16-II Modified Surfaces 
Contact angle measurements were conducted to determine whether the hydrophobicities of mica and 
HOPG surfaces change upon modification by EAK16-II. Figure 4.7 and Table 4.1 summarize the 
water contact angle measurements on mica and HOPG surfaces before and after the modification with 
EAK16-II. The water contact angle on a freshly cleaved mica surface is less than 10° (Figure 4.7a), 
indicating that the surface is very hydrophilic and almost completely wettable.211 Once mica is 
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modified with EAK16-II nanofibers, the water contact angle of the surface increases to about 20° 
(Figure 4.7b and Table 4.1). This increase could result from the amphiphilic nature of the peptide 
molecule enhancing the hydrophobicity of the surface after the modification. However, a water 
contact angle of 20° indicates that the EAK16-II-modified mica surface still remains hydrophilic. On 
the other hand, the water contact angle of an EAK16-II-modified HOPG surface decreases to about 
39° (Figure 4.7d). This value is much lower than that obtained on a freshly cleaved HOPG surface, 
which ranges between 82° and 60° likely due to variations in surface morphology (Figure 4.7c and 
Table 4.1). This result indicates that HOPG becomes more hydrophilic after treated with EAK16-II 
and is consistent with what would be expected from the proposed single layered β-sheet structure 
with lysine and glutamic acid oriented toward the aqueous solution (Figure 4.6c). 
(a) (b) 
(c) (d) 
Figure 4.7 Photographs of water contact angles of mica and HOPG surfaces and their EAK16-II 




Table 4.1 Contact angles measured on mica, HOPG and their EAK16-II-modified surfaces 
surfaces mica EAK16-II/mica HOPG EAK16-II/HOPG 
contact angle < 10° 20.3° ± 2.9° 71.2° ± 11.1° 39.4° ± 4.3° 
 
4.3.4 Stability of EAK16-II Modified Surfaces in Acidic and Alkaline Solutions 
To gain more insight concerning the structures of EAK16-II on mica and HOPG surfaces proposed in 
sections 4.3.1 and 4.3.2, we investigated the stability of the assembled nanostructures on these two 
surfaces in acidic and alkaline solutions. Also, in view of the possible practical applications of such 
modified surfaces, information regarding their stability in different environments would be useful. 
The stability is interpreted from the change in the surface coverage by the EAK16-II. As shown in 
Figure 4.8a-c and Table 4.2, EAK16-II remains on a mica surface as randomly oriented nanofibers in 
pure water, 10 mM HCl and 10 mM NaOH solutions, although differences in the surface coverage of 
EAK16-II are observed. After contact of the EAK16-II modified mica surface with the 10 mM HCl 
solution for 10 hours, the surface coverage of nanofibers does not change much (21.4 ± 3.5%) from 
that obtained prior to contact with the acid (23.7 ± 7.3%). However, the surface coverage decreases 
significantly to 7.7 ± 3.7% after the modified mica surface has been immersed in a 10 mM NaOH 
solution for 10 hours. These results indicate that an EAK16-II-modified mica surface is stable in an 
acidic solution but not in an alkaline solution. It has been reported that EAK16-II nanofibers remain 
stable in the bulk of acidic and alkaline solutions.26 Thus, the decrease of the amount of nanofibers on 
mica surface under alkaline conditions may be due to a weakening of the peptide-surface interaction 
due to a change of the charge of the EAK16-II residues. Under acidic or neutral conditions, EAK16-II 
can adsorb on mica through the electrostatic interaction between positively charged lysine and the 
negatively charged surface. At pH 12 (10 mM NaOH), the lysine residues of EAK16-II become 
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neutral, making the peptide nanofibers negatively charged overall due to the glutamic acid residues. 
The repulsion between the negatively charged fibers and the negatively charged mica surface would 
cause the detachment of peptide nanofibers from the mica surface. If this interpretation is correct, it 
further demonstrates that the electrostatic interaction is a major driving force in the adsorption of 
EAK16-II onto mica surfaces.  
   
(a) EAK/mica in pure water (b) EAK/mica in 10mM HCl (c) EAK/mica in 10mM NaOH 
  
(d) EAK/HOPG in pure water (e) EAK/HOPG in 10mM HCl (f) EAK/HOPG in 10mM NaOH 
 
Figure 4.8 AFM images of EAK16-II modified mica and HOPG surfaces after immersion in pure 
water, 10 mM HCl and 10 mM NaOH solutions for 10 hours. Scan areas are 2000 nm × 2000 nm for 
mica surface and 1000 nm × 1000 nm for HOPG surface. (a) Mica, water; (b) mica, 10 mM HCl; (c) 
mica, 10 mM NaOH; (d) HOPG, water; (e) HOPG, 10 mM HCl; (f) HOPG, 10 mM NaOH. 
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Table 4.2 Surface coverage on EAK16-II-modified mica and HOPG surfaces after 10 hours under 
different environments  
surface coverage % water 10mM HCl 10mM NaOH 
mica 23.7±7.3 21.4±3.5 7.7±3.7 
HOPG 65.6±7.4 63.9±7.3 65.1±3.8 
 
In the case of the EAK16-II-treated HOPG surface, the surface coverage of peptide nanofibers 
does not change in either the acidic or alkaline environment from that observed previously in pure 
water. As shown in Figure 4.8d-f and Table 4.2, the surface coverages of peptide nanofibers are 65.6  
± 7.4%, 63.9 ± 7.3% and 65.1 ± 3.8% after immersion in water, 10 mM HCl and 10 mM NaOH 
solutions, respectively, for 10 hours. These results indicate that the EAK16-II-modified HOPG 
surface is stable under neutral, acidic and alkaline conditions. This also supports our proposal that the 
association of the peptide with HOPG surface is mainly through hydrophobic interaction, which 
should not be strongly affected by the charge state of the peptide. Also, the fact that fibers remain 
stable on a modified HOPG surface in an alkaline solution, but not on a modified mica surface, 
provides further support that the loss of stability in the latter case is due to a change in the mica-
EAK16-II interaction but not to chemical attack on the nanofibers.  
The use of amphiphilic self-assembling peptides for surface modification offers a number of 
advantages. First, the modification process occurs spontaneously by adsorption of peptide fibers onto 
the surface followed by molecular self-assembly to elongate pre-deposited fibers on the surface. This 
process can be achieved by simply immersing the substrate into an aqueous peptide solution under 
suitable conditions. Second, the peptide secondary structure and self-assembled nanostructures have 
been shown to exhibit excellent chemical stability by resisting degradation in acidic or alkaline 
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environments and even in the presence of denaturation reagents,21,26,97 while exhibiting good in vitro 
and in vivo biocompatibility.86,97,136,202 Third, various substrates, including gold,212,213 can be modified 
by these peptides through various molecular interactions, which may not depend on specific thiol-
gold chemistry. Fourth, since the solution pH affects the charge state of the peptide, it provides 
another means by which the surface charge of the modified substrate can be adjusted for specific 
applications. Furthermore, the peptide sequence can be specially designed and synthesized to 
incorporate certain amino acids with desired functions. With these promising features, surfaces 
modified by self-assembling peptides may be useful in biosensor technology and tissue engineering. 
The advantages of using EAK16-II-modified HOPG surfaces specifically for a number of 
applications are as follows. First, the hydrophobicity of the modified surface can be significantly 
reduced to improve its water wettability. The improvement of the water wettability of a given 
hydrophobic surface by EAK16-II could be utilized to help stabilize hydrophobic compounds in 
aqueous systems. If successful, this could have significant implications for hydrophobic drug 
delivery.32,147 Second, the biocompatibility of the HOPG surface may be improved by EAK16-II, 
which has been found to support mammalian cell attachment.97 Third, outward orientation of charged 
residues (K and E) toward the solution may provide electrostatic interaction and covalent linkage with 
other analytes and biomolecules so that chemical or enzymatic reactions on the surface can be 
accelerated. This could be important in electrochemical sensor and biosensor applications as well as 
the catalysis of biochemical reactions. For example, the carboxylate group of the glutamic acid 
residues on EAK16-II can be covalently linked to the amine group of an enzyme (e.g. glucose 
oxidase, GOx) Thus, the enzyme molecules can be immobilized on a graphite surface with the 
assistance of EAK16-II assembled nanostructures. Since HOPG is electronically conductive, this 
modification could make it a promising enzymatic biosensor (see Appendix A). It is also worth noting 
that the charge state of a peptide or protein can be changed by adjustment of the solution pH. For 
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example, the surface charge of EAK16-II-modified HOPG can be altered to be positive (K) or 
negative (E) in acidic or basic solutions, respectively, to selectively bind with target molecules.  
4.4 Conclusions 
The ionic-complementary peptide EAK16-II has been shown to assemble on both mica and HOPG 
surfaces to form nanofibers. The interaction between the peptide and mica is mainly through 
electrostatic attraction, whereas the adsorption of peptides and nanofibers on HOPG occurs through 
hydrophobic interaction. EAK16-II forms randomly orientated nanofibers with uniform width on the 
hydrophilic mica surface. In contrast, EAK16-II nanofibers with preferential orientations at angles of 
60° or 120° to each other are observed on the hydrophobic HOPG surface. This orientation resembles 
the crystallographic structure of the graphite surface. After modification with EAK16-II, the contact 
angle of mica surface increases from <10° to 20.3 ± 2.9°, but the surface remains hydrophilic. 
However, the hydrophobicity of the HOPG surface is significantly reduced as seen from a contact 
angle change from 71.2 ± 11.1° to 39.4 ± 4.3°. An EAK16-II-modified mica surface is stable in acidic 
solution, but not in alkaline solution, while the modified HOPG surface is stable in both acidic and 
alkaline solutions for at least 10 hours. This work has shown the potential of using ionic-
complementary peptides to modify both hydrophobic and hydrophilic surfaces and may open up the 
possibility of other surface modifications beyond traditional thiol-gold technology. In addition, the 
controllable peptide assembly on HOPG surface has an exciting potential application in constructing 






Chapter 5*                                                                    
Mechanical Force-Induced Peptide Assembly at Liquid/Solid 
Interfaces 
5.1 Introduction 
Self-assembling peptides have emerged as new nanobiomaterials and received considerable attention 
in the areas of nanoscience and biomedical engineering.1,8,55 They are either fragments of naturally 
existing proteins or derived by de novo biomolecular design. Among the many self-assembling 
peptides is a class of ionic-complementary peptides, which contain a repetitive charge distribution 
and alternating hydrophobic and hydrophilic residues in the amino acid sequence, resulting in the 
unusual properties of amphiphilicity and ionic complementarity. Such peptides can self-assemble into 
various stable nanostructures via electrostatic interactions, hydrogen bonds and hydrophobic 
interactions.8,50,86 Their self-assembled nanostructures have a wide range of potential applications 
such as templates for nano-fabrication,24,35,70,111 scaffoldings for tissue repair and tissue 
engineering,36,37 nanocarriers for anti-cancer drug and gene/siRNA delivery32,147 and surface modifiers 
for enzyme immobilization in biosensors. 
Many applications of self-assembling peptides involve interface and surface patterning with 
peptide micro-/nanostructures. Therefore, understanding and controlling the peptide assembly on a 
surface becomes critical in developing these applications. Our previous studies have shown that the 
surface can facilitate and/or direct the assembly of a model ionic-complementary peptide, EAK16-II; 
(See Chapter 3) the surface-assisted peptide assembly follows a nucleation and growth mechanism, 
and the assembly kinetics can be influenced by the surrounding environment such as solution pH.(See 
Chapter 3) Although the solution conditions can be used to help control the density of peptide 
nanostructure formed globally over an entire surface, it would be useful, for example, in the 
*This chapter is based on a paper “ H. Yang, S.Y. Fung, M. Pritzker and P. Chen, Mechanical Force-Induced Peptide 
Assembly at Liquid/Solid Interfaces, Angew. Chem, Int. Ed.” (submitted) 
 
 104
fabrication of nanoscale devices to develop techniques that can produce patterns over local regions of 
a surface. Scanning probe lithography has been successfully used to pattern self-assembled 
monolayers (SAMs) on surfaces by mechanically scratching the SAM-covered surface using contact 
mode Atomic Force Microscopy (AFM).44,214,215 Mechanical force/stress has recently been shown to 
induce chemical reactions216 and to deliver single molecules to specific locations,217 opening up the 
field of nano-mechanochemistry. It would therefore be important to determine whether a 
mechanochemical approach can be extended to molecular self-assembly, peptide self-assembly here 
in particular, through the application of a relatively gentle mechanical force by a tapping AFM tip. 
Note that molecular self-assembly is often governed by weak, non-covalent interactions. To the best 
of our knowledge, an investigation on this topic has not been reported in the literature. 
More specifically, our aim is to determine whether the mechanical force applied by a tapping 
AFM tip can be used to better control the nanostructure of a model peptide that self-assembles over 
desired regions of a substrate and produce patterns that otherwise would not be possible. The primary 
effect of such a mechanical force is expected to break the peptide-assembled nanostructures; these 
broken fragments may serve as new nuclei for subsequent assembly or nanostructure growth. If so, 
the process of breaking peptide-assembled nanostructures by an AFM tip alone could form the basis 
for a nanolithography method to pattern the surface. 
5.2 Materials and Methods 
5.2.1 Materials 
The ionic-complementary self-assembling peptides EAK16-II (C70H121N21O25, Mw = 1657 g/mol) and 
EFK16-II (C118H153N21O25, Mw = 2265.6 g/mol) have sequences of AEAEAKAKAEAEAKAK and 
FEFEFKFKFEFEFKFK, respectively; where A and F correspond to alanine and phenylalanine, E to 
glutamic acid and K to lysine. At neutral pH, A and F are neutral hydrophobic residues, while E and 
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K are negatively and positively charged, respectively. These peptides were purchased from 
CanPeptide Inc (Québec, Canada). The N-terminus and C-terminus of these peptides were protected 
by acetyl and amino groups, respectively, to minimize end-to-end electrostatic attraction between 
peptides.27 The purity of EAK16-II is above 95% (purified by reverse-phase high-performance liquid 
chromatography), while that of EFK16-II is ~60% (crude). 
EAK16-II and EFK16-II stock solutions were prepared in pure water (18.2 MΩ; Millipore 
Milli-Q system) at a concentration of 30 µM and 44 µM, respectively, and stored at 4 °C before use. 
Reagent grade sodium hydroxide with purity of 99+% and hydrochloric acid (36-38% by weight) 
were obtained from BDH Chemicals Ltd. (Toronto, Canada) and from Fisher Scientific (Nepean, 
Canada), respectively. 
Grade V-4 muscovite mica (KAl2(AlSi3)O10(OH)2) and HOPG (ZYB grade), both obtained 
from SPI Supplies (West Chester, PA, USA), were used as the two model surfaces for AFM imaging. 
Mica and HOPG were fixed on the AFM liquid sample plate using double-sided tape. An adhesive 
tape was used to remove the outer layer of the mica and HOPG surfaces and expose fresh layers prior 
to the addition of peptide solution. 
5.2.2 In-Situ AFM Imaging 
To monitor in real-time the effect of the mechanical force applied by the AFM tip on EAK16-II 
nanofibers on substrates, in-situ AFM imaging was performed on a PicoScanTM AFM (Molecular 
Imaging, Phoenix, AZ) in a liquid cell (custom-made). The liquid cell was mounted on freshly 
cleaved mica or HOPG and filled with 500 µl pure water. Peptide stock solution was then injected 
into the liquid cell with a micro-syringe. The final peptide concentration in the liquid cell was 2, 4 or 
6 µM, as indicated in the figure captions and the main text. After certain time periods, the peptide 
nanofibers formed on the surfaces were then scanned with the AFM tip to apply a mechanical force. 
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For the experiments on the effect of solution conditions, the liquid cell was filled with 1 mM HCl, 10 
mM HCl or 10 mM NaOH solution instead of pure water prior to the injection of the peptide stock 
solution. 
The amplitude of the AFM tip was calculated with the following equation from the AC mode 









=                           (5.1) 
The sensitivity of the AFM tip operating in liquid was obtained from amplitude-distance spectroscopy 
and found to be 18.0 ± 0.8 and 14.7 ± 1.5 nm/V for HOPG and mica substrate, respectively. The 
display voltage was ~1 V during imaging. Thus, the amplitude of silicon nitride cantilever oscillation 
in liquid was calculated to be ~3-4 nm. 
Atomic force microscopy images were taken using a scanner with a maximum scan area of 6 × 
6 µm2. All AFM experiments were conducted in an environmental-controlled chamber at room 
temperature to avoid evaporation of the working solution. Silicon nitride cantilevers with a nominal 
spring constant of 0.32-0.58 N/m (DNP-S, Digital Instruments) and a typical tip radius of 10 nm were 
used for tapping mode in liquid. To obtain the best imaging quality, the tapping frequency was 
usually set between 16 and 18 kHz and the scan rates were set to 0.814 Hz (~5 mins for each AFM 
image). All AFM images were obtained at a resolution of 256 × 256 pixels. 
In general, the indicated times in the figures refer to the moment when the EAK16-II stock 
solution was injected into the liquid cell containing the desired solutions. The indicated 
concentrations for the acid and alkaline solutions refer to the original concentrations added to the 
liquid cell. An initial image of a newly cleaved mica/HOPG surface under the working solution was 
taken to confirm the absence of contaminating particles. 
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The surface coverage of EAK16-II nanofibers on the HOPG surface at different time periods 
was measured with the Image J software (http://rsb.info.nih.gov/ij/). The width and height of EAK16-
II nanofibers were determined by the cross section analysis tool of the PicoScan software. The 
peptide nanofiber widths reported herein were obtained using the deconvolution method reported by 
Fung et al.21 
5.2.3 Surface Tension Measurements 
The experimental set-up for the Axisymmetric Drop Shape Analysis-Profile (ADSA-P) technique to 
study the dynamic surface tension of 30 µM EAK16-II in various solutions was described in more 
detail in an earlier publication.101 Briefly, a pendant drop of the peptide solution was formed at the tip 
of a vertical Teflon needle (0.92 mm inner diameter) connected to a motor-driven micro-syringe (1 
ml, release speed of 0.04 ml/s). The sample was placed in a temperature-controlled environmental 
chamber, saturated with the corresponding solvent vapor to maintain a constant humidity. The entire 
system was placed on a vibration-free table. The images of the pendant drop were magnified by an 
optical microscope and then captured by a CCD camera before being transferred to a computer. The 
surface tension of every sample was measured for 2 hours. During each run, images were acquired at 
0.5 s intervals for the first 70 s and then at 20 s intervals for the remaining time. Software was used to 
digitize the images and generate a profile of the pendant drop. A theoretical curve governed by the 
Laplace equation of capillarity was then fitted to the profile, generating the surface tension value as a 
fitting parameter.218 The standard deviation of the surface tension values obtained was less than 0.2 
mJ/m2. 
5.3 Results and Discussions 
The studied peptide EAK16-II has a molecular structure shown in Figure 5.1a. This peptide 
predominately adopts a β-sheet secondary structure, resulting in a unique amphiphilic structure with 
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hydrophilic residues on one side and hydrophobic residues on the other side. Such a molecular 
structure may allow it not only to self-assemble but also to interact with both hydrophilic and 
hydrophobic surfaces (Figure 5.1b and c). Negatively charged mica and hydrophobic HOPG were 
used to create liquid/hydrophilic and liquid/hydrophobic interfaces, respectively. It is expected that 
the positively charged lysine residues can interact with the mica surface, while the hydrophobic 













Figure 5.1 (a) Schematic diagram of EAK16-II molecular structure. Interfacial orientation of 
EAK16-II assemblies on (b) negatively charged hydrophilic mica surface and (c) hydrophobic HOPG 
surface. The green dotted lines represent hydrogen bonds between two peptide backbones. 
Hydrophilic side  
             −                −                   +              +                 −             −                     +                 +
                                                              
Hydrophobic side  
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The experiments were carried out by first depositing EAK16-II nanofibers on two model 
surfaces: negatively charged mica and hydrophobic highly ordered pyrolytic graphite (HOPG); in-situ 
AFM was then applied not only to generate the mechanical force on the peptide nanofibers formed on 
the surfaces during tip scanning, but also to monitor the force-induced/directed peptide assembly in 
real-time (in the presence and absence of peptide molecules in the solution). The total work applied 
from a tapping AFM tip to the biomolecules could be manipulated by adjusting the amplitude of the 
tip oscillation, the size of the scan area and scan speed. 
5.3.1 Cutting EAK16-II Nanofibers by a Tapping AFM Tip 
Figure 5.2a-c shows that EAK16-II nanofibers formed on a mica surface can be broken up by an 
AFM tip in tapping mode operation in pure water. Initially, continuous nanofibers are imaged when 
scanning over a large area of 2 µm × 2 µm (Figure 5.2a). However, when the scan is performed over 
the 500 nm × 500 nm dotted area, the nanofibers in this region appear to be discontinuous and broken 
(Figure 5.2b). The repetitive scanning at the same location leads to further truncation and 
displacement of the segments of the nanofibers (Figure 5.2c). This result shows that in the absence of 
dissolved peptide in solution, the applied mechanical force from the AFM tip can cut the nanofibers 










Figure 5.2 AFM images showing the effect of the mechanical force applied by the AFM tip on 
EAK16-II nanofibers adsorbed on mica in pure water. (a) 2 µm × 2 µm scan area; (b) zoom-in scan of 
the dotted area in (a); (c) 4th scan at the same location as (b). The scale bar corresponds to 200 nm. 
 
The effect of the scan area on the breakage of the peptide nanofibers on the mica surface may 
be related to differences in the total work done by the AFM tip at different scan sizes. The total work 
that an AFM tip does on a nanofiber can be approximated using the following equation: 
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          (5.2) 
where Fspring represents the tension in the spring that the AFM tip applies to the nanofiber during each 
tap; Sn represents the total displacement of the AFM tip during interaction (attraction or repulsion) 
with the nanofiber during the nth tap; m is the total number of taps by the AFM tip on a nanofiber 
during a scan. The damping force (due to friction) and the driving force (that drives the oscillation of 
the cantilever) are ignored as they are negligible when compared to Fspring. When the AFM tip scans 
the surface, it applies an intermittent force to the surface during each tap. This intermittent force is 
determined by the mechanical properties (e.g., spring constant k) and the amplitude x of the 
oscillating tip, which is governed by Hooke’s law, i.e., kxFspring = . The amplitude of the tip 
oscillation/displacement calculated from Equation 5.1 has a typical value of ~3-4 nm for tapping 
mode AFM imaging in liquid. For a given tip, the spring constant is fixed and the amplitude is 
experimentally adjusted to be constant during each scan, leading to a near constant Fspring. Therefore, 
the total work done on the nanofiber is predominantly determined by the number of taps m. In our 
experiments, m can be calculated using the following equation: 






m            (5.3) 
where w is the width of the nanofiber, which is typically 7 nm for EAK16-II; f is the oscillation 
frequency of the AFM tip, usually set to 80% of the tip resonant frequency; α is the angle formed 
between the nanofiber and the scan direction; a is the scan distance in the horizontal direction and v is 
the scan speed (line/s). According to Equations 5.2 and 5.3, for a given scan speed and oscillation 
frequency, more work is done on a given location of a nanofiber as the scan range becomes smaller 
due to the increase in the number of taps per unit distance. If the total work applied by the AFM tip 
overcomes the total cohesive energy of the nanofiber, the nanofiber will break. This may explain our 
 
 112
observation that the AFM tip can effectively cut the nanofiber when scanning over a small area (e.g., 
500 × 500 nm2). 
5.3.2 Mechanical Force-Induced EAK16-II Nanofiber Growth 
An application of this discovery is to locally induce/control the growth/morphology of peptide 
nanofibers on surfaces. Previous studies have demonstrated that surface-assisted nanofiber growth 
follows a nucleation and growth mechanism (see Chapter 3). In the presence of EAK16-II molecules 
in solution, a nanofiber “seed” can continue to grow by the addition of EAK16-II molecules at the 
active ends of the “seed”. The mechanical force of the AFM tip truncates the peptide nanofibers, 
which in turn can serve as the “seeds” for the growth of new nanofibers (Figure 5.3). After three 
zoom-in scans (500 nm × 500 nm) of an original single nanofiber, many new nanofibers appear 
(Figure 5.3c). These newly growing nanofibers may either repair the breakage (i.e., self-healing) or 
form a new branch depending on the orientation of the truncated nanofibers and the growth direction. 
As shown in the larger scale scan in Figure 5.3d, the nanofiber density is higher in the scanned area 
than at any other location. This provides a method to promote nanofiber formation at a desired 












Figure 5.3 AFM images showing mechanical force-induced EAK16-II assembly on mica in 2 µM E 
AK16-II solution (a) 2 µm × 2 µm scan area; (b) zoom-in scan of dotted area; the arrow points to the 
broken nanofibers serving as new nuclei for subsequent nanofiber growth; (c) 3rd repetitive scan at the 
same location as (b) showing many new growing nanofibers; (d) large-scale scan after (c) showing 
that mechanical force can induce local nanofiber growth in the dotted area. The scale bar corresponds 




In addition to a mica surface, mechanical force-induced peptide assembly and nanofiber growth 
are also observed on a hydrophobic highly ordered pyrolytic graphite (HOPG) surface. In the absence 
of peptide molecules in solution, the continuous long nanofibers observed initially (Figure 5.4a) are 
truncated after the first zoom-in 500 nm × 500 nm scan (Figure 5.4b). Subsequent repetitive scans 
over the same region lead to shorter and fewer nanofibers remaining on the surface (Figure 5.4c). 
Evidently, some truncated nanofibers may detach from the HOPG surface. On the other hand, in the 
presence of peptide molecules in solution, repeated zoom-in scanning results in many short 
nanofibers on the HOPG surface (Figure 5.4d-g); the number of short nanofibers increases 
dramatically and covers the whole scan area (1 µm2) after several cycles of scanning.  On locations 
which do not receive continuous multiple scanning, the nanofibers are longer and more loosely 
covered in hexagonal patterns, resembling the crystallographic symmetry of the HOPG surface 
(Figure 5.4h).43 Comparison of the surface coverage by the peptide nanofibers as a function of time 
with/without repetitive scanning (Figure 5.4i) clearly indicates that the mechanical force can induce 
nanofiber formation. This leads not only to a faster increase in the surface coverage but also to a 
coverage as high as ~80 % when equilibrium is reached, more than a two-fold increase over that 
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Figure 5.4AFM images of EAK16-II nanofibers adsorbed on HOPG in pure water (a-c) and 4 µM 
EAK16-II solution (d-g) under a mechanical force applied by a tapping AFM tip: (a) large-scale 1 µm 
× 1 µm scan; (b) 1st zoom-in scan of the dotted area in (a); long peptide nanofibers are broken into 
short nanofiber segments under the mechanical force; (c) 4th scan at the same location of (b) leads to 
further breakage of nanofibers into shorter ones; (d) 1st, (e) 2nd and (f) 10th 1 µm × 1 µm scan of the 
same location of (d); amount of peptide nanofibers on HOPG increased with the number of repetitive 
scans; (g) zoomed-in scan image after the 10th scan reveals many truncated nanofibers formed on 
HOPG; (h) a representative image of other locations that were not repetitively scanned; peptide 
nanofibers loosely covered the HOPG surface with a hexagonal pattern; inset FFT image shows the 
nanofiber are patterned in 6-fold symmetry; (i) surface coverage of peptide nanofibers as a function of 
time; squares represent the surface coverage of peptide at one location with repetitive scans and 





From these observations, it can be concluded that the relatively gentle tapping force applied by 
the AFM tip during scanning is able to break the peptide nanofibers on both mica and HOPG. 
However, the effect on the two surfaces is different. The peptide nanofibers on the HOPG surface 
appear to be more easily broken than on mica. This may be due to the slight difference in the peptide 
nanostructures on the two surfaces. Our previous work has shown that the average nanofiber heights 
on mica and HOPG are 1.8 ± 0.2 nm and 0.9 ± 0.2 nm, respectively (See Chapter 4). On the basis of 
the height of a single β-sheet of EAK16-II (~0.9 nm, ChemSketch, Toronto, Canada), it appears that 
nanofibers on mica tend to consist of two β-sheet layers, while those on HOPG contain only a single 
layer. Presumably, the breakage of a double layer of β-sheets requires more energy than that of a 
single layer. Thus, a smaller scan area, such as 500 nm × 500 nm, is usually required to break the 
nanofibers on the mica surface, whereas a larger scan area of 1 µm× 1 µm is sufficient to cut the 
nanofibers on HOPG. Since these nanofiber segments function as new nuclei for growth, the local 
coverage of nanofibers on the surface increases. 
The mechanical force-induced peptide assembly may provide insight into a number of 
biological events and help develop new biomedical applications. For example, it has been found that 
applying sonication to proteins can cause their aggregation into structures resembling amyloid 
fibrils.219 Although sonication involves many aspects including mechanical/shear stress, local heating, 
the formation of liquid-gas interfaces and free radical reactions,220 the result is the formation of active 
seeds that facilitate protein aggregation into amyloid fibrils. The result of our study suggests that 
sonication may be able to induce amyloid fibril formation through the creation of a mechanical force, 
which induces seed formation. 
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5.3.3 Fabrication of Patterned Nanostrucutures on HOPG  
Thus far, we have demonstrated one approach of using an AFM tip to apply mechanical force and 
locally induce peptide assembly and nanofiber growth on both mica and HOPG surfaces. To fabricate 
patterns with specific shapes in desired locations, more precise control may be achieved by modifying 
the present nanolithography approach and exploiting the chemical properties of EAK16-II. An 
important aspect of this approach is the removal of the broken nanofibers from specific regions of the 
surface. This is possible due to the effect of pH on the adsorption of peptide molecules/nanofibers on 
HOPG. Experiments have shown that the peptide nanofibers adhere strongly to a HOPG surface in 
pure water, 1 and 10 mM NaOH solutions, but less so in 1 and 10 mM HCl solutions (Figure 5.5). 
This pH dependence may be due to the effect of pH on the peptide amphiphilicity, as supported by the 
surface tension data shown in Figure 5.6. In acidic solutions, the peptide solutions exhibit a much 
higher surface tension (~71 mJ/m2), indicating that they are more hydrophilic and less able to adsorb 
to the hydrophobic HOPG surface. On the other hand, their lower surface tension in pure water and 
basic solutions indicates a higher hydrophobicity and tendency to adsorb on HOPG in these media. 
Once the peptide nanofibers adsorb onto this surface, they remain stable regardless of the pH (see 
Chapter 4). However, formed nanofibers can be removed by repetitive AFM tip scanning in an acidic 
solution. 
It is worth noting that a related peptide EFK16-II is able to adsorb to the HOPG surface and 
form patterned nanofibers in 1 mM HCl solution as well as in neutral and basic conditions (Figure 
5.5f). This is because the phenylalanine residues make EFK16-II more hydrophobic than EAK16-II. 
This observation also suggests that the hydrophobicity of the peptide molecules is important for their 


















Figure 5.5AFM images of 6 µM EAK16-II assemblies on the HOPG surface under different 
environments: (a) pure water; (b) 1 mM NaOH; (c) 10 mM NaOH; (d) 1 mM HCl; (e) 10 mM HCl. 


































Figure 5.6 Dynamic surface tensions of 30 µM EAK16-II in various solutions: pure water (×);10 
mM NaOH (∆); 1 mM NaOH (○); 1 mM HCl (□); 10 mM HCl ( ). The inset shows the dynamic 
surface tensions of the solvents: water (+); 10 mM HCl (-); 10 mM NaOH (∗). 
This property of weak adsorption of peptides to HOPG in acidic solutions forms the basis for 
an effective method to fabricate nanofiber patterns on HOPG that utilizes AFM tip nanolithography 
through a combination of bottom-up and top-down approaches. First, EAK16-II molecules (30 µM) 
are allowed to assemble into nanofibers on the HOPG surface in a neutral solution until the surface is 











is then submerged in a 10 mM HCl solution. Tapping mode AFM is applied to break the nanofibers in 
a particular region of the surface through repetitive scanning. In the acidic solution, nanofibers 
preferentially detach from the repetitively scanned portion of the substrate until the underlying HOPG 











Figure 5.7 Results of AFM tip nanolithography performed in 10 mM HCl solution to fabricate 
EAK16-II nanofiber-patterned HOPG surface: (a-d) repetitive AFM scanning to break and remove 
peptide nanofibers to expose bare HOPG surface; (e) a representative AFM phase image of EAK16-II 
nanofiber patterned HOPG surface; peptide nanofibers were removed within the four strips (dotted 
area). Scale bar corresponds to 200 nm. 




A representative peptide nanofiber pattern on HOPG is shown in the larger scale image in 
Figure 5.7e. Four parallel stripes were made by repetitive scanning in 10 mM HCl solution. Since the 
nanofiber-covered area is hydrophilic while the bare HOPG surface is hydrophobic (See Chapter 4), 
alternating hydrophilic and hydrophobic patterns can be created via this method. Such a structure 
could serve as a template to pattern proteins or enzymes by selective adsorption due to the variation in 
protein affinity based on differences in hydrophobicity of the surface. Many biomolecules and cells 
can also be immobilized on the patterned peptide nanofibers through functional amino acid residues 
to construct biosensors and protein/DNA chips and to study cell-to-cell communications.97,203 Also, 
since HOPG is an electronic conductor and the regions covered by the peptide are likely to be 
passivated, it may be possible to use electrodeposition to produce nanoscale metal patterns and 
features.  
This method, however, cannot be applied to the negatively charged mica since the solution pH 
significantly affects the electrostatic attraction between the peptides and the mica surface (see Chapter 
4). The peptides dissociate from the surface at high pH even without a mechanical force from the 
AFM tip. On the other hand, peptides adsorb strongly at low pH and cannot be easily removed by 
AFM tapping. Thus, it will not be possible to selectively remove nanofibers from desired portions of 
the surface using this AFM nanolithography method. 
5.4 Conclusion 
Mechanical force applied by the tapping of an AFM tip can break EAK16-II nanofibers on both mica 
and HOPG surfaces. Such a process can be controlled by adjusting the scan area and the scan speed. 
The broken nanofibers can serve as seeds for new nanofiber growth. The mechanical force-induced 
peptide assembly allows one to locally grow nanofibers that densely cover specific regions of the 
surface. In addition, a new AFM lithography method based on applying a mechanical force with the 
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AFM tip to break the peptide nanofibers in an acidic solution is proposed to fabricate an alternating 
hydrophilic and hydrophobic patterned surface on HOPG. These patterned peptide nanofibers could 





Chapter 6*                                                                    
Design and Characterization of a Metal Ion Binding Self-
Assembling Peptide for Metallic Nanowire Fabrication 
6.1 Introduction 
Molecular self-assembly is a widely recognized phenomenon in nature. Under certain conditions, 
amphiphilic molecules can spontaneously assemble into aggregates with certain size and structure. 
Self-assembling peptides are a novel class of amphiphilic molecules that are relatively easy to design 
and synthesize. In recent years, considerable advances have been made in the use of self-assembled 
nanostructures of these synthetic peptides as building blocks for functional biomaterials.8,56 These 
biomaterials have many potential applications such as templates for nanowire fabrication,29,35,70,71,73 
platforms or scaffolds for tissue engineering,86,96,97 delivery of proteins and peptide medicines93,221 and 
biological surface engineering.203  
Among the new class of self-assembling peptides are ionic-complementary peptides, whose 
sequence motif was serendipitously discovered from a Z-DNA binding protein in yeast.97 These small 
peptides contain alternating hydrophobic and hydrophilic residues in sequence and possess a unique 
property of ionic complementarity. In solution, they can self-assemble into various nanostructures not 
only through hydrogen bonding, but also through electrostatic and hydrophobic interactions. Most of 
these peptides, such as EAK16-I and EAK16-II, readily self-assemble to form stable nanofibers that 
have been shown to resist degradation in acidic or alkaline environments.21,26,97 The size and unusual 
stability of these nanofibers under extreme solution conditions make these peptides promising 
materials for applications in nanotechnology. In particular, the possibility of fabricating conductive 
nanowires using self-assembled peptide nanostructures as templates is of special interest to the 
electronics industry. The “bottom-up” nanofabrication technique based on molecular self-assembly to 
*This chapter is based on the paper “H. Yang, M. Pritzker, S.-Y. Fung, Y. Sheng, W. Wang and P. Chen, Anion Effect on 
the Self-Assembled Nanostructures of a Metal Ion Binding Peptide, Langmuir 2006 22(20) 8553-8562”. 
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construct supermolecules from single molecules can overcome the various limitations of traditional 
‘top down’ (an approach starting from large-scale operation) approaches, such as optical 
lithography.56 These top-down methods have approached their physical limits of resolution due to 
constraints mainly arising from the wavelength of the optical sources and quantum mechanical 
effects.222 In addition, increasing costs also impede the further scaling down of conventional silicon 
technology.210 The search for alternative technologies for metallic nanowire and electronic device 






Figure 6.1 Schematic diagram of EAK16(II)GGH structure. The gray portion shows the functional 
GGH group 
One important application of peptide self-assembled nanofibers is to act as templates for 
metallic nanowire fabrication.29,35,228 Our current effort in this direction focuses on the production of 
nanowires from copper due to its widespread use in the electronics industry. Our strategy is to 
incorporate copper into the nanofibers via a metal binding site in a self-assembling peptide. EAK16-
II, an ionic complementary peptide well-known for its ability to self-assemble into nanofibers, has 
been chosen to serve as the model peptide. It is modified by adding a functional Cu2+ binding group 
GGH229 (G, glycine; H, histidine) to the C-terminus of EAK16-II. The molecular structure of this 
































































metal binding group and located at the C-terminus for the following reasons: (1) it can provide 
nitrogen donors to coordinate with Cu2+ in a tetragonal geometry230,231 and is not expected to 
significantly affect the self-assembly of EAK16-II into nanofibers due to its small size, and (2) GGH 
has been shown from quantum mechanical calculations to have a higher binding constant for Cu2+ 
than other tripeptides.230 Thus, the designed peptide may bind with copper strongly and the metal-
peptide complex may have high stability, an important factor for the later metallization of the peptide 
nanofiber. 
During preliminary experiments, it became apparent that the type of Cu2+ salt present has a 
strong impact on the geometry of the peptide self-assembled nanostructures. This chapter describes 
the results of a detailed experimental study on the influence of SO42-, Cl- and NO3- anions on the 
molecular structure, self-assembled nanostructure and thermodynamic behavior of the newly designed 
peptide EAK16(II)GGH. The binding of EAK16(II)GGH to Cu2+ was characterized by Nuclear 
Magnetic Resonance (NMR) and UV-Vis Absorption spectroscopy. The peptide secondary structure 
was characterized by Fourier Transform Infrared spectroscopy (FTIR). The nanostructures of the 
peptide assemblies were observed using Atomic Force Microscopy (AFM). Since EAK16(II)GGH 
has an amphiphilic structure and surfactant-like properties similar to EAK16s,21,26,27 with hydrophilic 
residues on one side and hydrophobic residues on the other side,  the self-assembled nanostructure 
may also exhibit such amphiphilicity. Thus, the surface tensions of solutions containing 
EAK16(II)GGH and the copper salts were measured using the Axisymmetric Drop Shape Analysis-
Profile (ADSA-P) technique. Surface tension can be used to assess the surface activity of peptide 
assemblies and kinetics of peptide adsorption at surfaces. 
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6.2 Materials and Methods 
6.2.1 Materials 
The self-assembling peptide EAK16(II)GGH (C80H134N26O28, molecular weight 1908 g/mol) has a 
sequence of AEAEAKAKAEAEAKAKGGH (see Figure 6.1) where A corresponds to alanine, E to 
glutamic acid, K to lysine, G to glycine and H to histidine. At neutral pH, A and G are neutral 
hydrophobic residues, whereas E is a negatively charged hydrophilic residue, K is positively charged 
and H may be partially charged since its normal pKa is about 6.0. The real pKa value of histidine in a 
specific peptide or protein can be changed by the formation of peptide bond,232 terminal 
modification,233 the location,234,235 and the interaction with other amino acids.234 The proportion of 
charged histidine groups can be expressed as 10(pKa – pH)/[1+10(pKa – pH)]. This peptide was purchased 
from Invitrogen (Burlington, Canada) with a purity of >95% (purified by reverse-phase high-
performance liquid chromatography). The N-terminus and C-terminus of the peptide were protected 
by acetyl and amino groups, respectively, to minimize end-to-end electrostatic attraction between 
peptides.27 
Peptide solutions were freshly prepared in pure water (18.2 MΩ; Millipore Milli-Q system) and 
copper salt stock solutions (from 0.05 mM to 10.0 mM) at concentrations of 0.025 and 0.05 mg/ml 
(12.4 and 24.8 µM EAK16(II)GGH). In order to avoid interference from other anions, a buffer 
solution was not used to control pH. However, in the copper binding experiments, a minute amount of 
NaOH was used to adjust the solution pH to 6.0 to enable the binding of copper to peptide molecules 
and to stabilize the chemical shift of protons in NMR (see below). At a peptide concentration of 0.05 
mg/ml, the pH measured in the presence of 1.0 mM copper salts without the addition of NaOH was 
about 5.9 regardless of the anion present, whereas the pH was 6.2 in the absence of the salt. The ionic 
strength of the solutions was not further adjusted by the addition of any other electrolyte to avoid 
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interference from other ions. All peptide solutions were stored at 4 °C before use. Copper sulfate, 
copper chloride, copper nitrate, sodium sulfate and sodium chloride (Sigma-Aldrich, Oakville, 
Canada) with purity of 99.9+ % were used in the experiments. 
6.2.2 Methods 
Nuclear Magnetic Resonance (NMR)  
The 1H NMR spectra were acquired at 25°C on a Bruker Avance DMX 600 MHz spectrometer 
equipped with a triple resonance xyz-gradient probe and processed using Felix 97.0 software (MSI, 
Inc.). The spectra were recorded using 90% H2O/10% D2O solutions, typically at a peptide 
concentration of 1.0 mM. The pH of the peptide solution was adjusted to 6.0 using small aliquots of 
0.1 M NaOH prepared in 90% H2O/10% D2O solution. The choice of this pH was dictated by the 
solubility of Cu2+ (Ksp of Cu(OH)2, 1.6×10-19) and the capability of copper binding to histidine. The 
measured pH values were uncorrected for the isotope effect. In the metal ion binding study, small 
aliquots (0.25 mM) of CuCl2 and CuSO4 solution were added to the peptide solution, respectively. 
Correction for the volume change during copper titration was made during the analysis. 
UV-Vis Absorption Spectroscopy  
The absorption spectra were obtained on a UV-Vis spectrophotometer (Biochrom Ultraspec 4300 Pro, 
Cambridge, England) using a 1 cm path-length quartz cuvette. The copper ion titration was performed 
by adding small aliquots of CuCl2 or CuSO4 stock solution (70 mM) to 0.6 mg/ml (0.3 mM) 
EAK16(II)GGH solution. The final contents of copper ions for each titration ranged from 0.19 to 1.82 
mM. The solution pH was adjusted to 6.0 by adding small amounts of 0.1 M NaOH, HCl (for 
experiments involving CuCl2) or H2SO4 (for experiments involving CuSO4). The spectra were 
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smoothed and deconvoluted after background correction using the PeakFit 4.12 software (Hearne 
Scientific Software LLC, Chicago, USA) to obtain the absorbance of bound copper ions at ~611 nm. 
Fourier Transform Infrared Spectroscopy (FTIR)  
FTIR spectra over the range from 1600-1700 cm-1 where the characteristic amide I band appears were 
obtained to determine the secondary structure of peptide in different copper salt solutions. 
Examination of this band enables distinction to be made between β-sheets and α-helices/random 
coils. The peptide (1.0 mM) or peptide/copper salt (1.0 mM) solutions (~100 µl, incubated for one 
week to allow secondary structures to form) were placed on a crystal slide of calcium fluoride (CaF2) 
and dried at room temperature. The FTIR spectra of the thin films were obtained at a wavenumber 
resolution of 4 cm-1 with a Bio-Rad spectrometer (FTS3000MX, EXCALIBUR series, Hercules, CA). 
The baseline was subtracted from the observed absorption intensity and the resulting spectrum was 
normalized with respect to the maximum intensity.  
Atomic Force Microscopy (AFM)  
The nanostructures formed by self-assembly of the peptide in pure water and the copper salt solutions 
were characterized by AFM. Approximately 10 µl of sample solution was placed on the surface of a 
freshly cleaved mica sheet fixed to a steel AFM sample plate. The sample was then covered by a 
Petri-dish to avoid dust and allowed to settle for 10 minutes to allow the peptide to adhere onto the 
mica surface. It was then rinsed twice with ~50 µl of pure water to remove any unattached peptides 
and salt components before being air-dried for 3 hours. Imaging was performed at room temperature 
on a PicoScanTM AFM (Molecular Imaging, Phoenix, AZ) using the tapping mode. This mode was 
used in order to reduce sample surface distortion due to tip and sample interactions. All images were 
acquired using a 225 µm silicon single-crystal cantilever (NCL type, Molecular Imaging, Phoenix, 
AZ) with a typical tip radius of 10 nm and resonance frequency of ~170 kHz. A scanner with the 
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maximum scan size of 6 × 6 µm2 was used. All AFM images were obtained at a resolution of 512 × 
512 pixels on a scale of 2 µm × 2 µm. All the peptide fiber widths reported herein were corrected 
using the deconvolution method reported by Fung et al.21 The actual fiber width W* can be calculated 
from the equation W* = W - 2 )2( HRH c − , where W is the apparent fiber width from the AFM 
image, H is the height of the fiber and Rc (10 nm) is the AFM tip radius. The dimensions of at least 50 
fibers were measured at each concentration of peptide and copper salts to obtain the average fiber 
widths and heights. Fiber lengths were determined using the point-and-click measurement tool 
available with the PicoScan software. When a fiber was curved, a series of lines was used to trace the 
fiber axis and then all the individual line segments were added to yield the fiber length. At least 100 
fibers were measured for each solution condition (concentration of peptide and copper salts) to obtain 
the distribution of the fiber lengths. The frequencies of the fiber length at the following size ranges 
were determined to generate the distribution histogram: very short fibers (<300 nm), short fibers 
(300-500 nm), intermediate fibers (500-1000 nm) and long fibers (>1000 nm). 
Surface Tension Measurement  
The experimental set-up of the Axisymmetric Drop Shape Analysis-Profile (ADSA-P) technique to 
study the dynamic surface tension of EAK16(II)GGH in pure water and copper salt solutions was 
described in more detail in an earlier publication.101 A pendant drop of the peptide solution was 
formed at the tip of a vertical Teflon needle (0.92 mm inner diameter) connected to a motor-driven 
micro-syringe (1 ml, release speed of 0.04 ml/s). The sample was placed in a temperature-controlled 
environmental chamber, saturated with water vapor to maintain consistent humidity. The entire 
system was placed on a vibration-free table. The images of the pendant drop were magnified by an 
optical microscope and then captured by a CCD camera before being transferred to a computer. The 
surface tensions of the samples with pure copper salts and containing peptides were measured for 2 
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and 3 hours, respectively. During each run, images were acquired at 0.5 s intervals for the first 70 s 
and then at 20 s intervals for the remaining time. Software was used to digitize the images and 
generate a profile of the pendant drop. A theoretical curve governed by the Laplace equation of 
capillarity was then fitted to the profile, generating the surface tension value as a fitting parameter.218 
The standard deviation of the surface tension values obtained was less than 0.2 mJ/m2. 
6.3 Results 
6.3.1 Copper Binding Study 
The effect of Cu2+ on the 1H NMR spectrum of EAK16(II)GGH was studied to obtain evidence for its 
binding to the peptide. In the absence of Cu2+, the signal for one of the aromatic protons of histidine 
appears at 7.10 ppm, as shown in Figure 6.2a. This chemical shift has been previously assigned to the 
H-δ2 proton of histidine at pH ~6.0.236 The other aromatic protons are difficult to identify as a result 
of their overlapping with the amide protons of the peptide. The addition of the paramagnetic ion Cu2+ 
(CuCl2 or CuSO4) to EAK16(II)GGH causes line broadening of the proton resonance in the amide 
regions. These regions include NH groups from the peptide backbone, histidine and lysine residues, 
and the NH2 of C-terminus. The most affected signal belongs to the H-δ2 proton of histidine (7.10 
ppm). The addition of Cu2+ to the solution causes this resonance to broaden significantly (Figure 6.2b 
and c) and almost disappear. This line broadening is associated with protons close to the 
paramagnetic ion.237,238 With such a low level of Cu2+ present (0.25 mM), the observation of 
significant broadening of the resonance of the δ proton of histidine provides evidence for the binding 
of Cu2+ to the histidine residue. In the meanwhile, the selective line broadening of the proton 
resonance in the amide regions may indicate that some amides in addition to histidine were also 
involved in the copper binding. The NMR spectra (Figure 6.2) do not vary depending on whether the 

















Figure 6.2 1H NMR spectra of 1.0 mM EAK16(II)GGH at pH 6.0. The lower spectrum (a) 
corresponds to EAK16(II)GGH, whereas the upper spectrum (b) corresponds to EAK16(II)GGH with 
0.25 mM of CuCl2 titrated in and (c) corresponds to EAK16(II)GGH with 0.25 mM of CuSO4 titrated 
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The effect of anions on the amount of copper binding to EAK16(II)GGH was studied via UV-
Vis absorption spectroscopy. As shown in Figure 6.3a, the addition of Cu2+ led to an increase in 
absorbance in the spectra between 500 nm to 1000 nm. In this region, the presence of copper led to an 
absorption band centered at 611 nm for the first 0.19 mM Cu2+ and a second feature centered near 800 
nm wtih further increasing Cu2+ concentration. The latter band is similar to that observed in pure 
copper chloride solutions, indicating that it is associated with the free (unbound) copper in solution. 
Thus, the absorption band at ~611 nm is correlated to the absorption band of the copper-peptide 
complex. This observation provides further evidence of the binding of Cu2+ with the peptide 
EAK16(II)GGH. The plot of the deconvoluted absorption at 611 nm with increasing concentration of 
CuCl2 and CuSO4 (Figure 6.3b) shows a linear increase of the absorbance up to 0.37 mM of Cu2+ 
before reaching a plateau for both copper salts. The addition of excess Cu2+ did not result in a further 
increase in the absorbance. The presence of different anions (Cl-, SO42-) did not show a significant 
change in the absorbance of the peptide-copper complexes. This indicates the amount of copper 
bound to the peptide EAK16(II)GGH was not affected by the presence of different anions, at least to 


























Figure 6.3 UV-Vis spectra resulting from Cu2+ titration of 0.6 mg/ml EAK16(II)GGH (0.3 mM) at 
pH 6.0. Absorbance spectra of EAK16(II)GGH titrated with increasing concentraions of CuCl2 are 
shown in (a). A plot of the deconvoluted absorbance at 611 nm versus increasing concentrations of 
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6.3.2 Secondary Structure of EAK16(II)GGH 
To study the effect of the different copper salts on the peptide conformation, FTIR spectroscopy was 
used since it can distinguish between β-sheets and α-helices/random coils within the amide I band 
(1600 to 1700 cm-1) caused by C=O stretching. Figure 6.4 shows the FTIR spectra of the amide I band 
for EAK16(II)GGH samples obtained in the absence and presence of the copper salts. Two 
characteristic bands appear in these spectra. The peak at about 1626 cm-1 can be attributed to the 
formation of a β-sheet structure.27,239 The assignment of the band at about 1655 cm-1 is complicated 
since absorbance in this region can arise from α-helix and random coil structures.240 In the absence of 
copper salts, a prominent peak appears at 1655 cm-1, revealing that α-helix/random coils form a major 
portion of the secondary structure. However, a distinct peak also occurs at 1626 cm-1 and indicates 
that β-sheets form as well. The addition of the copper salts causes significant changes to the spectra. 
In the presence of CuCl2 and Cu(NO3)2, the absorbance at 1655 cm-1 diminishes whereas the 1626  
cm-1 peak increases relative to that obtained in the salt-free solution. This clearly shows that the salts 
promote the formation of β-sheets over the other structures. The absorbance at 1655 cm-1 is slightly 
higher when CuCl2 is present than when Cu(NO3)2 is added. As with the other measurements of this 
study, the behavior observed in the presence of CuSO4 differs considerably from that of the other two 
salts. The absorbance signal for the α-helix/random coil structure disappears entirely and the peak 
characteristic of a β-sheet structure becomes sharper and shifts slightly toward lower wavenumbers. 
A shift of approximately 2 cm-1 of the β-sheet peak toward lower frequency relative to that observed 
in the other spectra may reflect an increase in the number of hydrogen bonds.241 Based on the ratio of 
the 1626 cm-1 and 1655 cm-1 peak heights, the relative content of β-sheet to α-helix/random coil 
structures formed in the presence of the different anions can be estimated and follows the order SO42- 
> NO3- > Cl-. CuSO4 is apparently more effective than the other two salts at promoting the formation 













Figure 6.4 FTIR spectra of EAK16(II)GGH film formed with (a) no salt and in the presence of (b) 
CuCl2 , (c) Cu(NO3)2  and (d) CuSO4  
6.3.3 Effect of Anion on Nanostructures 
Figure 6.5 (a, b, c and d) shows the AFM images of self-assembled nanostructures in solutions 
containing 0.025 mg/ml EAK16(II)GGH in the presence and absence of 1.0 mM copper salts. A 
significant difference in the morphology of the peptide nanostructures is observed depending on the 
solution composition. In pure water (Figure 6.5a), copper chloride (Figure 6.5c) and copper nitrate 
(Figure 6.5d) solutions, the peptide tends to form randomly dispersed short fibers and a few small 
aggregates, whereas elongated fibers are formed in copper sulfate solution (Figure 6.5b). This 
phenomenon is also observed at a higher peptide concentration of 0.05 mg/ml and over salt 
concentrations ranging from 0.05 to 10.0 mM (see below). The dimensions of the EAK16(II)GGH 
















nanofibers shown in the AFM images (Figure 6.5a-d) are summarized in Table 6.1. The peptide forms 
ribbon-like structures in pure water and copper salt solutions, as reflected in the fiber dimensions (the 
fiber width is much larger than the fiber height). No significant changes in the fiber width and height 
are found in the different solutions. The average fiber widths and heights vary from 40 to 50 nm and 
0.5 to 1.0 nm, respectively (Table 6.1). Statistical analysis in Figure 6.5e shows that the percentage of 
fibers that lie in the very short range (< 300 nm) are 92%, 88% and 67% in pure water, 1.0 mM CuCl2 
and Cu(NO3)2 solutions, respectively. However, no fibers in this category are found in 1.0 mM CuSO4 
solution. Instead, 94% of fibers formed in this solution have a length longer than 1000 nm.  The fiber 
lengths obtained in the presence of the three copper salts are affected by the anion in the following 
















Figure 6.5 AFM images of nanostructures formed in 0.025 mg/ml EAK16(II)GGH solutions 
containing 1.0 mM salts after 4 h incubation time: (a) no salt, (b) CuSO4, (c) CuCl2, (d) Cu(NO3)2, and 


































To investigate if the observed anion effect applies to salts without copper, we conducted 
control experiments in which 0.025 mg/ml peptide was dissolved in 1.0 mM Na2SO4 and NaCl rather 
than the corresponding copper salts. As shown in Figure 6.6, EAK16(II)GGH formed short fiber 
network structures, not long fibers, in the presence of sodium salts (NaCl and Na2SO4). There is no 
significant change depending on the presence of the different anions. This observation showed that 
the presence of Cu2+ is important for the anion effect on the peptide self-assembled nanostructures. 
  
 
Figure 6.6 AFM images of nanostructures formed in 0.025 mg/ml EAK16(II)GGH with solutions 
containing 1.0 mM (a) Na2SO4 and (b) NaCl after 4h incubation time. Scale bar represents 300 nm  
6.3.4 Effect of Salt Concentration on Nanostructures 
Figure 6.7 presents the nanostructures obtained in 0.05 mg/ml EAK16(II)GGH solutions in the 
absence of a copper salt (Figure 6.7a) and at different CuSO4 concentrations (Figure 6.7b-e). The 
peptide forms short fibers and a few small aggregates in pure water (Figure 6.7a), but longer fibers 




concentration of copper sulfate (Figure 6.7b-e). The dimensions of the peptide fibers are shown in 
Table 6.1. The average widths of the peptide fibers vary from 50 to 60 nm while the average heights 
vary from 0.5 to 1.0 nm, both independent of copper sulfate concentration. The statistical analysis 
(Figure 6.7f) shows that 80% of fibers formed in pure water are very short (<300 nm). In 0.05 mM 
CuSO4 solution, only 12% of fibers are very short, but 82% of fibers have a length ranging from 300 
to 1000 nm; few fibers (6%) are longer than 1000 nm. With an increase of copper sulfate 
concentration from 0.05 mM to 10.0 mM, the population of fibers with a length above 1000 nm 
increases from 6% to 94%. When the copper sulfate concentration is above 1.0 mM, the peptide 






















Figure 6.7 AFM images of nanostructures formed in 0.05 mg/ml EAK16(II)GGH containing 
different CuSO4 concentrations after 4 h incubation time: (a) 0, (b) 0.05 mM, (c) 0.5 mM, (d) 1.0 
mM, (e) 10.0 mM, and (f) histogram of fiber length analysis. The scale bar in each image corresponds 
to 500 nm. 
 
The nanostructures found in 0.05 mg/ml EAK16(II)GGH solutions containing CuCl2 (0.05 mM 
to 10.0 mM) consist predominately of very short fibers (Figure 6.8a-d). No long fibers (>1000 nm) 
are observed over the salt concentration range studied. The width and height of these fibers are 
independent of CuCl2 concentration, as shown in Table 6.1. The fiber width and height are found to 
be ~60 nm and ~0.5-1.0 nm, respectively. The statistical analysis shows that ~80% of fibers have a 
length below 300 nm over the CuCl2 concentration range of 0.05 mM to 10.0 mM (Figure 6.8e). 
Similar behavior is observed in Cu(NO3)2 solutions, with very short fibers being evident at both 0.05 
mM and 10.0 mM concentrations (Figure 6.9a and b). The fiber width and height are found to be ~50 
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slightly increases at a higher Cu(NO3)2 concentration of 10.0 mM, the predominant population of 










Figure 6.8 AFM images of nanostructures formed in 0.05 mg/ml EAK16(II)GGH containing 
different CuCl2 concentrations after 4 h incubation time: (a) 0.05 mM, (b) 0.5 mM, (c) 1.0 mM, (d) 
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Figure 6.9 AFM images of nanostructures formed in 0.05 mg/ml EAK16(II)GGH containing 
different Cu(NO3)2 concentrations after 4 h incubation time: (a) 0.05 mM, (b) 10.0 mM, and (c) 

































Table 6.1 The Width (W) and height (H) of EAK16(II)GGH self-assembled nanofibers at various 
conditions 
Peptide     
(mg/ml) 
Water 1.0 mM CuSO4 1.0 mM CuCl2 1.0 mM Cu(NO3)2 
W (nm) H (nm) W (nm) H (nm) W (nm) H (nm) W (nm) H (nm) 
0.025 
41.5±8.5 1.0±0.20 36.4±5.8 0.5±0.1 38.8±7.0 0.9±0.2 50.0±6.4 0.6±0.1 
56.3±8.3 0.6±0.1       
CuSO4 CuCl2 Cu(NO3)2 
Salt (mM) 
W (nm) H (nm) W (nm) H (nm) W (nm) H (nm) 
0.05 63.8±14.3 0.6±0.2 59.8±9.3 0.6±0.1 51.5±11.4 0.6±0.1 
0.5 58.2±8.3 0.8±0.3 60.9±9.9 0.4±0.1 − − 
1.0 51.7±9.4 0.5±0.2 68.1±12.2 0.5±0.1 − − 
0.05 
10.0 58.7±7.8 0.4±0.1 63.7±11.2 0.6±0.2 49.7±8.8 0.8±0.2 
 
6.3.5 Effect of Anion on Surface Tensions of EAK16(II)GGH Solutions 
Surface tension measurements can give information on the amphiphilicity of the peptide and the 
nature of its self-assembly in different copper salt solutions. The greater the peptide amphiphilicity, 
the greater is its activity at the air-liquid interface and the lower its surface tension. Figure 6.10 shows 
the variation of surface tension with time for 0.05 mg/ml EAK16(II)GGH in salt-free solution and in 
the presence of 1.0 mM copper salts. The surface tensions of the control samples, including pure 
water and 1.0 mM copper salt solutions, remain constant (~72 mJ/m2) over 2 hours. For peptide 
solutions with and without copper salts, the surface tensions decrease rapidly at the outset before 
leveling off and slowly approaching equilibrium. The equilibrium surface tension values were 
calculated based on the average over the last ten points of data. The peptide has an equilibrium 
surface tension value of 64.1 mJ/m2 in pure water. The presence of the copper salts causes the surface 
tension to decrease to a level that depends on the salt type. Once again, the behavior in CuSO4 
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solution appears to stand out from that observed in the other two copper salt solutions. The 
equilibrium surface tensions of the peptide in CuCl2 and Cu(NO3)2 solutions are 62.6 and 62.2 mJ/m2, 
respectively, but only 57.6 mJ/m2 in the presence of CuSO4. These results indicate that the surface 
activity of peptide self-assemblies in different copper salt solutions depends on the anion type in the 
following order: SO42- > NO3- ≥ Cl-. Although the equilibrium surface tension value of the peptide in 
the presence of CuCl2 is only slightly higher than in the presence of Cu(NO3)2, this trend is 
consistently observed in repeated experiments. 
 
 
Figure 6.10 Dynamic surface tension of pure water, copper salts, and 0.05 mg/ml EAK16(II)GGH 
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6.4.1 Peptide Design and Secondary Structure in the Absence of Copper Salts 
EAK16-II, the molecular motif for EAK16(II)GGH, is an ionic complementary peptide which has 
been well studied and shown to form a β-sheet structure in pure water.27 It is expected that the 
secondary structure of EAK16-II is formed through hydrogen bonding and stabilized by hydrophobic 
and electrostatic interactions. However, with the addition of the short metal ion binding group GGH 
at the C-terminus, the peptide EAK16(II)GGH has been found to form a predominantly α-
helix/random coil structure (Figure 6.4), suggesting that the GGH group located at the C-terminus 
affects the secondary structure of the peptide. One possible reason for this phenomenon is that the 
introduction of the GGH group reduces the ionic complementary character on the C-terminal side of 
the peptide. This makes it more difficult for the peptide to self-assemble into β-sheets than in the case 
of the more ionic complementary EAK16-II. Another contributing factor may be the presence of the 
glycine residue introduced by the modification of the peptide. Since the glycine residue is the shortest 
among all amino acids, its presence may increase the backbone flexibility of the peptide chain and 
disrupt the β-sheet secondary structure. It has been reported that the replacement of alanine by glycine 
can hinder the formation of β-sheets.11 Although the modification causes a change in the secondary 
structure, it should be emphasized that the modified peptide can still self-assemble into nanofibers, 
only to a less extent. 
6.4.2 Effect of Anion on the Secondary Structure of EAK16(II)GGH 
The secondary structure of a peptide molecule in solution can be affected by the solution 
composition.242-245 Our FTIR spectra show that the secondary structure of EAK16(II)GGH is affected 
by the presence of the copper salts containing different anions (Figure 6.4). In the presence of sulfate, 
the peptide predominantly forms β-sheets. However, in the presence of chloride and nitrate anions, 
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the peptide forms a mixture of α-helices/random coils and β-sheets. The observed anion effect on 
EAK16(II)GGH may be due to the different valence of anions. The divalent sulfate anion may serve 
as a bridge to link two peptide molecules by interacting with two positively charged lysine residues. 
Such an intermolecular interaction may bring the two peptide molecules together, promoting the 
formation of β-sheets. Monovalent anions (i.e., chloride and nitrate) cannot function as bridges and so 
their primary effect may be to shield the charges on peptide molecules electrostatically. This shielding 
may still facilitate β-sheet formation, but not to the extent with a “bridging agent” such as sulfate. 
Therefore, a mixed secondary structure was observed in copper chloride and copper nitrate solutions.  
6.4.3 Effect of Anion on the Self-Assembled Nanostructure of EAK16(II)GGH 
Our results show that the self-assembled nanostructure of EAK16(II)GGH in aqueous solution 
depends significantly on the particular anion present. Sulfate can induce long fiber formation, while 
chloride and nitrate cannot. This phenomenon is observed at different peptide concentrations (0.025 
and 0.05 mg/ml) and over salt concentrations ranging from 0.05 to 10.0 mM (Figures 6.5, 6.7-6.9). 
Anions have been previously shown to increase or decrease the pKa of histidine by 0.1 to 0.3 pH unit 
depending on the location of histidine on a peptide chain and the type of anion present.235 A change in 
the pKa value of histidine could affect the amount of copper binding to the peptide. However, our 
UV-Vis titration and nuclear magnetic resonance (NMR) results show that the type of anion does not 
affect the amount of copper binding to the peptide (Figures 6.2 and 6.3). This indicates that the 
observed anion effect may not be due to differences in the extent of copper binding.  
The divalent SO42- anion may bridge the peptide molecules through the electrostatic interaction 
with the positively charged residues from two peptide molecules similar to the role of divalent cations 
in DNA condensation.108 Many multivalent cations have been found to be more efficient than 
monovalent cations in inducing the condensation and fiber formation of DNA and other synthetic 
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polyelectrolytes.246,247 It has been reported that when the size of a divalent cation is much smaller than 
the space between two neighboring negatively charged residues along a polyelectrolyte chain, the 
primary effect of the divalent cation may not be to electrostatically interact with the charges from 
these two residues; instead, it is more likely for the cation to interact with one negative residue of one 
chain and one negative residue of another chain and bring about the onset of condensation.248 A 
similar effect may explain the influence of sulfate on the positively charged residues of 
EAK16(II)GGH. The minimum spacing between two positive residues on EAK16(II)GGH is greater 
than 7.3 Å (estimated from Chemsketch software without optimization), which is considerably larger 
than the sulfate ionic radius of 2.9 Å.249 Thus, it is not likely that the divalent anion can interact with 
the two neighboring lysine residues on a single peptide. Instead, it may electrostatically interact with 
one positive lysine residue of one peptide molecule and serve as a sticky point for a positive lysine 
residue of a second peptide molecule. In this way, sulfate facilitates the peptide molecules to interact 
with one another. Such intermolecular attraction might greatly favor β-sheet formation of 
EAK16(II)GGH (Figure 6.4). The extensive β-sheet formation may cause the peptide to form long 
fibers due to the growth in the direction perpendicular to the β strands or the interaction between β-
sheets. On the other hand, monovalent chloride and nitrate anions may not have such a bridging 
capability and so the peptide secondary structure contains mixed α-helices/random coils and β-sheets 
in copper chloride and copper nitrate solutions. These mixed structures may prevent long fiber 
formation and cause the peptide to self-assemble into short fibers and small aggregates, similar to that 
observed in pure water. A very preliminary model of peptide self-assembly and fiber growth is 
proposed in Appendix C. 
It should be noted that the binding of copper to the peptide may play an important role in the 
way that the anion affects the peptide nanostructures. The self-assembled EAK16(II)GGH 
nanostructures formed in sodium salt solutions were similar, regardless of the anion type present as 
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shown in Figure 6.6. This suggests a close relationship between the binding of Cu2+ to the peptide and 
the effect of anions on the self-assembled nanostructures. We investigated this question further by 
carrying out experiments to compare the effects of the different copper and sodium salts on the self-
assembled nanostructures of EAK16-II, which does not contain a specific copper binding moiety (see 
Appendix B). Once again, the specific anion present had no effect on the self-assembled 
nanostructures. These results provide strong support that the copper binding to the peptide is pivotal 
to the effect of the different anions on EAK16(II)GGH nanostructures.  
6.4.4 Surface Activity of Peptide Assemblies in Copper Salt Solutions 
The change in the morphology of peptide self-assembled nanostructures due to the presence of the 
different anions was also studied from surface tension measurements. The peptide solution exhibits a 
lower surface tension in the presence of sulfate than that of the other two anions. Experiments 
conducted with the copper salt solutions in the absence of the peptide show that the surface tensions 
of different salts are very similar to each other and to that of pure water (~72.0 mJ/m2). The different 
surface tensions shown in Figure 6.10 are therefore likely due to amphiphilicity changes of the 
peptide self-assemblies in the presence of the different anions. According to the order of surface 
tension values of the peptide in different copper salt solutions, the amphiphilicity of the peptide self-
assemblies may decrease depending on anion type in the following order: SO42- > NO3- ≥ Cl-. This 
order correlates well with the variation of the β-sheet content in the peptide secondary structure 
(Figure 6.4). 
A characteristic feature of an EAK16(II)GGH molecule is that most of its hydrophobic (●) and 
hydrophilic (○) residues are arranged in an alternating pattern ●○●○●○●○●○●○●○●○●●○, except at 
the GGH end. As discussed previously, such an alternating pattern in a β-strand will result in a unique 
structure: hydrophilic residues on one side of the peptide chain and hydrophobic residues on the other 
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side.250 Thus, β-sheets containing this unique structure are predominantly amphiphilic and tend to 
move to an air-water interface. The orientation of the β-sheets with the hydrophobic side facing the 
air and the hydrophilic side directed into the aqueous solution would result in a lower surface tension. 
On the other hand, since α-helix/random coil structures of EAK16(II)GGH do not have such a unique 
amphiphilic feature, they may not have the same surface activity as a β-sheet structure does. This last 
comparison may explain our finding that the order of the surface activity in different copper salts 
correlates well with the β-sheet content in the secondary structure of peptide self-assembled 
nanofibers (Figures 6.4 and 6.10). 
6.5 Conclusions 
EAK16(II)GGH peptide capable of binding with Cu2+ has been successfully designed by adding a 
GGH group to the C-terminus of the peptide EAK16-II. The binding of Cu2+ to the histidine group of 
the peptide has been confirmed by 1H NMR and UV-Vis absorption spectroscopy. The effect of 
anions (SO42-, Cl- and NO3-) in solution on peptide self-assembly was investigated using AFM, 
surface tension measurement and FTIR spectroscopy. The experimental results suggest that the type 
of the anion has a significant effect on the EAK16(II)GGH secondary structure, self-assembled 
nanostructures and surface activity over a range of peptide and salt concentrations. The length of 
peptide nanofibers, the β-sheet content and the surface activity increase according to the type of the 
anion present in the following order: SO42- > NO3- ≥ Cl-. The divalent SO42- may serve as a bridge 
linking two peptide molecules resulting in long fiber formation.  
Our study showed that the dimension of EAK16(II)GGH self-assembled nanostructures could 
be controlled by adding copper salts with different types of anions. Sulfate induces long fiber 
formation, whereas chloride and nitrate cause short fiber formation. This may be important for 
different applications in nanotechnology, especially metallic nanowire fabrication. By controlling the 
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dimension of a peptide template, desired dimensions of the fabricated nanowire may be obtained. 
Furthermore, the successful design of peptide EAK16(II)GGH with the combined properties of fiber 
formation and metal ion binding capability provides a simple way to create functional biological 





Chapter 7                                                                     
Original Contributions and Recommendations 
7.1 Original Contributions to Research: 
Surface-Assisted Peptide Assembly on Mica. In this thesis, the assembly of a model ionic-
complementary peptide EAK16-II on hydrophilic mica and hydrophobic HOPG surfaces has been 
systematically studied. On the mica surface, the growth of peptide nanofibers was monitored in real-
time via in-situ AFM and growth kinetics of single nanofibers was quantified. In pure water, the 
average nanofiber growth rate is 0.74 ± 0.40 nm/s. From DLS experiments, nanofiber growth was 
found to be a surface-assisted phenomenon: nanofibers that have virtually ceased growing in solution 
begin to grow again once they adsorb onto the surface. This surface-assisted nanofiber growth 
appears to follow a nucleation and growth mechanism, which involves (i) adsorption of nanofiber 
“seeds” or fiber clusters formed in stock solution to serve as nuclei and (ii) fiber elongation from the 
active ends of these nuclei. Such surface-assisted nanofiber growth can be controlled by adjusting the 
solution pH to regulate both nucleation and growth steps. The amount of nanofiber “seeds” that 
adsorb on mica decreases as the solution pH increases. Once nuclei have formed, the growth rate of 
nanofibers in different solutions follows the order: pure water > 1 mM HCl > 1mM NaOH > 10 mM 
HCl ≈10 mM NaOH ≈ 0. The surface-assisted EAK16-II assembly has many similar characteristics to 
amyloid fibrillization on surfaces and thereby provides a model to help understand and control 
surface-assisted fibrillization of disease-related peptides/proteins. In addition, the controllable 
nanofiber growth may be beneficial to the design and fabrication of functional, supramolecular 
structures on surfaces. 
Surface-Assisted/Directed Peptide Assembly on HOPG. On a hydrophobic HOPG surface, 
EAK16-II was found to form well-ordered nanofiber patterns with preferential orientations at angles 
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of 60° or 120° to each other. This orientation resembles the crystallographic structure of the graphite 
surface. Nanofiber growth on HOPG is also surface-assisted and follows a nucleation and growth 
mechanism similar to that on mica. Interestingly, this surface-assisted peptide assembly can also be 
affected by adjusting the solution pH to regulate the adsorption of peptide molecules/nanofibers on 
HOPG, although the adsorption presumably occurs through hydrophobic interaction in contrast to 
electrostatic interaction on mica. It was found that the surface-assisted assembly occurs in pure water 
and basic solutions (1 and 10 mM NaOH), but not in an acidic environment (1 and 10 mM HCl), very 
different from that on mica. This phenomenon can be explained by the pH-dependent hydrophobicity 
of the peptides revealed by surface tension measurements. In acidic solutions, the peptide has a 
surface tension value very close to pure water (~72 mJ/m2), indicating that the peptide is more 
hydrophilic and less likely to adsorb on hydrophobic HOPG surface. However, the peptide has lower 
surface tensions in pure water and basic solutions (<65 mJ/m2), suggesting that it is more 
hydrophobic and likely to adsorb on HOPG. 
Mechanical Force-Induced Peptide Assembly and Fabrication of Patterned Peptide 
Nanostructures on Surfaces. An interesting finding in EAK16-II assembly is the mechanical force-
induced nanofiber growth by a tapping AFM tip on both mica and HOPG surfaces. The force applied 
by the AFM tip can be controlled by adjusting the scan area and the scan speed. This force-induced 
nanofiber growth occurs when the tip first cuts the adsorbed nanofibers into small segments that serve 
as seeds for new nanofiber growth. This finding allows one to locally grow nanofibers that densely 
cover desired regions of the surface. In addition, breakage of the peptide nanofibers using such a 
method combined with adjustment of the solution pH (in acidic solutions) provides a new AFM 
lithography method to fabricate patterned peptide nanostructures at desired locations on a surface. 
These patterned peptide nanofibers could serve as templates to immobilize proteins/enzymes, DNA 
and cells for biomolecular sensing and other biomedical applications.  
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Surface Modification of Hydrophilic and Hydrophobic Surfaces Using Peptide Assemblies. In 
order to apply ionic-complementary peptides for surface modification applications, the work was 
extended to study the wettability and stability of the peptide-modified mica and HOPG surfaces. After 
modification with EAK16-II, the water contact angle of a mica surface increases from <10° to 20.3 ± 
2.9°. However, the hydrophobicity of the HOPG surface is significantly reduced as the water contact 
angle decreases from 71.2 ± 11.1° to 39.4 ± 4.3°. The EAK16-II-modified mica surface is stable in 
acidic solution but not in alkaline solution, while the modified HOPG surface is stable in both acidic 
and alkaline solutions for at least 10 hours. This work shows the potential of using ionic-
complementary peptides to modify both hydrophobic and hydrophilic surfaces and function as 
possible new surface modifiers in addition to traditional thiol-gold technology.  
The controllable peptide assembly on the surface has an exciting potential application in 
constructing biocompatible electrodes for biosensors. Preliminary results showed that the EAK16-II 
modified HOPG electrode can successfully immobilize the model GOx enzyme to fabricate 
enzymatic biosensors. 
Ionic-Complementary Peptides for Metallic Nanowire Fabrication. Another potential application 
of EAK16-II assembly on surfaces is to fabricate one-dimensional metallic nanowires. This can be 
achieved by first giving metal ion binding capability to the peptide by adding a metal ion (Cu2+) 
binding motif GGH to the C-terminus. This newly designed peptide EAK16(II)GGH was shown to 
bind with Cu2+ through the histidine group while maintaining its ability to self-assemble into 
nanofibers. Further studies of the effect of various electrolytes on the peptide assembly showed that 
anion type (SO42-, Cl- and NO3-) significantly affects the peptide secondary structure, self-assembled 
nanostructure and surface activity over a range of peptide and salt concentrations. The length of 
peptide nanofibers, β-sheet content and surface activity increase according to anion type in the 
following order: SO42- > NO3- ≥ Cl-. This effect may be due to the fact that divalent SO42- can serve as 
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a bridge linking two peptide molecules, facilitating β-sheet formation and leading to formation of 
long fibers. The control of nanofiber length by adding copper salts with different anions may enable 
better control of the fabrication of metallic nanowires with desired dimensions. Furthermore, this 
successful peptide design could serve as a simple model to study metal ion binding proteins such as 
prions and β-amyloid proteins. 
7.2 Recommendations 
Recommended future studies regarding the fundamental understanding and the potential applications 
of peptide assembly on surfaces include the following: 
1.  Other types of surfaces in addition to negatively charged mica and hydrophobic HOPG 
should be studied to determine if the surface effect on peptide assembly investigated in this study is a 
general phenomenon and to develop other surface modification applications. Example surfaces 
include gold, silicon and GaAs in order to examine if ionic-complementary peptides can assemble and 
modify semiconducting and metallic surfaces. Different surface lattices may direct peptide assembly 
into various patterned nanostructures. In addition, the formation of biocompatible coatings on a 
semiconductor surface may aid in the development of novel implants and (bio)sensors. 
2.  Effects of salts (including salt types and ionic strength) and organic solvents on peptide 
assembly in solution and on surfaces are important topics to provide further understanding and 
control of peptide nanostructure formation. The solvent selection should consider the (i) peptide 
solubility in the solvent and (ii) affinity of the solvent to the surfaces.  
3. Determination of the detailed kinetics of ionic-complementary peptide assembly is still a 
large hurdle due to the complexity of self-assembling systems. A primary difficulty is to accurately 
measure the concentration of peptide monomers and assemblies in solution. This is further 
complicated by the fact that the peptide powders, in their as-purchased form, already contain some 
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peptide assemblies formed during synthesis. To overcome such a challenge, one should develop a 
strategy to separate peptide aggregates from the monomers to obtain the monomeric peptide 
concentration or study the assembly kinetics from pure peptide monomers. Filtration with a small 
pore size filter or ultracentrifugation may serve this purpose. Another approach combined with could 
be to modify the peptide sequence (e.g., replacing Ala to Trp) to give detectable signals (e.g., UV 
absorption or fluorescence) that can be used to measure the peptide concentration. The kinetic model 
could be adapted from knowledge of the well-studied amyloid fibril growth or supramolecular 
polymerization.251,252 
4.  In addition to the mechanical force-induced peptide assembly on surfaces investigated in 
this study, the effect of mechanical force on peptide assembly in solution is another interesting topic. 
One approach is to monitor the assembly kinetics under conditions of well-controlled mechanical 
stirring. This work has already been initiated in our group. Studies on the detailed characterization 
and comparison of the assemble nanostructures with/without mechanical stirring are underway. 
5.  Although not discussed in the main body of the thesis, the potential application of ionic-
complementary peptides in molecular (bio)sensing has been preliminarily studied, using EAK16-II as 
the model peptide to modify the graphite electrode for immobilizing GOx enzyme (see Appendix A). 
Questions concerning the detection limit, selectivity, interferences, long-term reliability and storage 
stability of the fabricated biosensor should be further addressed. Furthermore, optimization of 
biosensor fabrication process should be done to enhance the biosensor performance. This approach 
can be applied to develop other enzyme biosensors in situations where ionic-complementary peptides 
are advantageous to other surface modifiers. In addition, since the fabricated glucose biosensor 
functions similarly to an anode in a biofuel cell, ionic-complementary peptides may have application 
to this field as well. 
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6. The designed peptide EAK16(II)GGH has shown promise for metallic nanowire fabrication 
with its ability to bind with metal ions and form controllable one-dimensional nanostructures. The 
next step would be to reduce the bound metal ions to produce metallic nanowires either by chemical 
reduction or electrochemical reduction. This should be followed by characterization and further 








A Potential Application of the Ionic-Complementary Peptide in (Bio)Molecular 
Sensing 
Understanding and controlling surface-assisted peptide assembly is beneficial for the design and 
construction of many biocompatible devices, such as immunosensors253 and enzyme biosensors.254 
Such devices often require surface modification to immobilize biomolecules on various conducting 
matrices. The surface modifiers should contain reactive groups to immobilize biomolecules, enhance 
the stability and maintain the activity of the immobilized proteins/enzymes and promote electron 
transfer from the proteins/enzymes to the electrode (for amperometric sensors). Self-assembling 
peptides could be an ideal material for these purposes. We have utilized EAK16-II assembled 
nanostructures to modify an electronically conductive highly ordered pyrolytic graphite (HOPG) 
electrode. An amperometric enzyme biosensor was successfully fabricated using this EAK16-II 
modified electrode by immobilizing a model enzyme of glucose oxidase (GOx) to the carboxylate 
groups on EAK16-II. The immobilized GOx exhibits good catalytic activity upon the addition of 
glucose. Further detailed studies of peptide-modified electrodes as biosensors will be discussed in 
following sections. 
A.1 Preparation of Enzyme Electrode 
100 µl 0.5 mg/ml EAK16-II stock solution was injected onto the freshly cleaved HOPG electrode 
(1.44 cm2) and immobilized for overnight, in order to fabricate EAK16-II-modified electrode. This 
EAK16-II-modified electrode was washed three times with pure water to remove the unattached 
EAK16-II. The carboxylic groups of EAK16-II on the electrode were then activated by 200 ml 50 
mM phosphate buffer (pH 5.5) containing 2 mM EDC and 5 mM NHS for 1 h at room temperature. In 
this step, EDC converts the carboxyl group into a reactive intermediate, which is susceptible to attack 
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by amines, and amide bonds then form between the enzyme molecules and glutamic acids. After the 
activation, the electrodes were rinsed with phosphate buffer three times and immediately placed with 
200 ml 50 mM phosphate buffer (pH 5.5) containing 1 mg/ml GOx (EC 1.1.3.4 type X-S, from 
Aspergillus niger, purchased from Sigma) overnight at 4 °C. The enzyme electrode was then rinsed 
with phosphate buffer (pH 7.0) and used immediately. Figure A1 shows this activation reaction 
process. 
 
Figure A1. The covalent attachment of an enzyme GOx to the glutamic acid residue of EAK16-II 
using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and n-hydroxysuccinimide (NHS).255 
A.2 Electrochemical Measurements 
Cyclic voltammetry was carried out in a conventional three-electrode configuration, with GOx-
immobilized-EAK-modified HOPG electrode (GOx/EAK/HOPG, geometric area of 1.44 cm2) as the 
working electrode, a platinum wire as the auxiliary electrode, and Ag/AgCl (3M NaCl) as reference 
electrode. The electrolyte was 100 mM phosphate buffer containing 2 mM ferrocenecarboxylic acid 













































prepared at least 24 h prior to use for mutarotation to occur). The acitivity of immobilized GOx was 
tested by measuring the current response to glucose.  
A.3 Electrochemical Characterization of EAK16-II-Modified HOPG Electrode 
Figure A2 shows the cyclic voltammograms (CV) of 1.0 mM K3Fe(CN)6 on the bare HOPG and 
EAK/HOPG electrodes at a scan speed of 2 mV/s. The CVs of bare HOPG and EAK16-II-modified 
HOPG show the similar well-behaved response characteristic of the ferricyanide-ferrocyanide redox 
couple, indicating that the presence of EAK16-II nanofiber coatings does not block the electron 






















Figure A2. Cyclic voltammograms of 1.0 mM K3Fe(CN)6 on bare HOPG (dashed line) and EAK16-




A.4 Electrocatalytic oxidation of glucose 
Figure A3 shows the CVs of a GOx-immobilized EAK/HOPG electrode in 100 mM potassium 
phosphate buffer (pH 7.0) containing 0.2 mM ferrocenecarboxylic acid (FCA, mediator)256 in the 
absence and presence of 10 mM glucose. In the absence of glucose, the characteristic and well-
behaved redox response of FCA is observed (Figure A3, dotted line). In the presence of glucose, an 
electrocatalytic anodic current is observed (Figure A3, solid line), indicating that GOx molecules are 

















with 10 mM glucose
 
Figure A3. Cyclic voltammograms of a GOx-immobilized EAK/HOPG electrode in 100 mM 
potassium phosphate buffer (pH 7.0) containing 0.2 mM FCA before (dotted line) and after (solid 




B Effect of Copper and Sodium Salts on the Self-Assembled Nanostructures 
of EAK16-II  
EAK16-II solutions were prepared at concentrations of 0.02 mg/ml (12 µM) or 0.05 mg/ml (29 µM) 
with 1.0 mM various copper and sodium salts. All peptide solutions were stored at 4 °C for 4 hrs 
before use. 
The peptide EAK16-II does not contain the specific copper binding group GGH. In the 
presence of the different copper salts, there is no significant difference in the peptide nanostructures, 
as shown in Figure B1a-c. In the presence of sodium salts (NaCl and Na2SO4), EAK16-II formed 
similar fiber network structures (Figures B1d and e). Comparing with the copper salt effect on the 
peptide EAK16(II)GGH, this shows that the presence of a copper binding motif and copper ions are 
important for the anion effect on the peptide self-assembled nanostructures. 
 
 





(d) (e)  
Figure B1 AFM images of 0.02 mg/ml EAK16-II with 1.0 mM of the copper salts CuSO4 (a), CuCl2 
(b), Cu(NO3)2 (c) and 0.05 mg/ml EAK16-II in 1.0 mM Na2SO4 (d) and 1.0 mM NaCl (e) after 4 h 
incubation time. Scale bar represents 500 nm.  
C Proposed Self-Assembly Model of EAK16(II)GGH in Copper Salt Solutions  
From the experimental results, a preliminary self-assembly model of EAK16(II)GGH in copper salt 
solutions was proposed in Figure C1. The two adjacent peptide molecules could be linked by a 
divalent SO42- interacting with two lysine residues, which enhances the β-sheet formation through 
hydrogen bonding between two peptide backbones (Figure C1a and b). The red dotted lines indicate 
the hydrogen bonding between two adjacent peptide backbones. The β-sheets could be either parallel 
or anti-parallel. In these arrangements, the hydrophilic residues (E and K) are on one side of the β-
sheet while the hydrophobic residues (A) are on the other side. In this case, two β-sheets could stack 
together either through electrostatic interaction or hydrophobic interaction, although the latter would 
be more likely to occur in the aqueous environment, as shown in Figure C1c. In this model, it is 
speculated that the peptide strands lie perpendicular to the long axis of the fiber (fiber growth 
direction). In the presence of the various copper salts, divalent SO42- tends to induce long fiber 
formation while monovalent Cl- and NO3- promote short fiber formation (Figure C1d). It should be 
emphasized that the proposed model of peptide self-assembly is very preliminary and there is little 
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evidence to support this model at current stage. Future experiments, such as solid-state NMR and x-
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